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SUMMARY
An attempt has been made to rationalise the multi-faceted inhibitory 
actions of trialkyltins on mitochondria, including studies on their 
inhibition of ATP synthase and concomitant depolarisation of mito­
chondrial membrane potential in rat liver mitochondria. These functions 
have been shown to occur in the absence of halide/hydroxyl exchange. 
The majority of trialkyltin compounds studied here show a concentration 
dependent differential inhibition of the ATP hydrolase and ATP synthase 
functions of the mitochondrial ATPase complex. The relative trialkyltin 
concentrations at which these events take place, are in the order 
of ATPase >ATP synthase ^¿p reduction.
A comparison has been made between the n-alkyltins and internally 
penta-coordinated alkyl tins, revealing penta-coordinacy per se does 
not give rise to potent inhibitory action. However, the infernally 
nitrogen-tin coordinated species (2- (dimethylamino) methyl diethyltin 
halide, provides an excellent specific inhibitor of the mitochondrial 
ATPase complex.
The relative sensitivities to the mitochondrial ATPase directed drugs, 
oligomycin and ossamycin, of wild type and drug specific mutants of 
the yeast Saccharomyces cerevi siae has been assessed both iji vivo 
and j_n vitro. DNA sequencing studies of mutant and wild type mito­
chondrial DNAs have established the localisation of the mutant alleles 
01 iR2-76 and 0ss"l-92, and their respective predicted aminoacid residue 
changes: methionine to phenylalanine and aspartic acid to asparagine, 
in subunit 6 of the OS-ATPase complex. Wild type DNA sequence has 
also revealed the genes for subunit 8 of OS-ATPase and a putative 
maturase sequence, downstream of the 01 i 2 gene.
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CHAPTER 1
INTRODUCTION
1.1 General Introduction
Studies on the mechanisms of energy conservation in living cells has 
proved a major challenge to biochemists. The central ideas of cellular 
electron transport liberating energy, which is in turn utilised for 
the production of ATP as functional biological units of energy are 
now firmly established. These processes appear to remain fundamentally 
similar, whether they are associated with the inner mitochondrial 
membranes of eukaryotic cells, the thylakoid membranes of chloroplasts 
in plant life, or plasma membranes of prokaryotic cells.
The present thesis is concerned with the ATPase complex which has
the capacity to synthesise ATP using the energy derived from the oxida­
tion of reducing equivalents by the respiratory chain, or hydrolyse
ATP to release free inorganic phosphate and the equivalent energy 
from breaking of the phosphate anhydride bond. Before discussino
these functions further, the structure and function of the respiratory 
chain will be outlined briefly (see Chance et al, 1969a and l?oSb 
for in-depth reviews).
1.2 The Respiratory Chain
The components of the respiratory chain and their order are represented 
schematically in Figure 1.1. This information is a result of several 
lines of evidence, based on the measurements of redox potential of
various individual components (Chance et al, 195?a), kinetic determina­
tion of the reaction sequence (Chance _et 1959a and b), studies 
on the donor and acceptor specificity of isolated components (Chance et al, 
1969a) and the interaction of electron transfer inhibitors with the 
electron transport chain (Onishi, 1973).
The protein fractionation studies of Hatefi ^t a]_, 1962a, b and c, 
have shown that the respiratory chain can be split into four complexes
Figure l.i. The relationship among the major oxidative pathways 
of mitochondria and their ultimate connection to the terminal 
ATP generating proton pump (the ATP synthase or the OS-ATPase 
or the Ccunplex-V). I, II, III, IV, and V are various respiratory 
complexes found in the mitochondrial inner membrane (see Hatefi 
et al , 1962; Racker, 1979). I, NADH - UQ oxidoreductase; II,
Succinate dehydrogenase (succinate UQ reductase); III, UQH2 - 
Cytochrome c reductase (cytochrome bc^  complex; IV, Cytochrome 
c oxidase; V, ATP synthase or the OS-ATPase.
Carbohydrates
Fatty Acids
CYTOSOL I
GLYCOLYSIS
ADP ♦ Pi
1designated complex I, II, III, and IV catalysing the following partial 
reactions:-
I - NADH - ubiquinone reductase 
NADH + Q + H+ -> NAD+ + QH2 
II - Succinate ubiquinone reductase
Succinate + Q -> Fumarate + QH2 
III - Ubiquinol cytochrome C reductase
QH2 + 2 ferricyt. c -> Q + 2 ferrocyt. c 
IV - Cytochrome c oxidase
2 ferrocyt. c + 2H+ + J02 -> 2 ferricyt. c + H20
These complexes may also be reconstituted stoichiometrically to produce 
a reconstituted electron transfer chain which behaves similarly to 
that found in intact mitochondria with respect to respiratory inhibitors.
Redox potential measurements on both _in situ and isolated respiratory 
complexes have enabled the electron carriers to be positioned on a 
potential diagram (Chance, 1972 and 1977). The respiratory components 
have been associated with three levels of mid-potentials where the 
carriers are clustered, between these groups are gaps or spans where 
electron movements equate to large decreases in free energy, each 
sufficient to provide the necessary energy for the phosphorylation 
of ADP with inorganic phosphate. These changes in free energy have 
been designated as sites I, II and III, v '.ch represent the spa-i 
between NADH and co-enzyme Q; cyt.b and cyt.c; cyt.a and oxygen respect­
ively (shown diagramatically in Figure l.ii). The electron carriers 
with fixed mid-potentials (or isopotential pools) have been suggested 
to be linked by carriers of variable potential at sites I, II and 
III. These have been proposed to be Fe-S)N2, cyt.by and cyt.a3  respectiv­
ely, based on the findings that their mid-potentials were ATP and 
pH dependant (Chance, 1972 and 1977). The isopotential pools act 
as redox ballasts which allow rapid equilibrium of electron transfer 
reactions which are independent of energy coupling reactions. Therefore,
i
Succinate/Fumarate
Cyt.b +-*Cyt.c.
T t
Fe-S
t
Cyt.c+->Cyt.a Site III
Cu 2 +
*Cy t . a. 
(Cu)
> ■
EH (mV) 
-3 0 0
ATP
— I---
♦ 300
1 ---
+ 6 0 0
Figure 1 .ii
The electron carriers of the respiratory chain arranged as a group 
of fixed potential (or isopotential 'pools') and individual components 
of variable mid-potentials (Modified from Chance, 1972).
energy transduction via the respiratory chain occurs through a series 
of quasi-equilibrium steps. For example, cyt.by may reside as four 
species, oxidised high mid-potential, oxidised low mid-potential, 
reduced high mid-potential and reduced low mid-potential. As the low 
mid-potential form cyt.b may only react with group II carriers and 
in its high mid-potential form can only react with group III carriers 
The sites of energy conservation appear physically unrelated, therefore, 
consideration must be given as to how the fall in potential via the 
respiratory chain and subsequent release of energy is related to the 
synthesis of ATP via complex V or the ATP complex.
1.3 Oxidative Phosphorylation
Oxidative phosphorylation is the process whereby the energy released 
from the electron transport chain is made available to the ATP complex. 
This relationship has been described under three broad headings:
1. Chemical Intermediate Theory (Slater, 1953)
2. Chemiosmotic Hypothesis (Mitchell, 1961)
3. Conformational Theory (Boyer, 1965)
The central common factor to each of the above theories is the function 
of a high energy intermediate from the respiratory chain which may 
drive ATP synthesis, transhydrogenation, ion transport as well as 
ATP driven reversed electron transport via the ATPase complex. However,
the above theories differ fundamentally in the nature of the high 
energy intermediates involved.
1. The Chemical Intermediate Theory
The chemical theory as originally proposed by Slater, 1953 was based 
on a mechanism of substrate level phosphorylation (Warburg and Christian, 
1939). The basis of the theory is the formation of high energy chemical 
intermediates by the redox reaction of the electron transport chain, 
which may in turn, provide the energy to drive ATP synthesis or other
energy-linked reactions. Chance and Williams, 1956 have postulated
the following reaction series involved in energy transduction via 
chemical intermediates.
1. AH2 + B + I i A ^ I + BH2
2. A ' I t X 1 A t X i I
3. X ~ I + Pi * X P + I
4. X ' P + ADP * x + ATP
AH2  and B are two adjacent respiratory carriers and l'v' refers to a high 
energy bond responsible for energy transmission (possibly an anhydride 
or thioester bond). The natures of X and I are unknown. X M  is regarded 
as the common energy transducing intermediate and the possible target 
of uncoupling agents which, directly or indirectly, catalyse its hydro­
lysis (Slater, 1966). Evidence for the chemical hypothesis is largely 
based on the actions of various inhibitors, for example oligomycin 
which is thought to block reaction 3 in the above scheme, possibly 
sited at the ATPase complex (Lardy et al, 1958; Lardy and McMurray, 
1958 and Slater, 1966). Further evidence for the chemical hypothesis
is derived from the observations that partial reactions such as trans­
hydrogenation and reversed electron transfer can be driven either 
by respiration or ATP. However, the chemical hypothesis makes no
provision for the observations that the integrity of the mitochondrial 
membrane appears to be a prerequisite for ATP synthesis, and the fact 
that a wide range of uncouplers with very different chemical structures 
are quite active. The theory also suffers from the failure of various 
workers to identify the proposed ubiquitous intermediate molecules 
(Greville, 1969 and Harold, 1972).
2. The Chemiosmotic Hypothesis
The chemiosmotic hypothesis was proposed by Mitchell in 1961, suggesting 
the intermediate in energy transduction was a proton gradient across 
the membrane. The chemiosmotic hypothesis is based on the following
four main postulates and is further summarised in Figure l.iii
1. The ATP synthase is a chemiosmotic membrane located reversible 
proton translocating ATPase, having a characteristic H+/P
stoichi ometry.
2. The respiratory chain is a membrane located vectorial metabolic 
proton translocating system, having a characteristic H+/2e stoichio­
metry and having the same polarity of proton translocation across 
the membrane under forward redox activity as the ATPase during 
the hydrolysis of ATP.
3. There are proton (or hydroxyl) linked solute porter systems for 
osmotic stabilisation and metabolite transport.
4. Systems 1-3 are vectorially arranged through a topologically closed
insulating membrane, called the coupling membrane, which is imper­
meable to ions, particularly to H+ and OH".
For further review see Mitchell, 1979.
The central dogma of th chemiosmotic hypothesis is based upon the 
generation of a proton electro-chemical potential (mH+ ) by the electron 
transfer chains of mitochondria, chloroplasts or bacteria, which in 
turn drives the synthesis of ATP via the passage of protons to produce 
a protonic circuit. The driving force of ATP synthesis has been defined 
as the proton motive force ( Ap) which is the sum of the pH gradient 
(ApH) and the membrane potential (ah' ), which are facilitated by the 
proton pumps of the electron transfer chains of respiration or photo­
synthesis, in accordance with the following equation (Mitchell, 1961; 
1966; 1968; 1976; 1977a; 1977b; and 1979):
m_H+ = Ap = AT - 2.3 RT ApH 
>  F
As the protonic circuit is completed by the passage of protons through 
the ATPase complex there should be a distinct stoichiometric coupling
1
9  .
Figure 1.i i i
The Fundamental Postulates of the Chemiosmotic Theory
(Mitchell, 1966)
1between the oxidation/reducti'an of the electron transport chain and 
the phosphorylation. The P/0 (P/2e) quotient of the overall process 
is given by the H+ /2e quotient of the redox system divided by the 
H+/P quotient of the ATPase, i.e. P/2e = (H +/2e)/(H+ /P) . A short 
circuit of the proton pathway or effective leakiness of the proton 
impermeable membrane would collapse a p, uncoupling phosphorylation 
and allowing the uncontrolled acceleration of redox activity. Such 
a phenomenon is thought to occur on the addition of an uncoupler to 
the system. Uncouplers are thought to effect their action by allowing 
the free diffusion of protons across the lipid bilayer either as the 
lipid soluble protenated acid or the conjugate base of the compound 
(eg. 2, 4- dinitrophenol or DNP). The existence of uncouplers had 
been described before the chemiosmotic hypothesis had been formulated 
and the demonstration that a number of these compounds increased protonic 
conductance through synthetic bilayers was considered an important 
piece of evidence in favour of the theory (for reviews of the activities 
and functions of uncouplers and ionophores, see Hendersen, 1971 and 
Ovchinnikov, 1979).
The chemiosmotic hypothesis has gained wide ranging acceptance over 
the last 20 years, however, at its conception it stimulated much debate 
between its advocates and those of the chemical theory (see Boyer 
jet al_, 1977). The result of which has been a great deal of research 
aimed at validation, or otherwise, which has led to the accumulation 
of a lot of data. Such data which may be ascribed to evidence derived 
from studies on mitochondria, submitochondrial particles and reconstit­
uted vesicles is summarised below.
1. Vectorial, transmembrane movement of H + and other ions accompany
both respiration and ATP hydrolysis (De Pierre and Ernster, 1977;
Garland, 1977; Hauska and Trobt, 1977; Croft and Wood, 1978;
Rottenberg, 1975).
2. Most of the energy transducing systems can generate a proton 
gradient and/or a membrane potential across the membrane in which 
they are located (Rottenburg, 1975).
3. Energy transfer may take place within membrane components via a 
proton gradient and/or membrane potential (Rottenburg, 1975).
4. Uncouplers may increase proton flux in membranes (Henderson, 1971; 
Haydon and Hladky, 1972 and McLoughlin, 1972).
5. Artificially generated electrochemical gradients are kinetically 
competent in driving ATP synthesis (Jaggendorf and Uribe, 1966;
Thayer and Hinckle, 1975 and Rottenburg, 1979).
Further, Mitchell has suggested that the intermediate proton gradient 
is generated by the action of H + translocating 'redox loops', formed 
by alternating hydrogen carriers and electron carriers of the respiratory 
chain (see Figure l.iva) (Mitchell, 1966). However, such a mechanism 
has attracted serious criticism, Harman et_ al_, 1974 have pointed out 
that although complexes I and III contain both hydrogen (NAD, FMN, CoQ) 
and electron carriers (Fe-S, cyt.b and cyt.c), (unlike complex IV, 
which has only electron carriers), they do not form transmembrane 
loops. This evidence led Mitchell to propose the 'protonmotive 
ubiquinone cycle' (or 'Q cycle') for proton translocation (see Figure l.ib) 
(Mitchell, 1975 and 1976). However, the 'Q cycle' requires the free 
diffusion of Q and QH£ through the membrane, and a certain distribution 
of b cytochromes, which has been questioned (De Pierre and Ernster, 1977). 
The mechanisms by which the respiratory chain and the ATPase complex 
transport protons and the subsequent H +/site quotient have generated 
considerable debate. Our current understanding is that the translocation 
of protons proceeds indirectly via a 'proton pump' linked to the turnover 
of the enzyme, evidence derived from studies on membrane topology 
of the catalysts involved and the measurement of H +/2e- and H+ /ATP
U
1. :
Figure 1.iv
Hypotheses for Proton Translocation by Electron-Transfer Chains
(Adapted from Nicholls, 1982).
a. Alternating hydrogen and electron carriers of the respiratory 
chain (Mitchell, 1966).
b. The proton motive ubiquinone cycle (or ‘Q cycle') for 
translocation by electron carriers (Mitchell, 1975).
proton
ratios (for reviews see Ernster, 1977; Reynafarje et^  £l_, 1979 and 
Wikstrom and Krab, 1980). A basic requirement for a model redox proton 
pump is that it should be compatible with the observed H + ejection 
stoichiometries, the loop hypothesis requires a H+ /site ratio of 2. 
Results supporting these predictions have been reported by Mitchell 
and Moyle (Mitchell and Moyle, 1965; 1967; 1968 and Moyle and Mitchell, 
1973), who have shown that electron transport from NADH to oxygen 
results in a translocation of 6H+. However, other researchers have 
observed significantly higher H +/site ratios, often exceeding 3, for 
both the electron transport and ATPase systems (see reviews: Brand, 1977; 
Reynafarje jit_ £l_, 1979 and Wikstrom and Krab, 1980). These results
are not consistent with 'redox loops' but may be accommodated into 
a model of a more general redox proton pump (see Papa, 1976 and Ernster, 
1975).
As the chemiosmotic hypothesis emerged in 1961, a second theory of 
energy coupling was also proposed by Williams, which envisaged the 
proton and charge separations of chemiosmosis but remained fundamentally 
distinct by virtue that the protons remain associated with the membrane 
and do not interact with the bulk aqueous phase (see reviews by Williams, 
1976 and 1978a). The authors have been unable to agree on this difference, 
the debate on delocalised versus localised proton pathways is presently 
rife (see Mitchell, 1977, 1985 and Williams, 1978b, 1985).
In Williams' original hypothesis the energy of the redox reactions 
could be transferred to the ATPase complex as an anhydrous (or partially 
hydrated) proton which moves in the membrane through a channel of 
fixed water molecules, which is connected to the ATPase. Thus, during 
of ATP from ADP and Pi, the H + moves so as to pull H molecules from 
the polyphosphate condensation site into the diffusion channel. The 
above hypothesis has certain distinct advantages over that of the
1chemiosmotic counterpart, namely a more efficient utilisation of energy, 
better central circuits, and the possibility of discriminative coupling 
to various energy-linked processes. However, authors have described 
how delocalised protons and imposed diffusion potentials may drive 
ATP synthesis (Paden and Rottenberg, 1973; Azzone et a_K 1978 and 
Thayer and Hinckle, 1978), and as Mitchell has pointed out, the hypoth­
esis is limiting in the respect that it is difficult to experimentally 
falsify. More recently, Kell (1979) has proposed his 'electrodic 
hypothesis' where a protonic circuit is set up between aqueous/membrane 
phases on either side of the bilayer completed by a proton translocating 
ATPase. This scheme envisages only limited interaction between the 
translocated protons and the bulk aqueous phase.
The evidence for and against a truly delocalised chemiosmotic mechanism 
or a localised proton pathway in energy coupling has recently been 
reviewed at length by Ferguson, 1985.
3. Conformational Theory
The conformational theory as originally proposed by Boyer, (1965),
proposed that the energy generated by electron transport was conserved
as a 'high energy' conformational state of the respiratory carrier.
This energy was in turn utilised to drive ATP synthesis.
AH + B t A* ♦ BH2
A* + ADP + Pi X A + ATP + H20
Support for the theory was based on the observation that mitochondrial 
structure was energy dependent (Green, 1970; and Hackenbrock, 1966) 
and electron flow in bacteria, chloroplasts and mitochondria is accom­
panied by changes in the conformation of their F, ATPase (Boyer, 1977; 
Ryrie and Jagendorf, 1972; McCarty and Ferguson, 1973; and Bertina.et.al, 
1973). However, little evidence has arisen to support a direct inter­
action between the redox centres and the ATP complex.
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1Later, a variation on this hypothesis was proposed, that ATP synthesis 
occurred at the active site of the ATPase prior to the input energy, 
which necessitated the release of the newly formed ATP molecule from 
the ATP synthase via an energy dependent conformational change (Boyer, 
1977; and Harris and Slater, 1975). This hypothesis was based on 
the findings that the exchangeability of adenine nucleotides bound 
to F, was dependent on the flow of electrons (Harris and Slater, 1975) 
and on the insensitivity of the phosphate anhydride formation to uncouplers 
of oxidative phosphorylation (Boyer et 1975). However, the mechanisms 
of the exchange reactions cannot easily be reconciled with Mitchell's 
proposals that protons are directly involved in the anhydride bond 
formation (Mitchell, 1977).
More recently, evidence fcr a conformational change during ATP binding 
has come from studies with isolated F i ATPase modified with inhibitors 
such as 7-chloro-4-nitrobenzo-2-oxa-l,3-diazole (NBD-C1), dicyclohexyl 
carbodimide (DCCD) and dialdehyde ATP derivatives (Kohlbrenner and 
Boyer, 1982; Rojendra et _al^ 1983 and Kumer et^  al_, 1979) modified 
Fi ATPase has been shown to be functionally catalytic in ATP synthesis 
but only experiencing slow reactivation of hydrolase activity when 
reconstituted on submitochondrial particles stripped of F, ATPase 
(Soong and Wang, 1984; and Matsuno-Yagi and Hatefi, 1984). Experiments 
such as these, and studies on the binding of tritiated nucleotides 
to modified enzymes has also led to arguments about the nature of 
the 6-subunit of F, ATPase, whether they act independently or cooperatively 
(Grubmeyer et £l^ , 1982; Wang, 1985; and Rajendra et al_, 1985).
1.4 The Mitochondrial ATPase Complex
The mitochondrial ATPase complex has been resolved into three basic 
segments, based on either their enzymatic function, sensitivity to 
various inhibitors or the physical properties of the constituitive 
polypeptide(s) (shown schematically in Figure l.v).
Iti
Outside Membrane Inside
F ig u re  i.V The possible structure of the O .S.ATPase or A TP synthase. The scheme is 
hypothetical, a , p, 7 , 6 , and t  are various subunit components of the F ,  segment. 6 , 8 , 9 
are three recognised subunits of the F 0 sector. The Oligomycin-sensitivity conferring pro­
tein (OSCP), the uncoupler binding protein (U BF), Factor-6 (F #), Factor-B (F ,)  have been 
tentatively placed in the diagram. I is the ATPase inhibitor protein which probably 
remains attached to the p subunit.
1. Factor 1 (F ,):- an oligomycin insensitive cold labile and water
soluble ATPase; sensitive to aurovertin and NBD (Cl)
2. Factor 0 (Fo):- The water insoluble membrane sector of the enzyme
which remains buried in the lipid bilayer and may 
provide an ion channel for the re-entry of protons 
as envisaged by the chemiosmotic hypothesis, prob­
ably the binding sites for DCCD, oligomycin, 
venturicidin and trialkyltins which effect the activ­
ities of the halo-enzyme or oligomycin sensitive 
ATPase (OS-ATPase).
3. O.S.C.P. (Oligomycin-sensitivity conferring protein)
a water soluble protein that serves to provide the 
link between the F, and Fo segments.
Additionally, a small peptide inhibitor of ATP hydrolytic activity 
has been characterised (Pullman and Monroy, 1963; Ebner, 1974). Proper­
ties of the various coupling factors associated with the ATPase complex 
are summarised in Table 1.1.
a) F, ATPase
F, ATPase consists of five subunits: a, B, y, i, and c (see Table l.ii) 
with the general stoichiometry o^BgySe (see Crass, 1981). The complex 
may be isolated by mechanical disruption, or by chloroform extraction. 
Isolated F, has only ATP hydrolase activity and remains oligomycin 
insensitive. The B subunit has been proposed to contain the catalytic 
site, based on reconstitution and inhibitor binding experiments (Yoshida, 
et a_K 1977; Ferguson, et al_, 1974 and 1975; Ho and Wang, 1983; Soong 
and Wang, 1985). Biogenesis experiments have confirmed that all five 
of these subunits are synthesised on cytoribosomes and imported into 
the mitochondria (Tzagoloff, et al_, 1973; Tzagoloff and Meagher, 1971).
b) O.S.C.P.
The oligomycin sensitivity conferring protein is a small basic protein 
of approximately 20 K Daltons, belonging to the mitochondrial ATPase 
complex (Tzagoloff, et al, 1968; MacLennon and Tzagoloff, 1968; Senior,
1T a b ic  1.1 P ro p e rtie s  o f  C oupling  F a c to rs  o f O xidative P h osp h o ry lation
Factor Alternate name Mol.wt Intrinsic activity Functions in v i t ro
360,000 ATPase Hydrolysis of ATP, 
Stimulation of: 
P/0, ATP - P f 
exchange, N A D  
reduction, Transhy­
drogenation.
200,000 None Proton translocation
r . F t  8,000 None Stimulation of: 
P/0, ATP - P, 
exchange, N A D  
reduction, Transhy­
drogenation.
O SCP 18,000 None Stimulation of: 
P/O, ATP - P f 
exchange, N A D  
reduction, Transhy­
drogenation.
F actor B F t  12,000 None Stimulation of: 
P/0, ATP - P, 
exchange, N A D ,  
reduction, Transhy­
drogenation. Stimu­
lation of ATP-P, 
exchange in 
O.S.ATPase
v'
J
l:i
Legend Table 1.11
a. Tzagoloff et al, 1973.
b. Serrano et al, 1976.
c. De Jong et al, 1979.
d. Devlin, 1982.
e. Koch, 1976.
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21971; Senior, 1979; and Glaser et 1980). The mediated interaction
between the F, and Fo segments of the ATPase complex has been probed 
by the ability of oligomycin, a ligand of the Fo fraction, to inhibit 
ATPase activity of F , (Van De Stadt et 1972; and Vadineanu
et al, 1976).
c) Fo Section
The Fo components of the OS-ATPase complex is the least understood 
part of the enzyme complex. Even the number of protein subunits is 
still under debate, let alone the stoichiometries of the components, 
all this controversy about an apparently abundant protein constituting 
27c of the organelle mass (Pederson et al_, 1978). Early biogenesis 
studies with yeast using radio-labelled aminoacids in the presence 
of cycloheximide, so as to prevent cytoribosome protein synthesis, 
allowed four mitochondrially synthesised polypeptides to be immuno- 
precipitated with the holoenzyme using antisera raised against F, 
(Tzagoloff and Meagher, 1972). These were identified as OS-ATPase 
subunits of approximate molecular masses 29, 22, 12 and 7.5 K Daltons 
(see Table 1.11). Of these original proposed mitochondrially encoded 
Fo components, the 22, 12 and 7.5 K Dalton proteins have been confirmed 
and further identified at the mtDNA level as bona fide mitochondrial 
genes (Hensgens et aj^ , 1979; Macino and Tzagoloff, 1979 and 1980; 
Novitski et al_, 1984; and Ray, 1985, see also Chapter 7 of this thesis), 
namely, subunits 6, 8 and 9 (or the DCCD binding protein) respectively. 
Subunits 8 and 9 have also been corroborated by full length aminoacid 
sequences (Sebald et al, 1979; and Velours et aj_, 1984). The ubiquity 
of the Fo components has also been established as homologous predicted 
aminoacid sequences have been identified in other fungi, higher plants, 
insects and mammals (for review see Ray, 1985). The 29 K Dalton protein 
equivalent in beef heart has been proposed to be necessary for oligomycin
sensitive ATP- Pi exchange and possesses sensitive titratable SH
groups (Zimmer et al, 1979 and 1982; and Baumert et al, 1981), however
32whether the 29 K Dalton protein(s) is essential for high ATP- Pi 
exchange and/or the structural integrity of the OS-ATPase complex 
has been questioned (Joshi and Tarok, 1984).
Two other recognised coupling factors exist which may be membrane- 
bound: Fg (Kanner et al_, 1976), and Factor B (see review by Sonadi,
1982). F^  has been purified and shown to be involved in the binding 
od F] to Fo as well as in the restoration of oxidative phosphorylation 
and ATP dependent reactions in depleted particles (Kanner et al^ , 1976). 
Recently, the primary aminoacid sequence of Fg has been reported (Fang 
et^  al^ , 1984). Fg is probably a membrane protein with charged residues 
clustered in the aqueous phase separated by hydrophobic segments of
9.006 K Daltons molecular weight. Factor B has also been purified 
(Apparent molecular mass 15 (Sonadi, 1982) or 11 K Daltons (You and 
Hatefi, 1976), which contains essential vicinal dithiols (Stigall
et al_, 1979; and Joshi and Hughes, 1981) which may prevent its function 
in oxidative phosphorylation if treated with sulphydryl reagents; 
as a consequence of this, Factor B will bind the ligand Cd (Kaplay 
et al^ , 1984; Sonadi et a_U 1984; Lakshmikantham et^  a U  1984; and Yagi 
and Hatefi, 1984). It has been suggested that the protein may exert 
its effect by decreasing the permeability of the membrane to protonic 
movements.
1.5 Genetics of Oxidative Phosphorylation
The genetics of oxidative phosphorylation has been focused on two 
organisms which may sustain the serious physiological disadvantage of 
being unable to grow on non-fermentable media, Escherichia coli 
representing prokaryotes, and the yeast Saccharomyces cerevisiae for 
eukaryotes. The E. coli enzyme is a simpler unit, consisting of the
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five F, subunits (analogous to its mitochondrial counterparts discussed 
in the previous section, however the s subunit has shown some homology 
with the eukaryotic OSCP) and three Fo subunits, namely a, b and c. 
Mutants of these genes have isolated and complemented, all the genes 
appear linked and subsequent DNA sequence analysis has revealed an 
atp operon consisting of all eight genes and an extra reading frame, 
I, of unknown function (see reviews by Hoppe and Sebald, 1984 for 
protein studies, and Walker et 1984, for DNA sequence analysis). 
Mutants affecting oxidative phosphorylation in S. cerevisiae fall 
into two phenotypes, drug resistant mutants of ATPase inhibitors and 
uncouplers (see Table l.iii from Griffiths, 1976) and those strains 
which are unable to grow on oxidative media (see Tzagoloff, 1982). 
Both sets of mutants may be nuclear or mitochondrially inherited, 
the latter group being discriminated genotypically as mit~ , a small 
lesion in a specific mitochondrial gene, and pet~ , a nuclear mutant 
allele unable to grow on oxidative media. However, it must be noted 
that these phenotypes are also common to those affecting other primary 
mitochondrial functions and were primarily distinguished by enzymatic 
analyses of mutant mitochondrial functions (Tzagoloff et al_, 1975a 
and b).
Mitochondrially inherited oligomycin resistant mutants were first 
reported by this laboratory some fifteen years ago (Avner and Griffiths, 
1970). Oligomycin resistant mutants may be considered in two main 
classes; thosewhich are truly mitochonrially determined (Class II) 
and those which display a wide range of cross resistances and are 
probably nuclear controlled, although undergoing apparent mitotic 
segregation (Class I), (Avner and Griffiths, 1973a and Lancashire 
and Griffiths, 1975a). Mitochondrial oligomycin resistant mutants 
were originally located at two unlinked loci by allelism tests (Avner
T a b le  l.iii Mitochondrial drugs used in the genetic studies of oxidative phosphorylation 
and their possible location of action (after Griffiths, 1976)
Drug Biochemical locus of action
Resistant mutants 
isolated and locus
Antimycin A Electron transport Yes; nuclear
CCCP Uncoupling agent Yes; cytoplasmic
T T F B Uncoupling agent Yes; cytoplasmic
1799 Uncoupling agent Yes; cytoplasmic
Oligomycin O .S. ATPase Yes; nuclear Sc cytoplasmic
Ossamycin O .S.ATPase Yes; cytoplasmic
Venturicidin O .S.ATPase Yes; nuclear, mitochondrial Sc cytoplasmic
Trialky Itin O .S .ATPase Yes; nuclear Sc cytoplasmic
Aurovertin F , ATPase Yes; nuclear
Dio 9 F , ATPase Yes, nuclear
Rhodamine 6G ADP translocase(?) Yes; cytoplasmic
Bongkrekic acid ADP translocase Yes; nuclear Sc cytoplasmic
Valinomvcin K  transport Yes; mitochondrial
CCCP, Carbonylcyanide m-chlorophenylhydrazone; T T F B , 4, 5, 6, 7-tetrachloro-2- 
trifluoromethy (benzimidazole; 1799, a , a  - bis (hexafluoroacetony!) acetone
and Griffiths, 1973b) and multifactorial crosses (Avner et a U  1973). 
namely, 01 i 1 and 01 i 2 . Further genetic analysis and the use of 
mitochondrially inherited venturicidin resistant mutants (Ven J_) allowed 
the characterisation of a third genetic locus associated with oligomycin 
resistance, 01 i 3 (Griffiths et^  al_, 1975; and Lancashire and Griffiths, 
1975b). The Oli 3 locus is closely linked to Oli 1 (typically 1% 
recombination) and Ven 1 suggesting they may lie on the same gene. 
A naturally resistant laboratory strain revealed a fourth locus, Oli 4, 
which was closely linked to Oli 2 (Clavilier, 1976). Isolation and 
characterisation of ossamycin resistant mutants (Oss 1 and Oss 2) 
has brought to light a fifth and final, up to press, locus for oligomycin 
resistance, Oli 5 (Lancashire and Mattoon, 1979). Oli 5 mutants are 
a rare class of oligomycin resistant mutants which are closely linked
p
to Oli 1, Oli 3 and Ven 1. In addition to the ant mitochondrial
mutants described above, there are two basic types of mit~ mutants, 
pho 1 and pho 2. Both pho 1 and pho 2 are deficient in OS-ATPase 
activity and are closely linked to the antibiotic resistance loci, 
Oli 1, Oli 3, Oli 5, Oss 2 and Ven 1 for pho 2 and Oli 2, Oli 4 and 
Oss 1 for pho 1 (Foury and Tzagoloff, 1976 and Coruzzi et_ al^ , 1978). 
All the above mutants appear to be clustered in two segments of the 
genome, suggesting two sites of synthesis for the components of the 
OS-ATPase.
More recently, DNA sequencing strategies have been employed to examine 
the Oli 1 and Oli 2 regions. The Oli 1 region revealed a reading 
frame of some 231 nucleotides (Hensgens et 1979; Macino and Tzagoloff 
1979; and Guat Ooi et al, 1985), specifying a protein which has an 
almost colinear aminoacid sequence with that of isolated subunit 9 
(Sebald et al_, 1979) and its DCCD binding counterpart (Sebald and 
Wachter, 1978). The Oli 2 region reveals a reading frame specifying
a protein of 259 ami noacids and 28.25 K Daltons molecular weight (Macino 
and Tzagoloff, 1980; Novitski £t al^ , 1984; and Ray et^  a U  1984 (see 
also Chapter 7 of this thesis). The mature protein appears to be
a 20 K Dalton product equating to subunit 6, which appears as a highly 
cycloheximide resistant band on gels of the immunoprecipitated complex 
(Somlo et al, 1982 and 1985). In addition to the antibiotic resistant 
defined loci is a third mitochondrially encoded product: subunit 8. 
This gene has been defined by a series of mit~ mutants and their 
revertants in a reading frame of 48 aminoacids upstream of the Oli 2 
locus, which have been correlated with the aberrant mobility of an
apparent 10 K Dalton protein on SDS-polyacrylamide gels (Macreadie 
et al, 1983). Further, this protein has been corroborated by the 
existence of a col inear ami noacid sequence obtained from a mito­
chondrially translated product, purified by reverse phase high pressure 
liquid chromotography (Esparza et al^ , 1981; and Velours et al^ , 1984).
The a and 6 genes of F, ATPase have been cloned recently, in both
S. cerevi siae and the fission yeast Schizosaccharomyces pombe, by
complementation of pet' mutants with a transformed DNA library in
a yeast shuttle vector capable of replication in yeast and £. coli 
(Saltzgaber-Muller et al^ , 1983; Takeda et al_, 1985; and Boutry et 
al, 1983).
CHAPTER 2
2. Dimethyl aminostyryl - 1 - Alkylpyridinium dyes as Fluorescent
Monitors of Mitochondrial Membrane Potential.
2.1. Introduction
Membrane potential ( av ) is a parameter in the joint determination 
with the pH gradient ( ApH) of the electrochemical potential difference 
( A|jH+ ) or proton motive force (¿p) which drives energy conversion 
in biological systems (Mitchell, 1968). 
mH+/F = ap = av -2.3 RT/F apH
Membrane potential has been defined as "The potential difference that 
would be measured between two identical electrodes positioned on opposite 
sides of a membrane", (Rottenberg, 1979). This idealised view must 
be considered within the context of the complex microstructure of 
systems. Thus, central to the chemiosmotic hypothesis is the generation 
of a transmembrane electrical potential and pH gradient by non- 
permeant ions. Techniques for measuring these parameters have been 
developed over the last decade, based on swift permeant radioactive 
ion separations, electrodic measurements of bulk phase changes and 
spectroscopic changes. (Details of these experiments have been reviewed 
by Rottenberg, 1979). The spectroscopic changes applied to the measure­
ment of membrane potential fall into two categories, the intrinsic 
probes which are endogenous electronic components found embedded in 
the membranes of chloroplasts and photosynthetic bacteria, that react 
when placed in an electric field (Witt, 1977), and the extrinsic probes 
which are foreign permeant lipophilic dyes which produce spectroscopic 
changes under the influence of electrical potential (Waggoner, 1979). 
Spectroscopic probes of the mitochondrial membrane potential fall 
into the latter category. The nature and uses of these probes have
been reviewed extensively (Azzi, 1975; Cohen and Saltzberg, 1978; 
Waggoner, 1979; Rottenberg, 1979; Bashford and Smith, 1979). In short,
although optical probes offer the advantage of fast time dependent 
assays, they suffer from difficult calibration and do not always approx­
imate to the Nernst equation (Burckhardt, 1977; Zorratti and Azzone, 
1980; Conover and Schneider, 1981; and Robertson and Rottenberg, 1983). 
The styryl dye 2-(dimethyl aminostyryl)-l-methyl pyridinium cation 
(DSMP+) has been shown to be, in contrast, a faithful and quantitat­
ive reporter over the working range of mitochondrial membrane potential, 
ûÿ (Bereiter-Hahn, 1976; Rafael, 1980; and Mewes and Rafael, 1981). 
The basis of the method fluorescence enhancement as DSMP+ enters the 
more lipophilic environment of the mitochondrial matrix.
DSMP+ also has the advantage of being relatively unreactive, and no 
direct interaction has been observed with inhibitors or membrane prepara­
tions. This is not the case with ANS which undergoes a strong batho- 
chromic reaction with trialkyltins (cf. Appendix 1 of this thesis), 
and will produce variant fluorescence readings dependent on relatively 
low concentrations of free inorganic phosphate, an unwelcome effect 
when dual enzymatic and fluormetric assays are to be performed on 
similarly phosphorylating mitochondria. However, at relatively high 
dye concentrations (4 nmoles DSMP+ /mg mitochondrial protein) uncoupling 
effects on oxidative phosphorylation have been reported (Rafael, 1980). 
The aim of this chapter is to estimate changes in mitochondrial 
aÿ by DSMP+ fluorescence, and to calibrate these changes by standard 
radioactive distribution assays. The application of this method to 
studies of the mode of action of various inhibitors of mitochondria 
is described, and extensive use of this technique is made in Chapters 
3, 4 and 5 in studies of the effects of triorganotins and triorganoleads 
on energy conservation.
2.2. Materials and Methods
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Materials
Sucrose was purchased from May and Baker (Pro-Anal grade). Triphenyl - 
methylphosphonium bromide (TPMP+ ) and 2-((2-(4-dimethylamino)-phenyl] 
ethyl) -1-ethyl quinolinium iodide (Quinaldine Red) were purchased 
from Aldridge Chemical Co. Carbonyl cyanide p-trifluoromethoxphenyl- 
hydrozone (FCCP) was purchased from Calibiochem. Trizma base, dinitro- 
phenol (DNP), oligomycin, valinomycin, Rotenone, Antimycin A and carbonyl 
cyanide m-chlorophenylhydrazone (CCCP) were purchased from Sigma Chemical 
Co. UK. 2-(dimethylaminostyryl)-1-methylpyridiniurn bromide (DSMP+ ) 
was obtained from Gallard-Schlessinger Inc. 2-(dimethylaminostyryl)-
1-ethylpyridinium iodide (DSEP+ ) was purchased from ICN Pharmaceutical 
Inc. Rubidium-sulphate was produced from the carbonate purchased 
from Fisons UK. Ossamycin was a gift from Bristol Myers Corporation 
and Venturicidin was a gift from Glaxo UK. Radiochemicals ®^RbCl, 
[3h ]- TPMP Br, [^C]-Sucrose, [^4C] -mannitol [^4C] -lactate and 
were purchased from Amersham. [^H]-DSMP I was a kind gift from Professor 
J. Rafael, Heidelberg. All other reagents were of 'Anal R' grade 
purchased from BDH.
Methods
Preparation of Rat Liver Mitochondria
Rat liver mitochondria were prepared from the livers of adult male 
Wistrar rats (200-300g) starved for 24 hours prior to sacrifice. 
Liver mitochondria were isolated by differential centrifugation, as 
as essentially described by Selwyn et al_, 1970. Excised rat livers 
were finely chopped at 4°C and washed with ice cold 250mM Sucrose, 
lOmM Tris/HCl pH 7.5, ImM EDTA before homogenisation with 2-3 passes 
in a glass homogeniser with teflon pestle. The homogenate was decanted 
into ice cooled 30ml polycarbonate tubes and centrifuged at 2k r.p.m.
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in a Sorvall RC-2B centrifuge using the SS-34 rotor (800 x g) for.10 
minutes at 4°C. The supernatant was then decanted into fresh 30ml 
polycarbonate tubes and recentrifuged as above. The supernatant was 
similarly treated before centrifuging again at 12K r.p.m. (10K x g) 
for 15 minutes at 4°C. The resulting supernatant was discarded and 
the mitochondrial pellet was resuspended and washed in 250mM Sucrose, 
lOmM Tris/HCl pH 7.5, before recentrifuging at 12K r.p.m. The mitochon­
dria were finally suspended in 250mM Sucrose, lOmM HEPES pH 7.5, at 
50mg/ml protein concentration and kept at 0° C prior to use within 
5 hours.
When mannitol determinations of internal space were performed, 250mM 
sucrose was replaced by 200mM mannitol; all other conditions remained 
similar.
Protein Determination
Mitochondrial protein was estimated by the biuret method of Gornall 
et al, 1949. Particulate protein was solubilised with 5» deoxycholate 
prior to determination.
Determination of Mitochondrial Volumes
Internal organelle space was determined by the subtraction of
[^C] -sugar permeable space from total space ascertained by 3H2 0.
The method described by Chappell and Crompton, (1979), was employed.
Mitochondria at lmg/ml protein were incubated at 30° C with shaking
in open 4ml plastic pots containing 250mM Sucrose/ 220mM mannitol
[14C] - , 0.2pCi/ml, lOmM HEPES pH 7.5, 5mM succinate, 2mM MgSO^ and
8>iM rotenone with HgO (lyCi/ml). At 1 and 2 minutes 1ml aliquots
were removed and centrifuged rapidly for 2 minutes in an Eppendorf
microcentrifuge. A 0.1ml sample of the supernatant was taken, acidified
with 10% HCIO^ and mixed with scintillant. The pellet was resuspended
in 0.25ml of 10% HC10 , repelleted and a 0.1ml sample was again mixed 
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with scintillant. The samples were counted repeatedly overnight at 
5 minute intervals and the mean counts per minute determined for each 
channel during dual counting in a Packard Tricarb liquid scintillation 
counter. Internal space was given by the water permeant space minus 
the sugar permeant space, as below:-
Internal Space = VS 3Hp __ ^4Cp
3Hs 14Cs
Vs - volume of supernatant sample 
3Hp - 3^  counts in pellet
3Hs - 3H counts in supernatant
l4Cp - 14C counts in pellet
14Cs - 14C counts in supernatant
(Also see Nicholls, 1974; Rottenberg, 1979; Halestrap and Quinlan, 1983). 
These values are expressed in pl/mg protein directly.
Radioactive Ion Distributions in the Determinations of Mitochondrial 
Membrane Potential
Methods essentially as described by Chappell and Crompton, 1979 were 
empl oyed.
Mitochondria at 1 mg/ml were incubated at 30“C with shaking, as described
above, except the radioactive isotopes were replaced by 2 uM [3H] -
TPMP+ (1 Pci/ml) or 50 PM 9<>Rb2S04 (0.2 pCi/ml) plus 0.1 PM Valinomycin
(®^Rb samples were counted in the high energy ^-channel of the liquid
scintillation counter). Membrane potential was calculated directly
from the Nernst equation taking the counts/space equivalents when
one isotope was employed.
av = RT In [X]i n 
F [X lout
When dual label experiments were performed the spillovers of each isotope 
were calculated, and the counts used in the following manipulations 
corrected (cf. Rottenberg, 1979). Corrections were determined by 
counting single and mixed standards in the dual channel mode, as follows.
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Correction factor* Counts in ^C-channel due to 8^Rb 
total counts in 14c channel alone
Scintillation Cocktail
The scintillant employed provided universal counting facilities for 
dual channel counting, / ^ C  or ^C/ 32p, 7 g 0f butyl-PBD and 80g 
of naphthalene were dissolved in 600ml of toluene and 400ml of methoxy- 
ethanol.
Fluorometric Monitoring of Membrane Potential
Routinely lmg/ml of mitochondria were incubated at 2 nmoles dye/mg 
protein in 250mM Sucrose, lOmM HEPES pH 7.5, 5mM succinate and 8 M M 
rotenone in 3ml four sided plastic cuvettes. Time dependent fluorescent 
readings were measured (Excitation 479nm-Emission 589nm) using a Perkin 
Elmer MPF 44 spectrofluorimeter and Hitachi recorder at 25*C. During 
calibration energised mitochondria were rapidly removed from the cuvette 
and the mitochondria separated by centrifugation, as described above, 
before counting the (JHl -DSMP bound. All other experimental details 
are to be found in the legends of the figures.
Inhibitor Solutions
All inhibitors were serially diluted from stock ethanolic solutions, 
ethanol never to exceed 1% of the assay medium.
2.3. Results and Discussion
Mitochondrial Membrane Potential Dependent Fluorescence Responses 
with DSMP*
Figure 2.i presents a series of time dependent fluorescence traces 
of mitochondrial suspensions in the presence of the fluorescent dye 
DSMP+. Changes in the emission of a single line, 589 nm (Excitation 
479 nm), are maintained as the mitochondria undergo succinate driven 
respiration in the presence of rotenone to render complex I non­
functional. The energisation of the mitochondrial membrane and develop­
ment of a transmembrane potential is paralleled by the simultaneous
DSMP+ Dependent Fluorescence Changes with Rat Liver Mitochondria
Legend
Mitochondria were suspended at Img/ml protein in 250nW Sucrose, 
lOmM HEPES pH 7.5, 8 mM Rotenone in 4ml four sided plastic cuvettes 
and placed in the fluorimeter +(Ex 479 - Em 589nm, slits 5mn) before 
additions of 15m 1 0.2mM DSMP and either succinate to make 5mM or 
ATP to make 2.5mM. Inhibitor additions were made in ethanolic 
solutions as directed.
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uptake of the lipophilic dye along the electrical gradient into a 
more apolar environment which results in a higher fluorescence intensity. 
Thus, the increase in fluorescence on addition of succinate monitors 
the establishment of a transmembrane potential via respiration, which 
may be circumvented by pre-incubation with antimycin A, thereby inhibit­
ing complex III. The signal is uncoupler sensitive and the addition
of CCCP or DNP result in sharp falls on the trace (see Figure 2.ia). 
In contrast, oligomycin produces a small increase in fluorescence 
(5-10%). Similar effects are achieved with the addition of potassium 
ions to mitochondria pre-incubated with valinomycin (see Figure 2.ib). 
Conversely, a transmembrane potential may be facilitated by the hydroly­
sis of ATP via the ATPase complex (V), which produces an increased 
signal, sensitive to uncouplers and inhibitors of the ATPase complex 
(see Figure 2.ic). The traces presented in Figure 2.i are consistent 
with the inhibitors' modes of action and the function of DSMP+ fluor­
escence to monitor mitochondrial membrane potential in a time dependent 
manner.
Calibration of DSMP+ Fluorescence
Calibration of DSMP+ fluorescence and mitochondrial membrane potential 
was undertaken by measuring the fluorescence intensities of various 
dye/mitochondrial protein ratios and determining the bound dye by 
differential centrifugation of radio-labelled DSMP+. Figure 2.1 ia
presents the fluorescence intensity against the bound DSMP+ for various 
fixed mitochondrial protein concentrations. These results are similar 
to those reported by Mewes and Rafael, (1981), indicating the relation­
ship between fluorescence intensity and the DSMP+ taken up by mito­
chondria approximates to linearity up to an intramitochondrial level 
of 3 nmoles dye/mg mitochondrial protein. Therefore, within the sensi­
tivity limit of 0.1 nmoles dye/mg protein and the deviation from
6Plots of Fluorescence Intensity Against DSMP* Bound
F i g u r e  2 . i i
A. B.
2 4 6 8 2 4 6 8
DSMP+ bound (n moles) DSMP* bound/profein
(nmoles/mg)
Legend
A. Fluorescence intensity of DSMP+ bound to rat liver mito­
chondria at (•) 1.8, (■) 0.9, (*) 0.5 mg/ml protein with
varying concentrations of [^H]-DSMP+ under energised conditions 
(see 'Materials and Methods').
B. Fluorescence intensity as a function of bound DSMP+ per
mg of mitochondrial protein.
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linearity at 3 nmoles dye/mg protein DSMP+ fluorescence reporting 
accurately the uptake of the dye, as shown in Figure 2.iib. Further 
kinetic analysis performed by Mewes and Rafael, (1981), has shown
that the uptake of DSMP+ is strictly first order up to an intra-
mitochondrial concentration of 4 nmoles/mg protein. This is strong
evidence that the accumulation of DSMP+ in mitochondria is solely
due to permeation along the electrochemical gradient.
This conclusion can be further validated when one attempts to ascertain 
a binding constant for the association of DSMP+ with rat liver mito­
chondria. The extent of accumulation dictating the binding constant 
and capacity are variable with energisation of the membrane. In practice, 
individual preparations of rat liver mitochondria at maximal stimulation 
of respiration (5 mM succinate in the presence of 8 mM rotenone) can 
produce a characteristic binding plot (see Figure 2.iii). Similarly 
uniform reductions in the membrane potential equate to varying dissocia­
tion constants. This experiment has been performed utilising a potassium 
diffusion potential in the presence of valinomycin to set up a controlled 
reduction in at, the extent of which can be monitored by DSMP+ fluoresc­
ence together with concentration dependent [^H] -DSMP+ binding and 
the standard isotope distribution techniques using 86Rb+ and [3h ]-tpmp+. 
Considering the upper limit of 3 nmoles dye/mg of protein on fluorescence 
linearity, the initial curve observed on the Scatchard plot for fully 
energised mitochondria fits well, with 3.2 nmoles dye/mg protein and 
an apparent Kq of 49 mM. The break in the Scatchard plot beyond 
3 nmoles dye/mg bound may be indicative of the formation of DSMP+ . 
aggregates which may not penetrate the lipid bilayer of mitochondria, 
this is consistent with the fluorescence observations and those of 
Mewes and Rafael, (1981), (n«8 nmoles/mg and apparent Kq-355pM).
Figure 2.1v demonstrates the imposition of a potassium diffusion
\
Figure 2.i ii
Scatchard Analysis of DSMP+ Binding to Energised Mitochondria
Legend:
Mitochondria (0.9mg) were incubated under energised conditions
O
with varying concentrations of [ H]-DSMP I before rapid separation 
of mitochondria and supernatant as described in 'materials 
and methods'. The supernatant count was equated to the free 
ligand and the pellet count to the bound dye. The superimposed 
curves are the products of two regression analyses and the 
intercepts calculated accordingly.
Figure 2. i v
Reduction in Mitochondrial Membrane Potential by Valinomycin
Mediated Potassium Uptake
Legend:
0.9mg/ml mitochondrial protein was incubated as described in 
'materials and methods' with 0.4pM valinomycin and the relevant 
radioactive ion, 50mM 86Rb+ (0.2uCi/ml), 2pM [3H]-TPMP+ (lMCi/ml) 
and 1 m M [ 3 H] -DSMP+ (0.2 uCi /ml ) and subjected to various KC1 
concentrations prior to removing 1ml aliquots for centrifugation, 
as described in 'materials and methods' (matrix volume taken 
as 0.59ul/mg, as determined in 'materials and methods').
potential on rat liver mitochondria, the reduction in at is measured 
by radioactive distribution techniques using [3 H ] -DSMP-I, [3H]-TPMP Br 
and 8^Rb2S04 . The collapse of membrane potential against the diffusion 
gradient is linear when plotted against negative log [K+] in all cases; 
further evidence of good calibration. These results are, in general, 
in agreement with those of Mewes and Rafael, (1981). It is also noted 
as observed by the previous authors that the methods are not equivalent 
at high potassium ion concentrations, although the discrepancies observed 
here are not so large, the over estimation of 86Rb+ uptake when [K+] 
is in the millimolar range may well be due to energy driven parallel 
proton extrusion.
Determining the apparent dissociation constant at various extrapolated 
values of a t , one observes a decline in their binding affinities as a 
logarithmic function. Plot 2.v represents the relationship between 
the apparent Kq and the imposed potential, where proportional fluorescent 
changes are observed (a F) below 3 nmoles/mg protein binding of DSMP+. 
at « log (cKp) « log (c^F)
(c and c^  are constants)
It must be noted further that the proportionality constants relating 
these terms must remain to be determined experimentally since systematic 
variation will occur, particularly when using high ionic strength 
solutions with diffusion gradients.
Robertson and Rottenberg (1983), have derived the following relationship 
between fluorescence probe relative binding and surface potential
(ATS).
K0 * exp ( G°/RT) exp (ZFa v s/RT)
Where Z is the charge of the ion and G° true Gibbs free energy, since
Kd° = exp (aG°/RT)
KD/KD° = exp (Za t s/RT)
ats = (RT/ZF) In (Kd/Kd°)
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Relationship of KQ (apparent) and at for DSMP+
Figure 2 .v
Legend:
The points were generated from individual Scatchard plots varying 
concentrations of potassium ions corresponding to known values 
of membrane potential calculated from the Nernst equation with 
with [ ]-DSMP+ (see Figure 2.iii). The straight line plot 
is the result of regression analysis.
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In the case of a probe obeying the Nernst equation and avoiding surface 
stacking effects, the actual dissociation constant (KD° ) should tend 
to unity where the observed potential becomes directly related to 
the log of the apparent dissociation constant, under similarly energised 
conditions. Validation of this relationship occurs in the case of 
DSMP+ as the monitoring permeant cation (see Figure 2.v), providing 
an intramitochondrial dye concentration of 3 nmoles/mg protein is 
not exceeded. Therefore, with defined fluorescence intensities per 
nmole DSMP+ bound, the mitochondrial membrane potential may be determined 
accurately. The following relationship has been defined by Mewes 
and Rafael (1981) for such determinations.
a* = -RT/F In [DSMP+ in
[DSMP+] out 
[DSMP+]in = Fj
* Vi
[DSMP+] out = [DSMP+] total - [DSMP+] in. Vi
V - Vi
Where F j and FQ equal the fluorescence intensity and intensity per 
nmole DSMP+ bound respectively, V the total incubate volume and Vi 
the matrix volume.
However, Mewes and Rafael (1981), have pointed out in practice that 
circumstantial definition of the fluorescence intensity/nmole DSMP+ 
bound (Fq ) is not required if the organelles under investigation are 
capable of maximal energisation, such as rat liver mitochondria. 
Under state 4 conditions, the fluorescence may be equated with the 
theoretical uptake of dye from an assumed membrane potential of -190mV 
and the measured matrix volume. Further extrapolations of various 
membrane potentials may be made with observed fluorescence intensities 
based on published data. However, the present study routinely estimates 
membrane potential at -180mV and fluctuations have been observed,
particularly when mitochondria continue to undergo fatty acid metabolism. 
The addition of bovine serum albumin will limit this problem.
The values of mitochondrial membrane potential presented here, -140 
to 180mV dependent on the method of estimation, are all sufficiently
high with moderate pH gradients to drive ATP synthesis as predicted
by the chemiosmotic hypothesis. However, the values are far in excess 
of those measured by Tedeschi and colleagues with microelectrodes
and giant mitochondria (Compo et al, 1984a). Furthermore, they have 
shown that the impaled giant mitochondria maintain only a small pH 
gradient by the injection of pyranine, a pH sensitive fluorescent 
probe, but still undergo succinate driven ATP synthesis (Compo et al, 
1984a,b). Therefore, the giant mitochondria appear to drive oxidative 
phosphorylation in the absence of a functional proton motive force,
as ascertained by the microelectrodic determination of av and pyranine 
fluorescence for ApH, a conclusion which is clearly at odds with the 
ion distribution data and the chemiosmotic hypothesis. Tedeschi has 
argued that the ion distribution techniques are prone to large over­
estimates of the accumulation of permeant labelled ions and dyes.
However, based on similar experiments to those discussed above with 
thylakoid membranes, Compo et^  _al_, (1985) have demonstrated a large
ApH component which they conclude as functional in photophosphorylation. 
Uncoupler Titrations of Mitochondrial Membrane Potential 
Further validation of the fluorescence method was made by comparing 
the titrations of potent protonophores with those produced by the 
ion distribution techniques. Fig 2.vi shows the titration curves 
for the uncouplers CCCP(A) and FCCP(B) by various methods. The tech­
niques employed are in basic agreement as to the actions and general 
potency of the uncouplers, but again discrepancies are observed between 
the fluorescence technique and the ion distribution methods. 86Rb+
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Uncoupler Titrations of Membrane Potential
Figure 2. vi
A- B.
[pmoles/mg] [pmoles/mg]
CCCP FCCP
Legend:
A. Titration with CCCP; El. Titration with FCCP.
lmg/ml mitochondrial protein was incubated as described inQC
'materials and methods’ with (•) 25mM Rb (0.2 uCi/ml)
(plus 0.2mM valinomycin), (*) 2uM [^H]-TPMP+ (luCi/ml), before 
separation by centrifugation and sampling. 10 pM DSMP+ (•) 
was utilised in the fluorescence assay. Matrix volumes
taken as 0.59pl/mg in sucrose media.
were
uptake consistently underestimates the membrane potential as ascertained 
by DSMP+ fluorescence and [^H] TPMP+ uptake, equilibrium of the rubidium 
cation via valinomycin carriage may not be as responsive as the direct 
diffusion of lipophilic cations. However, as soluble compounds of 
the membrane, the previous cations are prone to binding errors, although 
corrections are made for this in the case of DSMP+ during calibration. 
The underestimation of the ion distribution techniques may also have 
a systematic basis, since the mitochondrial suspensions are prone 
to anaerobiosis on centrifugation, together with the accumulation 
of inhibitor in the mitochondrial pellet.
The fluorescence determination of membrane potential provides a quick 
responsive time dependent assay which may be used for kinetic experiments 
The initial rate of depolarisation of ay after the introduction of 
an uncoupler can be monitored as membrane potential dependent fluoresc­
ence reduction, which should be indicative of the rate of proton equili­
brium across the membrane facilitated by the uncoupler. The concomitant 
equilibration of membrane potential on titration may then be the result 
of an equilibrium between the proton output via respiration and the 
carrying capacity of the translocator, which should be a function 
of its diffusion rate in the bilayer. However, respiration driven 
proton pumping does not have to proceed at a fixed rate, and resulting 
equilibrium stability may reflect this.
The observed change in the initial rate of time dependent fluorescence 
reduction is apparently directly proportional to the imposed uncoupler 
concentration, in the case of functional amounts of CCCP and FCCP. 
Figure 2vii demonstrates the linear relationship between fluorescence 
changes and CCCP concentration where the curve approaches the origin.
-dF = [CCCP] 
dt
This relationship is consistent with CCCP functionally acting purely
Time Dependent Fluorescent Changes of DSMP+ Against CCCP 
Concentration with Respiring Mitochondria
- jJ F
dt
[ CCCP] ( p moles/mg )
Legend:
lmg/ml mitochondria were incubated as described in 'materials 
and methods' before the addition of various titres of uncoupler 
at peak fluorescence. The resulting changes were recorded 
as a function of time via a chart recorder linked to the 
fluorimeter.
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in a charge carrying fashion rather than via interactions with the 
membrane or its components. Conversely, DSMP+ is functioning within 
the confines of the Nernst equation.
The effects of various inhibitors of the mitochondrial H+ -ATPase were 
tested in the DSMP+ based system (see Figure 2.i for initial experiments) 
Interestingly, low titres of oligomycin and venturicidin (1.0 pg/mg 
and 0.6pg/mg respectively) produced increases in the membrane potential 
of approximately -15 to -20mV. These effects are consistent with the 
inhibitors modes of action, preventing a back flow of protons via 
the ATPase. Further titrations produced small reductions in the membrane 
potential to -16QmV at >10vg/mg. The inhibitor ossamycin had no signifi­
cant effect on membrane potential, which, although plausible bearing 
in mind its function as an ATP synthase inhibitor, is inconsistent 
with a recent report on E.coli , where it apparently acts as an uncoupler 
(Perlin et 1985), albeit at high concentrations (>40pg/mg). 
Fluorescence Analogues of DSMP+
The DSMP+ analogues DSEP+ and Quinaldine Red were also tested as fluor­
escence indicators of mitochondrial membrane potential. Figure 2.viii 
presents the relative absorption and fluorescence maxima employed 
in mitochondrial experiments. Quinaldine Red produced a smaller relative 
fluorescence signal which proved to be insensitive to changes in mito­
chondrial membrane potential (Ex(max) 400nm - Em(max) 610nm). However, 
DSEP+ provided a comparably strong emission to that of DSMP+ which 
also responded in higher fluorescent yields in the presence of hydro- 
phobic membranes (Ex(max) 479nm - Em(max) 582nm). As presented in 
Figure 2ix, mitochondrial preparations showed energisation specific 
fluorescence similar to DSMP+ with the advantage of a lower basal 
fluorescence. However, DSEP+ produces a relatively smaller signal 
and as a consequence, does not provide the same sensitivity as DSMP+ .
Figure 2.viii
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100-1
DSEP*
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Spectroscopic Properties of DSMP+ , DSEP* and Quinaldine Red 
Legend:
A. Absorption spectra of DSMP+, DSEP+ and Quinaldine Red 
(0.5mM in 50% ethanol, slit width lOnm)
B. Fluorescence spectra of DSMP+, DSEP+ and Quinaldine Red 
Chemical structures of DSMP+, DSEP+ and Quinaldine RedC.
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Figure 2.ix
Comparison of the Fluorescent Responses of DSMP* and DSEP* on
Mitochondrial Energisation
Legend:
Mitochondria were incubated at 0.9mg/ml in 250mM sucrose, lOmM 
HEPES pH 7.5, 8 mM Rotenone in 4ml four sided plastic cuvettes 
and placed in the fluorimeter (A.DSEP Ex 479 * Em 582nm,
B.DSMP Ex 479 * Em 589nm) before additions of 15wl 0.2mM dye 
and succinate to make 5mM with rapid stirring. Inhibitor addi­
tions were made in ethanolic solution.
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DSEP+ behaved similarly to DSMP+in all other aspects, producing similar 
inhibitor response traces and uncoupler titration curves. Although 
the precise calibration of the DSEP+ response in mitochondria could 
not be attempted without a radioactive analogue, the compound provided 
a useful probe of mitochondrial membrane potential. Experiments will 
be described in Chapter 6 that utilise the compounds low non specific 
fluorescence to monitor in situ protoplast lysates of yeast for mito­
chondrial dependent potential changes. Similarly, OSEP may have 
some potential to monitor mitochondrial membrane potential changes 
in whole cells, similar to the studies of Rafael and Nicholls, (1984), 
with brown adipose tissue and DSMP+.
2.4 Conclusi on
DSMP+ has been shown to produce increased fluorescent yields in the 
presence of energised mitochondrial membranes, either respiration 
driven or by ATP. The fluorescence signal is sensitive to uncouplers 
which titrate the signal in a concentration dependent manner. The
increased fluorescence signal has been shown to be dependent on the 
intramitochondrial DSMP+ level by the uptake of [^H]-DSMP+ which 
produces a linear relationship up to 3 nmoles dye/mg protein. Further, 
the uptake of the dye occurs in response to the imposed potential 
giving rise to a series of apparent dissociation constants related 
in a linear log fashion, as predicted by the Nernst equation.
Membrane potentials calculated from DSMP+ fluorescence have consistently 
yielded higher estimates than those based upon the isotopic distributions
, o , + OC +
of ( HJ -TPMP and Rb in the presence of valinomycin. However, 
all these techniques produce similar titration trends with valinomycin 
mediated potassium uptake and uncoupling. The membrane potentials 
measured by the above methods are all sufficiently high enough to 
drive ATP synthesis in coupled mitochondria, as predicted by the
chemiosmotic hypothesis.
The DSMP analogue DSEP+ has also been shown to produce membrane 
potential dependent fluorescence responses with isolated rat liver
mitochondria.
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CHAPTER 3
The Effects of Trialkyltins on the Energetic Functions of Rat Liver 
Mi tochondria
3.1 Introducti on
Trialkyltin compounds have been shown to be potent inhibitors of mito­
chondrial oxidative phosphorylation, oligomycin sensitive adenosine
32triphosphatase (OS-ATPase) and some energy linked reactions eg. Pi- 
ATP exchange and transhydrogenase (Aldridge and Street, 1964; Aldridge 
and Rose, 1969 , Sone and Hagihara, 1964; Emanuel et^  aU 1984).
These effects have been attributed to three basic modes of action. 
The first is a direct inhibition of the Fi Fo-ATPase complex which 
manifests itself in the loss of both ATP hydrolytic and ATP synthetic 
activities (Aldridge and Street, 1964; Stockdale et 1970; Rose
and Aldridge, 1972). This 'oligomycin-like effect' appears to be
the result of an interaction with the Fo component of the F ,Fo-ATPase 
(Sone and Hagihara, 1964; Stockdale et al^ , 1970) causing the inhibition 
of H+ conduction through the complex (Gould, 1978; Dawson and Selwyn, 
1975; Papa et al_, 1982).
The second mode of action is to induce a chloride/hydroxyl exchange 
activity across the inner mitochondrial membrane, which facilitates 
an equilibrium of respiratory generated pH difference resulting in 
general uncoupling (Selwyn et 1970; Dawson and Selwyn, 1974).
The third reported activity is that of a gross swelling of the mito­
chondria in either potassium chloride or potassium isothionate media, 
causing loss of energetic function (Aldridge and Street, 1964; Aldridge 
et al_, 1977).
Studies on the nature of the trialkyltin binding site(s) of submito- 
chondrial particles from rat liver, beef heart and yeast, have yielded 
complex binding curves which have been interpreted as indicative of
at least two classes of binding site (Aldridge and Street, 1970; Dawson 
and Selwyn, 1975; Cain and Griffiths, 1977). The high affinity component 
which is consistent with the loss of ATPase activity (Rose and Aldridge, 
1972; Cain and Griffiths, 1977; Farrow and Dawson, 1978), and a low 
affinity component, the function of which has been questioned (Farrow 
and Dawson, 1978).
The chemical nature of the triorganotin binding site has been studied 
on the basis of organotin interactions with various proteins, and 
claims that histidine and thiol or dithiol groups are involved have.been 
made (Rose, 1969; Elliot and Aldridge, 1977; Elliot £t al_, 1979; Gould, 
1978; Dawson et aU 1982). Functional indications as to the nature 
of trialkyltin binding have come from experiments where mono- and 
dithiols have been used to specifically reverse the inhibitory activities 
of trialkyltins towards ATP synthesis in submitochondrial particles 
(Cain et cil_, 1977; Emanuel et al_, 1984; Yagi and Hatefi, 1984). It
has been suggested from such experiments that dithiols may play an 
important role in the conduction of protons through the Fo moiety 
of the mitochondrial ATPase complex.
The present chapter reports the activities of various trialkyltins 
on the ATP synthetic and hydrolytic enzyme functions of rat liver 
mitochondria, together with estimates of the parameters of proton 
motive force UP) during inhibition. Evidence will be presented that 
trialkyltins may act as potent 'oligomycin-like' inhibitors and also 
have the capacity to uncouple, independent of the phenomenon of chloride/ 
hydroxyl exchange. The relative trialkyltin concentrations in which 
these events take place are in the order of ATPase > ATP synthase ^ p  
reduction.
3.2 Materials and Methods 
Materi al s
All chemicals used were of analytical grade. All trialkyltin chlorides
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were purchased from BDH Chemicals Ltd., UK, except trioctyltinchloride 
which, with tricylchlohexyltin hydroxide was obtained from Dow Chemical 
Company USA. Tributyltin oxide, tributyltin phosphate, tributyltin 
malate and tributyltin acetate were gifts from Schering Industrie- 
Chemikalien, West Germany.
Triethyl tin sulphate was made in this laboratory from the hydroxide 
donated by the Tin Research Institute. Dibutylchloromethyltin chloride 
was synthesised in this laboratory by Dr. D.E. Griffiths. Yeast hexo- 
kinase (type F-300), glucose and lactate were purchased from Sigma 
Chemical Company. ADP and ATP were purchased from Boehringer Corporation 
Ltd. Other special reagents and inhibitors were obtained as listed 
in Chapter 2 of this thesis.
Methods
Rat liver mitochondria were prepared as described in Chapter 2. Sim­
ilarly, the techniques for measuring membrane potential and mitochondrial 
volumes were also described in Chapter 2.
ATP Synthesis
Oxidative phosphorylation was assayed in a glucose-hexokinase trap 
system, containing suspension buffer (250mM Sucrose, lOmM HEPES pH 7.5) 
plus 20rnM glucose, 5mM potassium phosphate, 2mM Mg SO4 , 2mM ADP, 5mM 
succinate and 5 units of yeast hexokinase. Mitochondria were pre­
incubated with inhibitors for 5 minutes on ice, prior to initiation
of the assay at 30°C in a shaking water bath.
The assay was run for 30 minutes in open 20ml phosphorylation pots
to ensure adequate aeration, in a volume of 1ml. The reaction was
terminated with 1ml of 10% trichloroacetic acid. The protein precipitate 
was then removed by centrifugation in a bench centrifuge, before 0 .1 ml 
aliquots were removed for phosphate determination. ATP synthesis 
was measured as the disappearance of inorganic phosphate from the
medi urn.
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ATP Hydrolysis
ATPase activity was determined by measuring the release of inorganic 
phosphate liberated from 5mM ATP. 1ml assays containing 0.2-0.5mg.of 
mitochondrial protein were preincubated in phosphorylation buffer minus 
hexokinase, glucose and ADP with or without inhibitors at 0°C for 5 
minutes. The reaction was then initiated with ATP at 30° C. Assays 
were terminated after 10-15 minutes with 1ml of 10% trichloracetic 
acid. The coagulated protein was removed by centrifugation in a bench 
centrifuge before removing a 0.5ml aliquot for phosphate determination. 
Estimation of ApH
The pH gradient between mitochondria and the medium was established
14using the distribution of [ C] - lactate, a permeant conjugate acid,
as described by Chappell and Crompton, 1979). Briefly, the pH gradient
3 8 6was determined in the presence of [ H]- T PMP or Rb while simultaneously 
measuring the membrane potential in 4ml incubations containing lmg/ml 
mitochondria, as described in Chapter 2. 1ml aliquots of the incubation 
medium was removed and the mitochondria rapidly separated by centri­
fugation for 2 minutes in an Eppendorf microcentrifuge. 0.1ml of
the supernatant was taken for the external count and the pellet re­
suspended and acidified with 0.25ml of 10% perchloric acid, before 
repelleting the mitochondria and taking 0 .1ml of the supernatant for 
counting. The samples were mixed with scintillant and dual channel 
counted in a Packard Tricarb Scintillation Counter.
Estimation of Inorganic Phosphate
Phosphate was determined by the methods of Fiske and SubbaRow, 1925, 
and Heinonen and Lahti, 1980. Both methods depend on the formation
of a phosphomolybdate complex, the earlier method relying upon reduction 
with 1-amino-2-napthol-4-sulphonic acid to form molybdenum blue, which 
is measured spectrophotometrically at 690nm against phosphate
standards. The latter method utilises the yellow chromophore of phospho- 
molybdate when dissolved in acetone, to monitor phosphate concentrations 
against standards at 355nm.
Fiske and SubbaRow Assay
Inorganic phosphate (10-500 nmoles) in 0.5ml H2 0 was added to a 4ml 
plastic test tube containing 1.5ml water and 0.3ml 2.5% amonium molybdate 
in 5M i^SO^. The contents were vortexed and 0.2ml of a 0.2% 1-amino-
2-napthol-4-sulphonic acid; 12% NaHSOj ; 2.4% Na2 S 0 3. 7H2 0 solution
(ANSA reagent) was added. The tube was vortexed once more and allowed 
to stand for 2 0  minutes before determining the optical density against 
a reagent blank at 690nm. The phosphate content of the sample was 
then obtained from a standard curve established under similar conditions. 
Heinonen and Lahti Assay
Inorganic phosphate (50-1500 nmoles) in 0.5ml H 20 was added to 5ml 
plastic tubes containing 4ml of a solution of 1:1:2 volumes of 1 OmM 
ammonium molybdate ((NH^ 6  Mo^ 02 ^.4H2 0), 5M H2 S0^ and acetone respect­
ively (AAM solution). The contents were vortexed and 0.4ml of 1M 
citric acid was added before vortexing once more, and reading immediately 
at 355nm against a reagent blank. Again the phosphate content of 
the sample was then obtained from a standard curve established under 
similar conditions.
Trialkyltin Solutions
All trialkyltins were added to the assays as ethanolic solutions serially 
diluted from lOrnM stock.
3.3 Results 
Mitochondrial Volume
It has been proposed by Aldridge et al_, 1977, that chloride dependant 
stimulation of ATP hydrolysis in rat liver mitochondria is related 
to small scale mitochondrial swelling, which precedes gross swelling
as the concentration of triorganotin is increased. To understand 
these effects and any possible effects on membrane potential determina­
tion, the mitochondrial volumes of progressively inhibited samples 
were measured under similar conditions to those employed for the deter­
mination of ATP hydrolysis activity (cf. ‘Materials and Methods'), in 
the presence and absence of 0.15M NaCl. These results are presented 
in Tables 3i and 3ii for [^C]-sucrose and [ ]-manni tol respectively.
As discussed earlier in Chapter 2 of this thesis, internal mitochondrial 
space, as determined using [ ] - mannito! over ['^C]- sucrose produces 
slightly different results. Internal space determined in the presence 
of mannitol, consistently gives smaller volumes although the magnitude 
of the decrease varies over a greater range (0.08-0.17^*1 /mg) under 
the influence of trialkyltin mediated swelling. This variation has 
been observed previously by Halestrap and Quinlan, 1983, although 
they reported typical values of 0.46 m1 /mg and 1. 6 8  m1 /mg for mannitol 
and sucrose respectively, under non-energised conditions. As pointed 
out by the above authors, this observation has an important consequence 
for the calculation of permeant ion concentrations within the mito­
chondrial matrix and ultimately the calculations of the parameters 
of proton motive force. However, the difference in matrix volume
observed here are not so great, and will make a maximal difference 
of 12mV to ¿p.
A chloride dependent ATPase activity was observed with triethyltin 
sulphate, at concentrations ranging between 0.25 and 1.00 nmoles/mg 
of mitochondrial protein. Within the range the mitochondrial volume 
appears to increase steadily before determinations became variable, 
presumably as the integrity of the membrane is disrupted. These pheno­
mena presumably result from chioride/hydroxyl exchange as they are 
not observed in minimal halide media (under these conditions the
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Table 3.i
The Effect of Triethyltin Sulphate on Mitochondrial ATPase Activity
and Volume
Triethyltin Sulphate 
(nmoles/mg protein)
Mitochondrial Volume 
( til /mg protein)
Mitochondrial ATPase 
(nmoles/mg/minute)
0.15M NaCl 0.15M NaCl
- + - +
0 0.70 0 . 6 8 32 32
0.25 0.71 0.78 30 42
0.50 0.71 0.97 25 49
1 . 0 0 0.70 1 . 2 0 2 2 38
2 . 0 0 0.76 1.98 18 23
5.00 0.77 - 1 2 18
1 0 . 0 0 0.85 - 2 4
15.00 0.96 - 2 2
2 0 . 0 0 1 .65 - 2 2
Legend:
These determinations of mitochondrial volumes are the averages of 
triplicates using [^4 C]-sucrose and [^Hj-HgO. Mitochondria were 
incubated with various titres of triethyltin on ice before dilution 
into the assay media at 4mg/ml and 0.2mg/ml for volumetric and ATPase 
assays respectively.
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Tab!e 3.i i
The effect of Triethyltin Sulphate on Mitochondrial ATPase Activity
and Volume
Triethyltin Sulphate 
(nmoles/mg protein)
Mitochondrial Volume 
(ul/mg protein)
Mitochondrial ATPase 
(nmoles/mg/minute)
0.1 5M NaCl 0.15M NaCl
- ♦ - +
0 0.59 0.60 34 34
0.25 0.60 0 . 6 8 32 39
0.50 0.64 0 . 8 6 30 50
1 . 0 0 0.62 1.09 29 43
2 . 0 0 0 . 6 8 1.83 27 29
5.00 0.73 - 15 18
1 0 . 0 0 0.78 - 3 5
15.00 0.85 - 2 4
2 0 . 0 0 1.48 - 2 2
Legend :
Again these mitochondrial volume determinations were made in tri pi icate
under similar conditions to those described in the legend to Table 3.i , 
the exception being [ ^ 4 C ]-mannitol replaced [ 1 \  ]-sucrose.
concentration of chloride in the media can never exceed O.OlmM). These 
results are in agreement with the functions proposed by Aldridge et al, 
1977, for mitochondria suspended in chloride containing media. The
mitochondria suspended in minimal halide did not swell at such low 
concentrations of triethyltin sulphate, but did increase rapidly in 
volume at 15 nmoles/mg. Further additions indeed appeared to perturb 
the integrity of the membrane in a non-specific manner. Concentrations 
of trialkyltin over 25 nmoles/mg have been previously reported to 
cause gross swelling and release of soluble protein, suggesting that 
trialkyltins induce lysis and/or dissociation of structural elements 
of the mitochondrial membrane (Wulf and Byrington, 1975). The prediction 
that high concentrations of triorganotins cause gross perturbations 
of the integrity of the mitochondrial membrane is consistent with 
the above findings. The concomitant increase in ATPase activity follow­
ing large scale swelling reported for trimethyltin by Aldridge et al, 
1977, was not observed in these experiments, presumably due to the 
enhanced 1 oligomycin-like' activity of triethyltin over that of tri­
methyl ti n.
It is clear from these results that concentrations of triorganotins
less than 2 0  nmoles/mg under minimal halide conditions should not
perturb the integrity of the mitochondrial membrane unduly.
The Inhibition of ATP Synthase and Hydrolase Activities
The results presented in Table 3iii confirm that trialkyltins are
potent inhibitors of oxidative phosphorylation and ATP hydrolysis
in rat liver mitochondria. The sensitivities of these reactions under
minimal halide conditions, as presented as Icri values in Table 3iii,bU
represent the abilities of various trialkyltins to apparently inhibit 
the mitochondrial ATPase complex. The most active compound presented 
here is dibutylchloromethyltin chloride (DBCT), which is equally the
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Tabl e 3i i i
The Effects of Trialkyl tins on Mitochondrial ATPase and ATP synthase
of Rat Liver
Trialkyltin plgQ (nm°les/m9 protein)±SD
Trimethyltin chloride (2 )
ATPase
> 1 0 0
ATP synthase 
> 1 0 0
Triethyltin chloride (5) 2.8 ±0.4 1 0 . 0 ±0.5
Triethyltin sulphate (5) 2.8 ±0.4 9.8 ±0.5
Tripropyltin chloride (4) 1 . 8  ± 0 . 2 7.6 ±0.5
Tributyltin chloride (6 ) 2 . 0  ± 0 . 2 7.8 ± 0 . 2
Tributyltin oxide (3) 1 . 8  ± 0 . 2 7.6 ±0.4
Tributyltin acetate (3) 2 . 0  ± 0 . 2 7.8 ± 0 . 2
Tributyltin phosphate (3) 2.5 ±0.5 8 . 0 ±0.5
Tributyltin malate (3) 2.5 ±0.5 8 . 0 ±0.5
Dibutylchloromethyltin chloride (6 ) 1 . 0  ± 0 . 2 2.5 ±0.4
Trioctyltin chloride (2 ) 5.0 ±0.4 14.5 ± 1 . 0
Tricyclohexyltin hydroxide (2 ) 3.0 ±0.4 9.0 ±0.4
Triphenyltin chloride (6 ) 1 . 8  ± 0 . 2 7.8 ±0.4
Legend :
ATPase and succinate driven ATP synthase activities were estimated as 
described in 'materials and methods'. The numbers in parenthesis corres­
pond to the numbers of separate duplicate experiments. Control ATPase 
and ATP synthase rates ranged between 30-40 nmoles/mg minute and 80-100 
nmoles/mg/minute respectively.
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most potent compound in affecting mitochondrial ATP hydrolysis and 
synthesis, with Ijq values of 1.0 and 2.5 nmoles/mg respectively.
It is apparent from the I values of the n-alkyltins that the peak 
of inhibitory activity is represented by the n-propyl and n-butyl 
derivatives, producing 50% maximal inhibition around 1.8-2.5 nmoles/mg 
and 7.6-8.0 nmoles/mg for ATP hydrolysis and synthesis respectively. 
Both shorter and longer alkyl groups are less active, although the 
triaryltin, triphenyltinchloride is equally potent. The peak potency 
of n-butyl and phenyl groups is also observed i_n vivo (Smith, 1982). 
By varying the anion of n-tributyltin, only slight differences are 
observed of 0.5 nmoles/mg, which are within the calculated deviation. 
The titration curves of these compounds are also similar and are presen­
ted in Figure 3i. In short, varying the anion of the trialkyltin 
appears to have a minimal effect on the 'oligomycin-like' activity 
of the compound.
Figure 3ii presents the titration curves for various n-trialkyltin 
chlorides which demonstrate their differential activities, as discussed 
above. Further, it is apparent that there is a differential effect 
on the ATP synthase and hydrolase functions of the mitochondrial ATPase 
complex. As reported earlier for beef heart submitochondrial particles, 
triorganotins cause differential inhibition of the ATP synthetic and 
hydrolytic activities of the F , Fo ATPase (Emanuel et al, 1984). This 
effect can be clearly observed with OBCT in rat liver mitochondria, 
(titration curve presented in Figure 3iii), where specific concentrations 
of triorganotin will completely prevent ATP hydrolysis while allowing 
>80% of the control value of ATP synthesis, which is titratable by 
non-additive amounts of oligomycin, ossamycin and venturicidin (data 
presented in Table 3iv). These phenomena appear to be the properties 
of triorganotins in their direct inhibitory modes of action, since
n a
Figure 3.i
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Inhibition of ATP Synthesis and Hydrolysis in Mitochondria by n-tributyltins
ATPase Synthase •1° -  TBT Oxide 
•• Chloride 
t|v-  •• phosphate
♦io- ■ malate 
■l°- •• acetate
Legend :
These estimates were performed as described in 'materials and methods' 
and expressed as percentiles of control values (ATPase 33nmoles/mg/ 
minute, ATP synthesis 8 8  nmoles/mg/minute).
Figure 3.ii
Inhibition of ATP synthesis and hydrolysis in Mitochondria by Various
n-trialkyltins
Legend :
Estimates of ATP synthesis (hatched symbols) and ATP hydrolysis (open 
symbols) were performed as described in 'materials and methods' and 
expressed as percentiles of the individual control rates. ATP synthesis 
rates and ATP hydrolysis rates ranged between 75-101 nmoles/mg/minute 
and 32-38nmoles/mg/minute respectively.
[Trialkyltins] (nmoles/mq)
°*TPrT
°-TBuT
"TOctT
û*TCyT
Figure 3.i i i
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Inhibition of ATP synthesis and hydrolysis in Mitochondria by DBCT
DBCT
° ATPase. •  ATP Synthase.
Legend :
Estimates of ATP synthesis (hatched circles) and hydrolysis (open 
circles) were performed as described in 'materials and methods' and 
expressed as percentiles of control rates, 38nmoles/mg/minute and 
79nmoles/mg/minute respective!y .
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Table 3.iv
Differential Inhibition of ATP Synthesis and Hydrolysis by DBCT
Inhibitors ATPase ATP synthase
(nmol/mg/min) (nmol /mg/min)
None 35 84
DBCT 0 56
DBCT + oligomycin (2ugm/mg) 0 0
DBCT + ossamycin (4pgm/mg) 0 0
DBCT + venturicidin (2Mgm/mg) 0 0
Legend:
Mitochondria were incubated on ice with 2.3 nmoles/mg DBCT
aliquoting into the ATPase and ATP synthase assays with or
antibiotic.
before 
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at these levels of triorganotin and halide, no competition is envisaged 
with non-specific or chloride/hydroxyl exchange mediated swelling. 
The less potent triorganotins do not appear to cause 100% ATPase inhibi­
tion, but allow 1 0 % residual enzymatic activity while still maintaining 
control levels of ATP synthesis. The differential effect is still 
presumed present in absolute terms, since the enzymatic rates are still 
very different, 40:1 synthesis against hydrolysis in rat liver 
mitochondria. The above data questions the complété reversible nature 
of the mitochondrial F, Fo ATPase complex.
The Effects of Trialkyltins on Proton Motive Force
Considering the inhibitory functions of trialkyltins, these experiments 
were performed to rationalise their activities with the components 
of proton motive force (Ap), the driving force of ATP synthesis (Mitchell, 
1961). Initial experiments were performed to monitor mitochondrial 
membrane potential (a v ) with the fluorescent probe DSMP , as described 
in Chapter 2. Presented in Figure 3iv are a series of time dependent 
fluorescent traces demonstrating the action of tributyltinchloride. 
Figure 3iva demonstrates the step-wise depolarisation of membrane 
potential by tributyltin, the residual potential of which is sensitive 
to uncouplers, eg. CCCP. Figure 3ivb demonstrates that trialkyltins 
have the capacity to titrate mitochondrial membrane potential in an 
apparent concentration dependent manner. After the addition of limiting 
amounts of trialkyl tin the membrane potential is depressed followed 
by equilibration at a lower level, the residual potential being sensitive 
to uncouplers or further additive amounts of trialkyltin. These effects 
were always additive independent of the triorganotin used, the net 
drop in potential is a function of the specific triorganotin concentra­
tion. The potency of particular triorganotins to lower mitochondrial 
membrane potential is assessed in Table 3v by their respective abilities
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F i gure 3.iy
The Effects of Trialkyltins on Mitochondrial Membrane Potential as Monitored
by DSMP* Fluorescence
Legend:
Mitochondria were suspended at 1.0-1.25mg/ml protein in 250mM sucrose, 
lOmM HEPES pH 7.5, 8 uM rotenone in 4ml four sided plastic cuvettes 
and placed in the fluorimeter (Ex 479 Em 589) before additions of 
15 pi 0.2mM DSMP Br and succinate to make 5mM with rapid stirring. 
Inhibitor additions were made in ethanolic solution and never exceeded 
lOul. In Figure 3.iv D mitochondria were preincubated with tributyltin 
on ice for 5 minutes before dilution into the assay.
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to depress At by +100mV. These values are again expressed as the 
amount of tr.iorganotins required per mg of mitochondrial protein. 
This ratio is again the criterion for triorganotin effect rather than 
net concentration.
These experiments were carried out in minimal halide conditions, there­
fore, the contribution of halide/hydroxyl exchange should be insignifi­
cant. When exogenous chloride is added to these assays the effect 
observed is negligible. Figure 3ivc undertakes the same titrations 
represented in Figure 3ivb in the presence of 0.15M NaCl, with little 
or no difference. Exogenous chloride (0.15M) did not appreciably 
alter the rate or steady state estimates of triorganotin mediated 
membrane potential depolarisation, performed using DSMP+ fluorescence
O
and the distribution of [ H] -TPMP+ respectively. This result is not 
unexpected when one considers the mechanism of chloride imposed uncoup­
ling via trialkyltins, chioride/hydroxyl exchange is essentially an 
electroneutral effect directed at the ApH component of proton motive 
force. However, it must be noted that Moore et_ aj_, 1980, have shown 
that high chloride medium does not effect transmembrane ApH shifts 
in plant mitochondria. Finally, Figure 3ivd demonstrates the precision 
of the trialkyltin titration, since preincubation with the inhibitor 
prior to a v estimates predetermines a v  by producing a marked reduction 
in the energisation capacity of the membrane, the depression in the 
maximal obtained membrane potential corresponding to a similar titre 
of trialkyltin required to reduce a v to an equivalent level.
As clearly seen in Table 3v, certain trialkyltins studied here have 
the capacity to cause a v depolarisation at concentrations which do 
not exceed the 2 0  nmoles/mg required to perturbate the integrity of 
the membrane. The exceptions to this are trimethyltin, which remains 
largely ineffective, tripropyltin and triphenyltin. These compounds,
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Tabl e 3. v
The Potency of Various Triorganotins in Affecting ay
Tri organoti n + 1OOmV a? ± SD 
(nmoles/mg)
Trimethyltin chloride 300 ± 20.2
Triethyltin sulphate 19 ± 2.3
Tripropyltin chloride 30 t 5.0
Tributyltin chloride 1 2  ± 2 . 2
Tricyclohexyltin hydroxide 1 1 ±3.1
Legend:
The above assays were carried out as described 
in the legend to Figure 3.iv. Fluorescent changes 
were calibrated against ay established using.the 
distribution of [^H] -DSMP I, as described in 
Chapter 2. The concentrations represent the 
mean of 5 individual assays ± standard deviation.
although having potent effects on oxidative phosphorylation, do not 
cause at depolarisation as readily as other trialkyltin species. 
Considering the minimal action of chioride/hydroxyl exchange under 
these conditions, the ability of these compounds to bring about enzymatic 
inhibition, represents their capacity to directly inhibit the OS-ATPase 
complex in an 'oligomycin-like' fashion. However, trialkyltins which 
promote uncoupling, may have a dual mode of action, even when assayed 
under minimal chloride conditions. They may simultaneously inhibit 
the ATPase complex while causing profound uncoupling effects on mito­
chondria, which may effect estimations of their ability to produce 
enzymatic inhibition. The extremely active compound DBCT (4.5 nmoles/mg 
to produce +100mV reduction in a t  ), certainly will function as an 
uncoupler to bring about the cessation of oxidative phosphorylation, 
indeed, the concentration required to totally inhibit ATP synthesis
(5 nmoles/mg) is very similar to that required to depolarise the membrane 
potential. Uncoupling may be the primary mode of action of OBCT on 
oxidative phosphorylation, however, it remains a potent inhibitor 
of the hydrolase reaction.
Further experiments were performed to measure steady state estimates
14of at and ApH utilising the distributions of [ C) - lactate for ApH 
and of [ n)-TPMP+ and 8 8 Rb+ (in the presence of valinomycin) for a t 
In general, the a t  estimates obtained from DSMP+ fluorescence appeared 
higher than the latter two methods, particularly at lower membrane 
potentials. A typical set of titration curves with tributyltinchloride 
are presented in Figure 3v. The estimations of a t differ by some
40mV between the lowest with ®8 Rb+ and the highest with DSMP+ for
for a given titre of trialkyltin. A more pronounced version of this 
phenomenon has been commented upon previously by Mewes and Rafael, 
1981, (cf. Chapter 2), observed when decreasing the mitochondrial
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Figure 3.v
------------- 1---------------- 1
10 20
l Tributyltin] (nmoles/mg)
Variation in av determination with 8 ^Rb+, [3 H]-TPMP* and DSMP+ based 
methods on Titration with Tributyltin chloride
Legend:
Mitochondria were preincubated with tributyltin chloride and diluted 
into the assay. The respective assays were performed as described 
in 'materials and methods'. 2pM OuCi) TPMP+ (•) and 50uM (0.2pCi ) 
Rb (a ) were utilised in steady state estimates and lpM DSMP+ (■) 
used in time dependent fluorescence experiments.
/
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membrane potential against a valinomycin mediated potassium diffusion 
potential. Certain differences in estimation may be inherent to each 
system rather than solely due to artefacts of high potassium concentra­
tions, as suggested by Mewes and Rafael; not least the possible concen­
tration of the inhibitor on centrifugation of the mitochondria with 
radioisotope based methods. Nevertheless, such deviations remain 
disturbing.
Estimation of a*, ApH and the resulting Ap are presented in Figure 3vi 
for titrations with various triorganotins. Two appropriate modes
of action can be observed in Figure 3vi represented by DBCT and tri- 
phenyltinchloride. DBCT is observed to titrate Ap from the onset 
of inhibition, whereas triphenyltin has a more passive function until 
a relative concentration of 10 nmoles/mg, by which time ATP synthesis 
is only some 20% active. These observed differences are diagnostic 
of the two contrasting modes of action: triphenyltin acting as an 
'oligomycin-like* inhibitor of oxidative phosphorylation; and DBCT 
operating principally by its uncoupling activity. The uncoupling 
function of triphenyltin is not maximised until 25 nmoles/mg are imposed 
upon the system, at which point the mitochondrial membrane may be 
disrupted and the enzymatic functions of the ATPase complex long since 
deceased.
3.4 Discussion
It is clear from these results that the inhibitory mechanisms of tri­
organotins on mitochondria are complex, even in the absence of chloride/ 
hydroxyl exchange. Triorganotins have been shown to inhibit proton 
conductivity in submitochondrial particles and chloroplasts (Papa 
et al, 1982; Gould, 1976 and 1978), presumably by their interaction 
with the Fo moieties of mitochondrial and chloroplast +H-ATPase. These 
effects should occur at low titres of triorganotins, that is, those
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Figure 3.vi
The Effect of Triorganotins on a t , a pH and ¿p in minimal halide media
Legend:
ay and ap estimates were based on those obtained with [ H]-TPMP 
The distributions of 2uM (1 v*Ci) [^H]-TPMP+ and 25pM (0.5mCi) [ ]
lactate were measured as described in 'materials and methods'.
(■) DBCT, (•) Triphenyltin chloride, (a ) Tributyltin chloride.
—TRiT 
*-TBT 
■-DBCT
7S
[ Triorganotin ] (n moles/mg)
iwhich are required to affect ATPase activity, since the present findings 
provide compelling evidence that at higher titres they will depolarise 
membrane potential, the very antithesis. These antagonistic effects 
are apparent between the individual activities of various triorganotins, 
as described earlier with the examples of DBCT and triphenyltin, which 
function at opposite ends of the spectrum. Therefore, the final activity 
of any triorganotin must be understood in terms of a composite mode 
of action. Nevertheless, it appears that most triorganotins will 
arrest proton conduction at the level of the H-ATPase at low titres, 
but at higher functional concentrations, will cause specific uncoupling 
and will ultimately destroy the integrity of the membrane, collapsing 
most energetic functions (the latter severe action being synonymous 
with the release of soluble protein and possible lysis (Wulf and 
Byrington, 1975)).
If a mechanism of direct trialkyltin mediated ion carriage is envisaged 
for uncoupling, a possible candidate for exchange is the tin-anion 
bond. The trialkyltin must be freely diffusible in the lipid bilayer 
and the putative exchange reaction should be pH and/or lipid phase 
dependent. Therefore, equilibria may exist which will ultimately 
re-equilibriate ionic imbalances across the membrane to facilitate 
a fall in membrane potential. The chemical nature of these interactions 
remain obscure at this time, particularly when one considers the anions 
oxide, chloride, acetate, phosphate and malate of tributyltin, all 
yield similar results. However, the observed effects may be mediated
by a solvolysis product(s) of the original trialkyltin species which, 
especially in the presence of hydrophobic membranes, may yield a large 
number of complex molecular species (Garner £t aU 1976; Hanson et al, 
1980 and Alcock _et 1985). Clearly, further chemical analyses
are required to secure the exact nature of general organotin mediated
reactions within, or at the surface of hydrophobic phases.
Alternatively, the reduction in membrane potential may be a result
of direct interaction of the trialkyltin species with an ion translocat­
ing component of the mitochondrial membrane, the function of which
should remain independent of the external chloride concentration.
Diwan, 1982 has reported that DBCT will enhance the rate of respiration 
dependent K+ influx in rat liver mitochondria, a phenomenon which
is pH dependent (Diwan and Tedeschi, 1975), but shows little dependence 
on chloride concentration (Diwan, 1982). Further studies by Diwan
et al, 1983, have revealed DBCT to have a composite mode of action, 
titres of 4.5 nmoles/mg were required to affect respiration as determined 
by an oxygen electrode experiment, while higher concentrations were
required to enhance radiolabelled K influx. The value of 4.5 nmoles/
mg required to inhibit respiration is remarkably similar to those
required for the inhibition of ATP synthesis and uncoupling in the
present study, the action of DBCT appears certainly multi-faceted.
Nevertheless, at titres of DBCT > 5 nmoles/mg which apparently reduce 
av and promote unidirectional K + influx, the associated changes in 
charge distribution are at least consistent. It is also interesting
to note that the effects of DBCT on K+ influx were reversible by the 
monothiol 2 -mercaptoethanol, which further preferentially reversed 
the K + influx activity over respiration. Further evidence that the
site(s) of trialkyltin interaction may be at specific thiol residues. 
The site(s) of action have also been shown to overlap with the covalent 
inhibitor DCCD which produces an inhibitory effect on K + influx. This 
inhibitory activity is not expressed in the presence of DBCT (Diwan
et jQ, 1983). The DBCT and DCCD binding sites on the ATP synthase 
complex have been shown to undergo some interaction (Kiehl and Hatefi, 
1980; Partis et al, 1980), but the possibility remains that the factor(s)
I l l
responsible for K+ transport may remain distinct. Jung et^  jil_, 1980 
have shown that such sites are certainly distinct from the DCCD binding 
subunit of the ATPase complex (subunit 9) but this evidence however, 
does not rule out a complex interaction between several subunits of 
the ATP complex and/or other membrane components.
Aldridge et a^, 1971 and 1977, have proposed that inhibition of the
OS-ATPase is brought about by penta-coordinate binding of the trialkyltin 
compound, at an inhibitor binding site. Penta-coordination presumed 
to explain the relative ineffectiveness of tetraalkyltins in contrast 
to their tri- and dialkyltin analogues, on OS-ATPase. The presence 
of a fourth alkyl group sterically hinders penta-coordination and 
therefore, its binding to the inhibitor binding site. However, dialkyl- 
tins may undergo penta-coordination with a hydroxyl function, forming 
the fifth ligand and consequently, will bind to the inhibitory site.
The effectiveness of each individual trialkyltin was also explained 
by the ease at which it may complex to the inhibitory binding site, 
where the optimal shape and sized alkyl group will be most effective. 
The optimal groups being represented by tri-n-propyl, n-butyl and 
phenyltin groups, which are good inhibitors of OS-ATPase activity, 
in contrast to trimethyltin which, although having the capability 
of penta-coordination, is a poor inhibitor. The lower binding affinity 
of trimethyltin against that of triethyltin in rat liver mitochondria 
(some ten times lower) was thought to represent this function (Aldridge 
and Street, 1970).
Although the trialkyltins studied here were found to be potent inhibitors 
of OS-ATPase and succinate driven ATP synthesis, the two enzymatic 
functions possess differential sensitivities. In all cases, the ATPase 
activity was found to be 3-4 times more sensitive to triorganotin 
inhibition than oxidative phosphorylation (Table 3iii). Further, the
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results presented in Table 3iv for DBCT demonstrate that the residual 
ATP synthesis after the cessation of ATP hydrolysis, is sensitive to 
non-additive amounts of other established inhibitors of oxidative 
phosphorylation. These results are comparable to those reported by 
Emanuel et 1984, for beef heart submitochondrial particles. These 
results may be interpreted that the inhibition of the two processes 
are different, either chemically distinct, and/or spatially different. 
Separate sites for ATP synthesis and hydrolysis have been suggested 
by Penefsky, 1974; and Pederson, 1975 to exist on the mitochondrial 
ATPase complex. These suggestions were based on the observation that 
adenyl imidodiphosphate inhibited ATP hydrolysis but did not affect 
oxidative phosphorylation in submitochondrial particles. It is envisaged 
that the inhibitor will preferentially bind the site of ATP hydrolysis, 
causing the inhibition of OS-ATPase activity, but allowing continued 
ATP synthesis at another separate catalytic site (Pederson et al,
1978). However, a 'conformational model' may be evoked to explain 
the preceding results. In this model, ATP synthesis and hydrolysis 
occur at the same site, but the direction of the reaction is dependent 
on the conformation of the ATPase complex. The presence of trialkyl tin 
may pertubate the reversibility of the two conformations, and preferen­
tially maintain the ATP synthetic mode, at the expense of ATP hydrolysis; 
although the rates of each do not have to be comparable. While consider­
ing the above explanations, Emanuel ^t 1^_, 1984, suggested that the 
residual ATP synthetic activity would be lost due to uncoupling. This 
may be true in the presence of chloride, but under the conditions 
maintained here, must depend upon the triorganotin. Indeed, DBCT 
should uncouple, but the functionally opposite triphenyltin should 
further inhibit the site of ATP synthesis. Further arguments regarding 
the inhibitory functions of triorganotins are presented on the penta-
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coordinate complexes discussed in the following chapter.
3.5 Cone 1usi on
The results presented in this chapter demonstrate that triorganotins 
are potent inhibitors of mitochondrial ATP hydrolysis and ATP synthesis. 
Triorganotins will also titrate membrane potential and the accompanying 
pH gradient in estimates of the proton motive force of isolated rat 
liver mitochondria in an apparent concentration dependent manner, 
in the absence of halide/hydroxyl exchange. Under these conditions 
the concentrations of triorganotin required to produce a drop of +80 
to +120mV in Ap approach, or are in excess of, those required to inhibit 
ATP synthase activity, which are at least three fold greater than 
those which inhibit ATP hydrolase activity. The addition of exogenous 
chloride ion did not appreciably alter the steady state or rate estimates 
of triorganotin mediated ay depolarisation. The evidence indicates 
that triorganotins possess an uncoupling effect which is independent 
of halide/hydroxyl exchange, and may not affect inhibition of the 
ATPase complex. The activities of various triorganotins may be best 
understood according to their abilities to uncouple or directly inhibit 
oxidative phosphorylation at the enzymatic level in the absence of 
halide/hydroxyl exchange.
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CHAPTER 4
The Effects of Penta-coordinate Organotin Complexes on the Energetic 
Functions of Rat Liver Mitochondria
As discussed in Chapter 3, Aldridge et al, 1971 and 1977, have proposed 
that inhibition of the OS-ATPase complex may be brought about by penta- 
coordinate binding. Indirect evidence for the above proposal has 
come from binding studies of trialkyltins with rat and cat haemoglobins 
(Rose, 1969; Elliot et al, 1977 and 1979). Triethyltin binds to rat
and cat haemoglobin with an affinity constant of 10^ -10^ M-* which 
is thought to be the result of interactions with histidine and thiol 
groups penta-coordinately (Rose, 1969 and Elliot et al, 1977), as 
well as two thiol groups, under certain conditions (Elliot et al,
1979). Penta-coordinacy is further supported by Mossbauer studies, 
and the lack of competition between triethyltin and penta-coordinate 
compounds (Elliot et. .al, 1979). Similarly, histidine residues are 
thought to be functional in the penta-coordinate binding of triethyltin 
to pyruvate kinase (Davidoff and Carr, 1973). However, Mossbauer
studies on the ATPase inhibitory site of triethyltin on rat liver 
mitochondria suggested the interaction was four-coordinate. Internally 
coordinated triethyltin analogues exerted potent ATPase inhibition
only as long as one coordination position was free, suggesting that 
only one bond is formed between triethyltin and its inhibitory site 
(Farrow and Dawson, 1978).
Aldridge further reported internally penta-coordinate triorganotin 
compounds as highly effective inhibitors of mitochondrial ATPase 
(Aldridge, 1978, and Aldridge et al, 1981), and suggested that because 
of their activity, binding must be four-coordinate. Similarly, trialkyl­
tins may produce four-coordinate species.
The following chapter describes the activities of several internally 
penta-coordinate organotins and, in particular, the function and 
synthesis of (2 - [ (dimethyl amino) methyl] phenyl) dialkyltin species, 
which have proven to be extremely potent inhibitors of the mitochondrial 
ATPase complex (Aldridge et^  al_, 1981 and Emanuel et _al_, 1984).
Materi al s
All chemicals used were of analytical grade. The internally coordinated 
ester tins, mono-, di- and tri- (B-carbobutoxyethyl)-tin (BuAc) and 
( B-carbomethoxyethyl)-tin (MeAc) chlorides (Hutton and Oaks, 1976; 
Burley and Hutton, 1981), were gifts from Akzo Chemie UK Ltd. (2- 
[(d i methyl ami no Jmethyl ] phenyl) dimethyl- diethyl- and dipropyl- tin 
halides (coded as the 'Ve' series), were synthesised in the laboratory 
using the dialkyltin dichlorides supplied by Ventron Corporation USA, 
n-butyl lithium and N'N'-dimethyl benzyl amine were purchased from Aldrich, 
UK. All other special reagents and inhibitors were obtained as listed 
in Chapters 2 and 3.
Methods
Enzymatic methods are described in Chapter 3. The methods used for 
estimating membrane potential and pH gradients are described in Chapters 
2 and 3.
Synthesis of (2-[(dimethyl amino) methyl]phenyl) dialkyltin halides 
(Ve series)
The syntheses were modified from those of Van Koten et al, 1975. 
30 nmoles of butyl lithium in 19ml of n-hexane were added to 75ml of 
dry ether under a nitrogen atmosphere to which was added 4.06g of 
N'N'-dimethyl benzyl amine dropwise with stirring. This solution was 
stirred at room temperature overnight to produce a yellow viscous 
solution, which was in turn added dropwise to a solution of 30 mmoles
6of dialkyltindihalide in 20ml ether at 0°C under nitrogen. The resulting 
colourless solution was stirred for three hours at room temperature. 
Colourless crystals of lithium bromide were formed and removed by 
filtration before evaporating the ether to yield a light yellow viscous 
oil which crystallised spontaneously. These crystals were further 
stirred with n-pentane before filtering and drying to produce a white 
product with a melting point of 105-106°C (yields between 60-65%).
Using the above protocol the methyl, ethyl, propyl bromides and ethyl 
chloride derivatives were synthesised. The dialkyltindibromides were 
produced from the dichloride species by exchange with sodium bromide 
in ethanolic solution, whereupon solid sodium chloride crystals were 
removed by filtration.
C H 2 N M e 2  C ^ N M ^
R = alkyl group
The products of these reactions were examined by elemental analysis
13 1(performed by Akzo Chemie at Duren) and high field 400MHz C-and H-NMR 
(Bruker WH400 located at Warwick) to confirm their structures and purity 
(99.50 to 99.90%). The ^H-NMR of (2- [(dimethylamino)methyl1 phenyl) 
diethyltin chloride (Ve2283(CU) is presented in Figure 4i, together
Li.Br
i*7
Figure 4,i
^H-NMR and Proposed Structure of (2- (dimethylamino) methyl phenyl)
diethyltin chloride
Legend:
A. 400MHz V nMR of Ve2283(Cl) 50mg in CD3 OD.
B. Proposed structure of Ve2283(Cl), in which the tin atom is five- 
coordinate as a result of intramolecular Sn-N bond formation, 
and in which the more electronegative ligands occupy axial positions 
(confirmed by Van Koten et al, 1980 utilising X-ray crystallography 
with Ve2283(Br) ).
*
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with its assignments. The assignments of the R-Sn CH2 -N and CHj-N 
resonances from integral values. However, previously unreported coup­
lings of 27Hz and 56Hz were observed around the R-Sn resonances, presum­
ably due to ^^Sn-C-C-H and Sn-C-H couplings respectively. The
downfield resonances are assigned H(3), (a single proton at the highest 
aromatic region resonance 7.08 «/ppm, ortho to the heteroatom), H(6), 
(a single proton at the lowest field resonance, 8.07 a/ppm, para to 
the heteroatom), and H(4) H(5) which resonate as a multiplet between 
the latter (7.30«/ppm).
Preparation of Rat Liver Submitochondrial Particles
Rat liver mitochondria were diluted to approximately lOmg/ml mito­
chondrial protein in 250mM sucrose lOmM HEPES pH 7.5, before sonication 
for two minutes on ice (6 x 20 second bursts with cooling periods 
of 20 seconds) in an MSE 60W sonicator at maximum amplitude.
The resulting suspension was then recentrifuged at 12K r.p.m. in a 
Sorvall SS-34 rotor for 10 minutes at 4°C. The supernatant was then 
centrifuged at 40K r.p.m. in a Beckman L5-65 centrifuge using the
42.1 Ti or 50 Ti rotors. The pellet from the above centrifugation 
was again resuspended in 250mM sucrose, lOmM HEPES pH 7.5 and recentri­
fuged as above. The resulting submitochondrial particles were re­
suspended as above, at approximately 25mg/ml for enzymatic analyses 
and storage at -80°C, or solubilised directly with 1% Triton X-100, 
10% CDj 00 in D2 0. Insoluble matter was removed by centrifugation 
at 40K r.p.m., as above.
Detection Ve2283 (Cl) binding to SMP using 1^Sn-NMR
The penta-coordinate tin complex Ve2283 was dissolved to saturation 
in C02 0D (»60mg/ml) and overnight ^®Sn-NMR spectrum obtained using 
the Bruker WH400 spectrometer in conjunction with a multi-nuclear 
probe. Similarly, Ve2283 was dissolved in 1% triton X-100, 10% CD^OD
in DjO with and without bovine serum albumin or submitochondrial protein 
(30mg/ml). Spectra of each of the samples were collected consecutively, 
around the chemical shift recorded for Ve2283 in deuteromethanol.
4.3 Results
The Inhibition of ATP Synthase and Hydrolase Activities 
Table 4i demonstrates the inhibitory functions of the penta-coordinate 
tin complexes. Clearly, those compounds based on N'N'-dimethyl benzyl - 
amine nitrogen coordination are the most potent. The oxygen facilitated 
penta-coordinacy of the ( 8  -carboalkoxyethyl)-tins adds little to the 
potency of these compounds. Comparisons of these activities with 
n-alkyltins demonstrates they are indeed less active inhibitors of
ATP hydrolysis and synthesis in rat liver mitochondria. However,
the penta-coordinate complexes with nitrogen coordination are signifi­
cantly better inhibitors, Ve2283 (Br) has I^q values of 0.10 and 
1.2 nmoles/mg mitochondrial protein for ATP hydrolysis and synthesis 
respectively, which makes it one of the most potent inhibitors of
the ATPase complex known. Clearly, penta-coordinacy per se does not 
lead to an increased inhibitory activity towards the ATPase complex.
In Table 4i the differential sensitivity of the ATP synthetic reaction 
against that of the hydrolase reaction is observed. This phenomenon 
is clearly visible with the penta-coordinate complex Ve2283 where 
the concentration of organotin required to inhibit ATP synthesis
(2.5 nmoles/mg) is 2J fold that required to completely inhibit ATP
hydrolysis (1.0 nmoles/mg protein). The conditions employed for these 
assays were performed in minimal chloride media similar to those dis­
cussed in Chapter 3 and should not facilitate chloride/hydroxyl exchange. 
The titration curve of Ve2283 (Br) is presented in Figure 4ii, together 
with that of the potent inhibitor DBCT for comparison.
Further comparisons of inhibitory actions of Ve2283 and DBCT are
<. t
Table 4.i
Legend :
ATPase and succinate driven ATP synthase activities were estimated 
as described in 'materials and methods' (Chapter 3). The numbers 
in parentheses correspond to the numbers of separate duplicate 
experiments. Control ATPase and ATP synthase rates ranged 
between 30-40nmoles/mg/minute and 80-100nmo1es/mg/minute 
respectively. Values >50nmoles/mg are expressed at their solu­
bility limits in aqueous solution.
Figure 4,ii
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ATPase/Synthase ° / •  Ve22&3
A / *  DBCT
Inhibition of Mitochondrial ATP Synthesis and Hydrolysis by Ve2283 and DBCT 
Legend:
The enzymatic estimates were performed as described in 'materials 
and methods' of Chapter 3 (ATPase open symbols, ATP synthase hatched 
symbols) and expressed as percentiles of control values (ATPase 31nmoles/ 
mg/minute, ATP synthesis 94nmoles/mg/minute).
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presented in Table 4ii where their activities were monitored in rat 
liver submitochondrial particles. The I5Q values for the ATP hydrolase 
are increased compared to those obtained with whole mitochondria, 
which may be indicative of an increased ATPase to protein ratio in 
SMP. However, when one considers the ATP synthetic activities, the 
I^q values for Ve2283 and DBCT do not increase proportionally; this 
may be indicative of an uncoupler mode of action on oxidative phosphory­
lation (certainly for DBCT, see Chapter 3), or the inhibitor binding 
site is in competition with non-specific binding prior to saturation. 
Total inhibition of ATPase activity by Ve2283 in rat liver submito- 
chondrial particles occurs between 0 . 6  and 1 . 0  nmoles/mg protein.
Estimates of around 0.5 nmoles/mg protein for the content of Fo in 
beef heart subrnitochondrial particles have been made (Slater, 1974), 
extrapolating these values to rat liver SMP (which are probably high), 
would suggest that Ve2283 is interacting with the ATPase complex between 
the ratios of 1 : 1  and 1 :2 , which makes the compound a valuable and 
sensitive probe for the mammalian F,Fo-ATPase.
Figure 4iii demonstrates the titration of ATPase and ATP synthetic 
activities of submitochondrial particles by Ve2283 (Br). Over the
range of concentrations presented here the ATP synthetic titration 
curve is tending towards a sigmoidal shape, that is, the compound
produces a steep mid-point of titration with less pronounced effects
at the extremes of high and low activity. This behaviour has been 
noted previously for the inhibitory behaviour of the antibiotic oligo- 
mycin (Ernster et al, 1963; Lardy et al, 1964 and Zoratti et aj_, 1982), 
but is by no means common to all inhibitors of the ATPase complex.
The results are consistent with those of Aldridge et _al_, 1981, on
rat liver mitochondria.
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Table 4,ii
Inhibition of ATP Synthesis and Hydrolysis in Rat Liver Submitochondrial
Particles
Triorganotin plgg (nmoles/mg protein) +SD
ATPase ATP synthesis
Di butyl chi oromethyl tin chloride 1 . 8  ± 0.18 2.5 t 0.4
Ve2283 (Br) 0 . 2  t 0 . 0 1 1 . 2  ± 0 . 2
Ve2283 (Cl) 0 . 2  t 0 . 0 2 1 . 2  ± 0 . 2
Submitochondrial particles were prepared as described in 'materials 
and methods' of this chapter. Each value presented is the mean 
of two separate duplicate experiments. ATPase and ATP synthase
rates ranged between 56-58 nmoles/mg/minute, and 75-83 nmoles/ 
mg/minute respectively.
Figure 4.i i i
)6
Titration of ATP synthetic and hydrolytic activities in Rat Liver 
Submitochondrial Particles by Ve2283 (Br)
[Ve22fc3] (nmoles/mg)
° -  ATPase 
• -  ATPsynfhase
Legend:
The enzymatic estimates were performed as described in Chapter 3 
and the preparation of submitochondrial particles described in 'materials 
and methods'. The ATPase activity (open circles) was 58nmoles/mg/minute 
and the ATP synthase activity (hatched circles) was 83nmoles/mg/minute.
w7
The Effects of Penta-coordination Complexes on Proton Motive Force 
The methods of isotope distribution (8 6 Rb+ [3 H]-TPMP+ and [1 4 C] lactate; 
cf. Chapter 2) and time dependent DSMP+ fluorescence have been applied. 
Table 4iii presents the organotin concentrations required to reduce 
the membrane potential by + lOOmV.
In all cases, the penta-coordinate tins are poor uncouplers. Although 
it must be noted the ester tins are comparatively better at reducing 
membrane potential, which is possibly their mode of action on oxidative 
phosphorylation. In contrast to their potent inhibition of ATPase 
and ATP synthase the N-coordinate tins do not disturb the membrane 
potential until quite high concentrations (30 nmoles/mg are required 
to reduce av by + lOOmV for Ve2283 (Br)). As argued in Chapter 3, such 
high inhibitor/protein ratios may seriously perturbate the integrity 
of the membrane, indeed, Ve2283 may not uncouple per se. The function 
of these inhibitors is thus analogous to that described for triphenyltin- 
chloride, in that they are direct inhibitors of the ATPase complex, 
only more potent. The nature of the tin-halide bond again appears 
not to affect the compound's inhibitory mode of action, Ve2283 (Cl) 
behaves similarly to Ve2283 (Br).
Table 4iii also displays titration variations imposed by different 
techniques of measurement, as noted earlier.
Comparing the functions of Ve2283 and DBCT, the 'mechanistic' differences 
of each become apparent. Both compounds inhibit ATP hydrolysis, the 
mechanisms of which we have no reason to believe are dissimilar, but 
their modes of action in halting oxidative phosphorylation certainly 
are (see Figure 4iv). DBCT is observed to titrate the membrane potential 
component of ap at relatively low inhibitory concentrations (3.0-5.0 
nmoles/mg), causing a decline in av from the onset of inhibition of 
oxidative phosphorylation. This is in direct contrast to Ve2283 which
9 8
Table 4,iii
The Abilities of Oraanotins to Reduce Membrane Potential
Triorganotin + lOQmV a t ±SD
(2- [ (dimethyl ami no) methyl ) phenyl)
- dimethyltin bromide 2 0  ± 1 . 6 26 ± 1.4 30 ± 4.1
- diethyl tin chloride 26 ± 1 . 8 28 ± 1.3 30 ±4.1
- diethyl tin bromide 26 ± 1 . 6 28 ± 1.3 30 ± 4.1
(B-carbobutoxyethyl)
Tri - tin chloride 25 ±4.0 30 ± 3.5 30 ±4.1
Di - tin dichloride - - >50
Mono - tin trichloride - - >50
(s-carbomethoxyethyl)
Tri - tin chloride 35 ±4.1 45 ± 4.0 45 ± 4.1
Di - tindichloride - - >50
Mono - tin trichloride - - >50
Legend:
These assays were performed as described in 'materials and methods'.of
Chapter 2. The fluorescence assay using DSMP+ was undertaken 4 times 
and the average value presented. The values for the Rb and [ H]-TPMP 
experiments are the mean of three separate duplicates. Values >50nmoles/mg 
are expressed at their solubility limits in aqueous solution.
Figure 4.iv
The Effects of DBCT and Ve2283 on a t , ¿pH and Ap
Legend:
— 2-------  3 +
av and Ap estimates were based on those obtained with [ H] -TPMP .
The distributions of 2 mM [^ H ]-TPMP+ (luCi) and 25m M [^C]-lactate
(0.5 uCi) were measured as described in Chapter 3 (•, Ve2283 (Br);
■, DBCT). The arrows represent the values at which ATP synthesis
is completely inhibited.
i n  j
-Ve22B3
-D B C T
actually produces a slight nett increase in ap (-15 to -20mV as ascer­
tained by [^H]-TPMP and [^C] -lactate distributions), before causing a
progressive reduction. This type of behaviour is consistent with 
Ve2283 having a direct interaction on the proton channel of the mitochon­
drial ATPase complex and DBCT as an active uncoupling agent. The 
high inhibitor concentrations which are necessary for Ve2283 to cause 
membrane potential depolarisation are at least one order of magnitude 
larger than those required for enzymatic inhibition, which indeed, 
as argued in the previous chapter, may result in the loss of the integ­
rity of the membrane, rather than a bona fide uncoupling action.
The Detection of Penta-coordinate Tin Binding
119Figure 4v presents the Sn NMR of Ve2283 (Cl) in duteromethanol.
The spectrum consists of a single decoupled peak at -109.48 6 /ppm.
This chemical shift was then used as a standard for the following
two experimental spectra obtained for Ve2283 (Cl) in duterated water
with 10% CD-jOD and 1% triton. These conditions were used to optimise 
the differing solubilites of the organotin complex and soluble protein 
extracted from successive preparations of rat liver submitochondrial 
particles. The chemical shift recorded in duteromethanol was consistent 
for an internally coordinated organotin complex (-90 to -110 «/ppm, 
unpublished data from the International Tin Research Institute).
Figure 4vi A and B presents the spectra for Ve2283 (Cl) in the presence 
of 10% CD^OD, 1% triton in D^O plus and minus soluble protein from rat 
liver submitochondrial particles respectively (*50mg). The effect 
of changing the solvent conditions from CD^ OD was to move the chemical 
shift by approximately 2.5a/ppm to -106.96 a/ppm, the addition of 
protein made only a slight further difference, -106.45 6 /ppm. Despite 
little change in the chemical shift a change in the spectrum in the 
presence of protein was noted. The generation of satellites around
101
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Figure 4.v
^Sn-NMR Spectrum of Ve2283 (Cl)
Legend :
119400MHz Sn-NMR of Ve2283 (Cl), 50mg in CDjOD
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Figure 4.vi
1 1 9 Sn-NMR Spectra of Ve2283 (Cl), the Effects of Soluble Mitochondrial
Protein
Legend :
A. 400MHz 1 1 9 Sn-NMR of Ve2283 (Cl), 50mg with 10% CD 3 OD, 1% Triton 
in D 2 O; total volume 2ml.
B. As described in A. with the addition of 50mg of bovine serum 
albumin.
C. As described in A. with the addition of 50mg of soluble mito­
chondrial protein.
C
G
N
N
T
M
P.
0
0
1
0  —
0
0 0 0 (D0
cd  0  ' O 0 Q L Ü OQ t o  m 0 — 0 0  — 0• p*1*«. • • • *LO • •CD •
CD ■ O'T'CO 0  — in 0 O T o
■ ^CVJOCCKM (\J — h - 0 0  • —
— (Û O CO ^f • 0 0 in r —1 r-H
OCÛ — 0 CD 51
ID —C'- CD H U
Li_>- —-"— >12
(VI
3 Q C 3 CD (VI
u \
\ 5Z
CDN tL.
c n c n o c n c n cl. a :  c e  2 : 0 - J X C L
o
CO
<
3
0
0
1
- 
_________
Q
Q
I- 
0
0
1
-
the central Sn peak in spectrum *B ' (J 1.043 and 1.788Hz) would
suggest that there are two separate tin based molecular species (the 
new species would have to be of insufficient quantity to generate 
a further peak, or of similar chemical shift) or perhaps the same
I
species in two very different environments. Although speculative, 
both the above interpretations are consistent with the penta-coordinate 
tin interacting with a mitochondrial membrane component. The component 
should be specific, triton soluble and present in a reasonable quantity; 
conditions which do not preclude the ATPase complex.
Unfortunately, the solubilities of the components of this system means 
that we are approaching the limits of information which the above 
experimental approach may yield. Nevertheless, the above experiment 
has indicated that Ve2283 may interact chemically with the mitochondrial 
membrane, not just by virtue of its lipid solubility.
4.4 Discussion
The internally coordinated ester tins (o-coordinate) are relatively 
poor inhibitors of the ATPase complex. Nevertheless, they do inhibit 
in the relative order of tri-, di- and mono- s-corboalkoxyethyltin, 
which, because of their potential for penta-coordinacy could facilitate 
4, 3 and 2 valent interactions with membrane components. Clearly, 
the 4-coordinate interaction would be favoured in terms of activity, 
the tri s -carboalkoxyethyltins are 3-4 fold more active inhibitors 
compared with the Di- e-carboalkoxyethyltin analogues.
Aldridge and Street, 1970, have postulated that the mechanism of tri- 
alkyltin binding to the inhibitor site on the OS-ATPase complex involves 
the formation of tin-nitrogen linkages between the trialkyltin and 
paired histidine residues (Figure 4.v11), similar to that proposed 
by Rose, (1969), for the binding of triethyltin to rat haemoglobin, 
and by Davidoff and Carr, (1973), to pyruvate kinase. However, Gould,
119
Proposed Sn-coordination with Histidine Residues Within Proteins
Legend :
Proposed structure for trialkyltin binding to haemoglobin, pyruvate 
kinase and OS-ATPase.
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(1978), has demonstrated that triphenyltin inhibition of OS-ATPase 
activity cannot be reversed by large excesses of exogenous histidine, 
and Siebenlist and Taketa, (1983), have concluded that triethyltin 
bromide ligands to neither cystein or histidine. Nonetheless, the 
possibility of polymeric coordination of histidine residues with tri­
al kyltins should exist, since other nitrogen based heterocycles have 
been reported to undergo such reactions, (Paller, 1965 and Luijten 
^t al, 1962).
Emanuel et^  ^ 1 , (1984), have shown that DBCT inhibition of oxidative
phosphorylation, OS-ATPase and ATP-driven transhydrogenase can be 
effectively reversed by dithiols and not monothiols in beef heart 
submitochondrial particles. Similar findings have been obtained by 
Cain ^t _a2> (1977), for dibutyltin dichloride. Gould, (1976), has
also shown that triphenyltin inhibition of photophosphorylation and 
on decreased proton permeability in CFj depleted chloroplasts were 
specifically reversed by dithiols. Recently, Yagi and Hatefi, (1984), 
have reported the reversal of triphenyltin inhibitors with not only 
dithiols, but also B-mercaptoethanol. Although such results are not 
conclusive evidence of the role of vicinal dithiols function in tri- 
organotin mediated inhibition of OS-ATPase, they are certainly suggestive 
of the interpretation. However, Nbf-Cl inhibition is also reversed 
by dithiothreitol, but is known to be a specific inhibitor of F,-ATPase, 
modifying an essential tyrosine residue of the 8 subunit (Ferguson 
et al, 1974 and 1975). It must also be noted that the penta-coordinate 
complex Ve2283 does not react with dithiols or monothiols, as ascertained 
by the 2, 6 -dichlorophenolindophenol technique of Aldridge and Cremer, 
1955, (Carver, 1980, unpublished results), neither is the inhibition 
reversed by thiol compounds (Emanuel, 1981). The interaction therefore 
noted in results may be novel for triorganotins.
As outlined in 'Results’, the N-coordinate compounds such as Ve2283 
are exceptional in their capacity to inhibit the mitochondrial ATPase 
complex, without uncoupling. Indeed, when Ve2283 is introduced into 
the system ap is seen to rise by -15 to -20mV at titres up to 4-5 
nmoles/mg protein. This behaviour is in total contrast to that of 
DBCT which functions as an uncoupling agent, although both inhibit 
ATPase activity. Ve2283 is therefore preventing proton conduction, 
and as a consequence, is preventing the catalytic functions of the 
OS-ATPase complex. Other triorganotins may produce similar effects 
to lesser degrees but will be superceded as other uncoupling functions 
mitigate. Nevertheless, it appears that triorganotins will arrest 
proton conduction at the level of the H+ ATPase at low titres, whereas 
at higher titres will cause uncoupling, and ultimately destroy the 
integrity of the membrane, collapsing most energetic functions (the 
latter severe action being synonymous with the release of soluble 
proteins and possible lysis (Wulf and Byrington, 1975)).
The phenomenon of continued ATP synthesis in the absence of the hydroly­
sis reaction has been addressed by Ferguson and Parsonage, (1984), 
for an inhibitor of the ATPase complex. They have postulated that 
an increase in ap potentiated by the inhibition of protonic conductance 
through Fo may cause the inhibited ATP synthase enzymes to increase 
their turnover rate, and result in a compensated rate of oxidative 
phosphorylation over ATP hydrolysis. This explanation is possible 
when one considers the nett stimulation of ap at low titres of Ve2283. 
However, the rate of ATP synthesis by the uninhibited enzymes would 
have to be truly drastic, particularly when one considers the situation 
in submitochondrial particles where 90% of the ATP hydrolytic capacity 
has been lost while oxidative phosphorylation is continuing at >80% 
of the control rate. It must also be noted that unlike beef heart
l ' - ’ J
1mitochondria where ATPase rates can be as much as 25 fold the ATP 
synthetic rate, rat liver mitochondria produce rates of the same order 
of magnitude, thus comparisons of the ATP synthetic and hydrolytic 
functions may be considered directly without preferential turnover 
rates of the enzyme complex. Further, the depression of ATP hydrolysis 
by the back pressure of protonic conductance leading to ATP synthesis,
i.e. the measurement of ATPase rates in the presence of Ap for mitochon­
dria, does not unduly affect the inhibitor titration as evidenced 
by similar observations in submitochondrial particles (Figure 4iii 
and Emanuel et a U  1984). However, the prediction of Ferguson and 
Parsonage, (1984), may have some bearing on the phenomenon of increased 
rates of oxidative phosphorylation (1 0 -2 0 %) of submitochondrial particles 
in the presence of low titres of triorganotin (Emanuel, 1981).
The data on the differential inhibition of ATP synthesis and ATP hydroly­
sis can be interpreted in terms of dual pathways for protonic conductance 
through the Fo portion of the mitochondrial ATPase complex. Protonic 
conductance should occur by two chemically distinct pathways, dis­
tinguishable by their differential affinities for triorganotins.
One path leading to the hydrolysis of ATP and possibly functioning 
in synthesis, and a second which is utilised solely for synthesis. 
Whether these entities are functionally mediated through conformational 
change in the complex, or via distinct protonic channels can only 
be speculated upon at the present time. Arguments continue as to
whether protons interact with the bulk aqueous phase and are transported 
by specific ion channels, or move via localised pathways whereupon 
an interaction with the ATPase complex is envisaged. Within the chemios- 
motic framework the above results should lead to the conclusion that 
two independent structural ion channels should be present on the ATPase 
complex, or that two functionally different complexes are present.
At the present time, of the ubiquitous eukaryotic proteins found in 
Fo, subunits 6 , 8  and 9, two have had their capacities to conduct 
protons in a voltage dependent manner demonstrated in reconstituted 
lipid vesicles; J. Velours (personal communication), and Shindler 
and Nelson, ( 1982), for subunits 8  and 9 of Saccharomyces cerevisiae 
respectively.
Protein sequences and protein sequences derived from nucleic acid 
sequence data of Fo subunits, now exist for a variety of eukaryotic 
organisms. When these are analysed for their histidine and cystein 
contents, aminoacid residues which have been linked with the binding
of triorganotins, these aminoacids appear sparingly. For example, 
in the yeast Saccharomyces cerevisiae, subunit 6  has four histidines 
and one cystein, subunit 8  has neither histidine nor cystein, and 
subunit 9 has one cystein and no histidine residues (data derived
from DNA sequence of the mitochondrial genome, see Chapter 7 of this 
thesis). On this basis that interactions are possible with subunits
6  and 9 whereas histidine interactions are only possible with subunit
6 . When various subunit 6  sequences are surveyed they display conserved 
histidine elements towards their carboxyl ends (cf. Table 4iv). This 
sort of interaction is attractive since the carboxyl side of subunit 
6  may be of some functional import, based on mutational analysis of
drug resistant mutants (see Chapter 7 of this thesis). If basic residue 
interactions are to be considered, for example the hydroxyl groups 
of serine residues, then all the above proteins have several such 
residues.
Of the triorganotins examined so far, Ve2283 is the most interesting, 
its specific inhibition of the OS-ATPase makes the compound of great 
value; particularly when one considers the lack of coincidental functions 
such as direct uncoupling, and chioride/hydroxyl exchange (Aldridge
1  *.Jl
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et _al, 1981), at titres which bring about inhibition. Ve2283 radio- 
actively labelled would make a useful affinity label for the H+ ' ATPase 
complex. Attempts to achieve this goal by standard chemical isotope 
exchange on the ring protons of N‘N*-dimethylbenzylamine (catalysed 
by borontrifluoride or aluminium chloride) have met with only limited 
success, some 12.5 to 18.5% as model diiteration (ascertained by observing 
m+1 totals on mass spectrometry). A much higher incorporation is 
required for the analogue to be a good probe of the ATPase complex. 
Tritiation in steam appears a better alternative, although impractical 
under normal laboratory conditions.
4.5 Cone 1u s i on
(2 -[(dimethylamino) methyl ] phenyl) dialkylhalide derivations are good 
inhibitors of the mitochondrial ATPase complex in both its synthetic 
and hydrolytic capacities. Penta-coordination per se does not lead 
to good inhibitory qualities, but does lend evidence to the 4-coordinate 
binding of triorganotins to the ATPase complex, as evidenced by the 
B-carboalkoxyethyltin halides. The N-coordinated complex Ve2283 does 
not effect a reduction in ap until high titres of the inhibitor are 
present, at which time all enzymatic functions of the ATPase have 
deceased. The compound is a specific functional inhibitor of the
+H-ATPase titrating the complex at approximately 1:1 or 2:1, suggesting 
a highly specific interaction or covalent binding- Sn-NMR provides 
evidence that Ve2283 binds to a triton soluble component of the mito­
chondrial membrane. The N-coordinate tins also differentially titrate 
ATP hydrolysis and ATP synthesis in both rat liver mitochondria and 
submitochondrial particles, which is indicative of dually functioning 
H+ATPase complex.
CHAPTER 5
1, ;
The Effects of Trialkylleads on the Energetic Functions of Rat Liver 
Mi tochondri a
5.1 Introducti on
As described for trialkyltins, the trialkylleads act on mitochondria 
by three basic mechanisms: namely, direct inhibition of the mitochondrial 
ATPase complex (Aldridge et 1^_, 1977), stimulation of chloride/hydroxyl
exchange (Coleman and Palmer, 1971, and Rose and Aldridge, 1972), and 
finally, by gross swelling of the mitochondrial membrane (Aldridge 
et 1977). Similarly to trialkyltins, the trialkylleads also show 
a peak of activity against the ATPase complex at tributyl and triphenyl 
on increasing the alkyl chain length (Aldridge et al, 1977). Overall, 
the trialkylleads appear to favour chloride/hydroxyl exchange in their 
mode of action, as ascertained by comparing relative concentrations 
at SOt maximal change (Aldridge _et 1977), a possible exception
to this is the triaryl lead, triphenyllead chloride.
Although as stated above, the organometal lies of lead and tin have 
similar activities, it is the aim of the present study to compare 
their activities in the light of chloride independent energy potentiated 
uncoupling, as discussed in Chapter 3 of this thesis. The organoleads 
triethyl- and tributyl lead acetates have been used for this purpose.
5.2 Materials and Methods 
Materi als
All chemicals used were of analytical grade. The trialkylleads were 
obtained from All other sources of chemicals have been listed
previously.
Methods
Trialkyllead Solutions
All trialkylleads were added to the assay as dimethylformamide solutions
1serially diluted from lOmM stock, kept at room temperature in the 
dark.
All other methods employed in the present chapter have been described 
in the methods sections in Chapters 2 and 3.
5.3 Results
The Inhibition of ATP Synthase and Hydrolase Activities 
Table 5.i compares the 150 values for the inhibition of ATP synthase 
and hydrolase activities of rat liver mitochondria with triethyl- and 
tributylleads and tins. Triethyllead is a poor inhibitor of the ATPase 
complex in both its synthetic and hydrolytic capacities. Indeed, 
triethyllead at 10 nmoles/mg protein is observed to stimulate ATPase 
activity. This activity predominates, which is in contrast to triethyl- 
tin where 70% inhibition is experienced at 10 nmoles/mg. A maximal 
two fold stimulation of ATPase activity has been reported in 0.15M 
chloride medium for both triethyllead and tin (Aldridge et al, 1977), - 
although inhibition follows at concentrations greater than 2 nmoles/mg 
protein of triethyltin (see Chapter 3). The 10% stimulation experienced 
on triethyllead addition is consistent with an uncoupler stimulated 
activity. Further profound differences are observed between the two 
compounds as triethyllead undergoes total ATP synthase inhibition 
before significantly affecting ATPase activity; the very opposite 
of that observed with triethyltin. These effects are presented graphic­
ally in Figure 5.i together with those produced by the tributylmetals. 
Similarly to triethyllead, tributyllead completely inhibits oxidative 
phosphorylation before halting ATPase activity, although the effect 
is noticably less marked. Overall, the trialkylleads appear more 
potent inhibitors of oxidative phosphorylation than the equivalent 
trialkyltins. However, despite this, their ultimate modes of action 
have been reported to be similar; clearly, concentration dependent
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Table 5.i
The Sensitivities of Mitochondrial ATPase and ATP Synthase
to triorganoleads and tins
Trialkylmetal I5q (nmoles/mg protein) ± SD
ATPase ATP synthase
Triethyl lead acetate (3) 18 t 1 . 6 1 . 6 ± 0.4
Triethyltin sulphate (5) 2.8 ± 0.4 9.8 ± 0.5
Tributyl lead acetate (3) 4.8 ± 0.5 1 . 0 ± 0 . 2
Tributyltin acetate (3) 2 . 0  ± 0 . 2 7.8 ± 0 . 2
Legend:
ATPase and succinate driven ATP synthase activities were 
estimated as described in the 'materials and methods' 
of Chapter 3. The numbers in parentheses indicate the 
numbers of duplicate experiments performed. Control rates 
of ATPase and ATP synthase ranged between 30-40 and 80-100 
nmoles/mg/minute respectively.
Figure 5.i
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Inhibition of ATP Synthesis and Hydrolysis in Rat Liver Mitochondria by
Trialkyl Leads and Tins
Legend :
A. Titration profiles for triethyllead acetate (• o) and triethyltin
sulphate (■□).
B. Titration profiles for tributyllead acetate '♦<>) and tributyltin
acetate {*a).
These estimates were performed as described in 'materials and methods' 
of Chapter 3. The open and hatched symbols are ATPase and ATP synthase 
respectively, where activities are expressed as percentiles of control 
values (ATPase 37nmoles/mg/minute, ATP synthesis 73nmoles/mg/minute).
A. i
B .
effects are operating.
Trialkylleads as Uncouplers of Mitochondria
Table 5ii demonstrates the relative potencies of the trialkyl leads 
and tins to uncouple, based on the DSMP+ fluorescence assay. The 
trialkyl leads are far more potent uncouplers, reducing a» by +100mV at
4.0 and 2.25 nmoles/mg protein for triethyl and tributyllead respect­
ively. The values are approximately five fold less than those observed 
with the trialkyltins. Clearly, uncoupling is a major function of 
trialkyl leads on rat liver mitochondria.
Figure 5ii presents the titrations of the tributylleads against the 
components of proton motive force. Comparison against the equivalent 
trialkyltins demonstrates the superior activities of the trialkylleads 
to facilitate energy potentiated uncoupling. These large variations 
are indicative of the inhibitors having profoundly different principle 
functions to bring about net inhibition.
5.4 Discussion
The trialkylleads are clearly potent inhibitors of oxidative phosphoryla­
tion, but appear to be only moderate inhibitors of ATP hydrolase compared 
with their trialkyltin counterparts. Such behaviour is inconsistent
with a direct interaction with the ATPase complex. The stimulation 
of ATPase activity at low concentrations of trialkyllead is consistent 
with an uncoupler stimulated activity releasing the accumulation of 
protons, albeit low, compared with the chloride dependent stimulation 
of trialkyltins and that reported for trialkylleads (Aldridge _e£ _al> 
1977). The effect may be small due to simultaneous antagonism of 
the ATPase or non-proportional proton mobility. Considering the higher 
reported activities in the presence of chloride, the latter explanation 
appears more likely, that is, presupposing the ATPase undergoes no 
prejudicial interaction with free chloride. Uncoupling should prevent
The Relative Potency of Trialkyl- leads and tins on 
the Membrane Potential of Rat Liver Mitochondria
Tri al kylmetal
Triethyllead acetate 
Triethyltin sulphate 
Tributyllead acetate 
Tributyltin acetate
+ lOOmV a* ±SD 
(nmol es/mg)
4.0 ± 0.5
19.0 i 2.3 
2.25 ±0.3
13.0 ± 2.6
Legend:
The above data is based on DSMP+ fluorescent 
changes calibrated against the distribution of 
[3 H] -DSMP I as described in Chapter 2. The 
concentrations represent the mean of 5 individual 
assays ± standard deviation.
Figure 5.ii
The Effects of Tributyl- Leads and Tins on a t , ApH and Ap
Legend:
a t and Ap estimates were based on those obtained with [^H] -TPMP+ . 
The distributions of 2 pM (1 v* Ci ) [^H]-TPMP+ and 25pM (0.5pCi) [^C ]-
lactate were measured as described in 'materials and methods' of 
Chapters 2 and 3 respectively. 
a Tributyltin acetate; • Tributyllead acetate.
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[Tributylmetal] (nmoles/mg)
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ATP synthesis.
This conclusion is substantiated by considering parallel changes in 
membrane potential and proton motive force. The membrane potential 
is reduced by +100mV at 2.25 nmoles/mg for tributyllead acetate, which 
appears sufficient to reduce the rate of ATP synthesis by 60% but 
still retaining almost control rate ATP hydrolase activity. Tributyllead 
further halts ATP synthesis at approximately 4.0 nmoles/mg, which 
produces a correspondingly low net Ap of 80-90mV. This proton motive 
force should not be capable of driving ATP synthesis in the presence 
of largely unmodified ATP synthase molecules requiring substantial 
proton flux. However, under such circumstances ATP hydrolysis should 
continue unabated.
These effects may be considered as an extreme case of those discussed 
earlier for DBCT and the very antithesis of those experienced with 
Ve2283. In general, the trialkyl tins appear as moderate to good inhibit­
ors of the ATPase complex in both its capacities; in contrast to the 
trialkyl leads which appear to function as potent uncouplers, independent 
of chloride/hydroxyl exchange.
5.5 Cone 1usi on
Trialkylleads have been shown to be potent uncouplers of oxidative 
phosphorylation. They exert their effects via reduction in proton 
motive force, which appear not to be parallelled by inhibitory actions 
on the ATPase complex. In the absence of appreciable chloride/hydroxyl 
exchange the trialkylleads appear to have different functional priorities 
over those of the majority of trialkyl tins.
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CHAPTER 6
Energetic Studies on Yeast Mitochondria
6.1 Int roduct i on
It has long been known that isolated yeast mitochondria appear poorly 
coupled compared to their mammalian counterparts, as ascertained by 
their lack of stimulation of the F, Fo-ATPase activity with uncouplers 
(Kovac et al_, 1968) and lower P/0 ratios (Linnane et al_, 1962; Vitols 
et £l_, 1961; and Mattoon and Balcavage, 1966). However, the membrane 
bound ATPase activity appears to be oligomycin sensitive, similar 
to mammalian systems (Kovac, 1968; and Somlo, 1968; see Lloyd, 1974 
for review).
Biochemical studies focussed on mutants of the yeast mitochondrial 
ATPase have revealed that oligomycin resistivity bears no apparent 
energetic handicap (Griffiths and Houghton, 1974; and Somlo et al , 
1974), merely a reduced affinity for the drug (Griffiths and Houghton, 
1974). However, studies on the mit mutations at the pho 1_ locus, 
closely linked to 01 i 2 on mitochondrial DNA (Somlo et al_, 1977), 
have revealed a highly abnormal ATPase complex. The mitochondrial 
ATPase produced by the mutant exhibits weak membrane linkage, exaggerated 
activation, an increased sensitivity to oligomycin, dual behaviour 
on purification and low rates of oxidative phosphorylation in isolated 
mitochondria (Somlo et al_, 1977 and 1979).
It is the purpose of the following chapter to determine the energetic 
properties of yeast mitochondrial preparations from various mutant 
strains, despite their inherently 'leaky' nature. The current study 
is focussed on the ability of yeast to generate a mitochondrial membrane 
potential, as ascertained by the fluorescent probes DSMP+ and DSEP+, 
under various inhibitory conditions.
Similar studies have been reported on whole yeast cel Is using the cyanine
dye 3,3'- dipropylthiocarbocyanine iodide as a fluorescence indicator 
(Kovac and Varecka, 1981). The fall in the steady-state fluorescence 
of the dye was attributed to a depolarisation of membrane potentials, 
the major contribution of which was provided by the mitochondrial 
membrane potential as indicated by specific uncouplers and pore-forming 
agents. However, a certain proportion was assigned to the plasma 
membrane which remained inducible in petites by the addition of 
metabolites.
6.2 Materials and Methods 
Materi al s
Sorbitol was purchased from Fisons. Nyastatin was purchased from 
Serva and '1799' (1,1 - bis (hexafluoroacetonyl) acetone) was obtained 
from Dow Chemical Corporation Inc. Zymolyase was purchased from Miles. 
All other reagents have been described in earlier chapters.
Yeast Strains
The yeast strains employed in Chapter 6  and 7 are listed in Table 6 .i 
together with their genotypes and origin.
Culture Medi a
Basically, three types of complex media were used: YPD, YPG and YPGal.
YPD YPG YPGal
2% (W/V) D - Glucose 3% (V/V Glycerol 3% (W/V) Galactose
U  (W/V) Yeast Extract 1% (W/V) Yeast Extract 1% (W/V) Yeast Extract
1% (W/V) Bactopeptone 1% (W/V) Bactopeptone 1% (W/V) Bactopeptone
When solid media was required 2.3% (W/V) agar was added prior to
autoclaving.
Antibiotic Media
Antibiotics were always added to the media after autoclaving and cooling. 
For solid media the antibiotics were added before pouring of the plates 
at 45-50°C. All antibiotics were added in ethanolic solution except 
triethyltin sulphate (TET) which was added in aqueous solution.
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Methods
Sterilisation
Pipettes were sterilised by dry heat at 150°C overnight. All other 
sterilisations were performed by autoclaving at 15 psi for 20 minutes 
at 160°C.
Preparation of Agar Slopes
Bijou bottles were filled to approximately half capacity with YPD 
plus 2.3% agar No.3, loosely capped and sterilised. After cooling 
in inclined racks, the slopes were allowed to dry before tightening 
the caps and storing at 4°C.
Temperature
All incubations were performed at 29±1°C, unless otherwise stated. 
Maintenance of Strains
Slopes were sub-cultured every six months and incubated for 2-3 days 
before storage at 4°C. All drug resistant strains were tested with 
various concentrations of antibiotics before use TET (5,10,20 ug/ml), 
R6 G (25, 50, lOOpg/ml), venturicidin (0.5, 1, 2 pg/ml), oligomycin
(0.5, 1, 2ug/ml), and ossamycin (1, 2, 4pg/ml).
Growth of Yeast
Batch cultures of yeast were grown to late log phase in YPG from pre­
culture, by forced aeration of 500ml aliquots in 2 litre fluted Erlenmyer 
flasks. The yeast were harvested in 250ml centrifuge bottles at 2,000 
x g for 10 minutes. The pelleted cells were washed in cold sterilised 
distilled water before suspension in breaking buffer (0.5M Sorbitol, 
lOmM Tris/HCl pH 7.5, ImM EDTA, 0.1* BSA) at 0.5ml per gramme of wet 
cel Is.
Preparation of the Mitochondrial Fraction
All the following operations were carried out at 0-4° C. The cell 
suspension was placed in a stoppered glass bottle with a half volume
of ballotini (0.4-0.5mm diameter) and broken by the hand-shaking method 
of Lang £i_aJ, (1977), in 3 x 2 minute cycles with 1 minute intervals 
on ice. The broken cell supernatant was decanted and the residual 
glass beads washed thoroughly with breaking buffer before pelleting 
the unbroken cells and cell debris at 2000 x g for 15 minutes. The 
supernatant from this spin was then transferred to 60ml polycarbonate 
centrifuge tubes and the mitochondrial fraction isolated by spinning 
at 16000 x g for 30 minutes. This pellet was suspended in breaking 
buffer minus BSA at 30mg/ml.
The mitochondrial suspension produced in this manner was then layered 
onto a discontinuous sucrose gradient (14ml each of 15%, 30%, 50%
and 70% (W/V) sucrose solutions containing 10% methanol, lOmM Tris/HCl 
pH 7.5, ImM EDTA) and centrifuged in a Beckman 42.1 Ti rotor at 28 K r.p.m 
for 3-4 hours. The mitochondrial band was visually collected at an
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approximate density of 1 .2 0 g/cm and diluted into breaking buffer 
minus BSA to 20mg/ml.
When small quantities of mitochondria were required from various strains,
the cells were broken enzymatically by digestion with Zymolyase 2,000
o
in 1M sorbitol, lOmM Tris/HCl pH 7.5, ImM EDTA 30 C for 1 hour. The 
resulting spheroplasts were then lysed osmotically by diluting the 
suspension mix to 0.6M sorbitol; the mitochondrial fraction was collected 
as above.
Fluorescence Monitoring of Mitochondrial Membrane Potential 
Yeast cells were spheroplasted as above with Zymolyase and pelleted 
and washed in 1M sorbitol, lOmM Tris/HCl pH 7.5, ImM EOTA before keeping 
on ice. The spheroplasts were diluted into 250mM mannitol, lOmM Tris/HCl 
pH 7.5 in the fluorescence cuvette and immediately placed in the fluor- 
imeter with overhead stirring before the addition of DSMP or DSEP 
at 1 uM. The fluorescence signal was allowed to achieve steady-state
before the addition of inhibitors or exogenous substrates, invariably 
the i_n situ liberated mitochondrial membranes appeared energised from 
wiId type cel 1 s.
6.3 Results and Discussion 
In Vivo Drug Resistance
The minimum inhibitory concentrations for the various mutant strains 
of yeast are presented with their wild type progenators 027 (a subclone 
of the a met strain D273/10BA1) and D27 in Table 6 ii. The majority 
of drug resistant mutations isolated show cross resistance to other 
mitochondrially directed drugs, in particular those selected for R6 G, 
TET and venturicidin resistance. However, specific drug resistant
D
alleles may be selected for 01 i 2 and Oss mutations, 01 i 2-76 and
p
Oss 1-92 respectively, for further molecular analyses. The mutations 
conferring specific drug resistance phenotypes are exceptions rather 
than the rule, in particular, those distinguishing resistance to oligomy- 
cin and ossamycin, suggesting that the sites of action of these drugs 
may overlap. A previous study in this laboratory, Griffiths and Houghton, 
(1974), failed to make this distinction in some forty independent 
drug resistant isolates examined. This conclusion is further exemplified 
by considering the 01 i 2 mutation Oli 2-118 of Macino and Tzagoloff, 
(1980), which appears to show cross-resistance to ossamycin and has 
been shown to be a point mutation at residue number 254 in the Oli .2/ 
subunit 6  coding sequence, as ascertained by DNA sequence analysis. 
However, these general conclusions must be validated by checking their 
resistance types at the mitochondrial level in vitro.
In Vitro Drug Resistance
Mitochondria were isolated from the mutant strains as indicated in 
the above paragraphs, chosen on the basis of their j_n vivo behaviour. 
ATPase assays were performed as described earlier and yielded rates
Strain
D273/10BA1
D27/76
D27/A118
D27/110
D27/92
D27/101
D22
D22/69
022/72
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Table 6  . i i
Inhibitor Tolerances of Mutant Strains 
Mutation Tolerance to Inhibitor (ug/ml)
Oligomycin Ossamyci n Venturicidin Triethyltin
Wild type 0 . 1 0.5 0 . 1 1 . 0
0 1  iR 2-76 1 . 0 0.5 0 . 1 1 . 0
0 1  iR 2 -n 8 > 1 0 > 1 0 0 . 1 1 . 0
0 1 iR 1 - 1 1 0 > 1 0 > 1 0 0 . 1 1 . 0
0 s s R 1-92 0 . 1 5.0 0 . 1 1 . 0
0ssR2-101 1 . 0 > 1 0 0 . 1 1 . 0
Wi Id type 0 . 1 0.5 0 . 1 1 . 0
VenR > 1 0 > 1 0 > 1 0 > 1 0
R6 GR > 1 0 > 1 0 > 1 0 > 1 0
tetr > 1 0 > 1 0 > 1 0 > 1 0D22/EC6
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of ATP hydrolysis in the range of 4-5 pmoles/mg/minute from wild type
and drug resistant mitochondrial preparations. In addition to the
drug resistant mutants surveyed are a series of mit* mutations spanning
the Oli 2 region presented for comparison as I^q values in Table 6 .iii.
The mit mutation pho 1 demonstrated a reduced activity of 1 .Opmoles/mg/
minute which is expected since it has been located within the Oli 2
gene (Connerton et al_, 1984 and Somlo ^t al^ , 1985), coding for a
20 K Dalton subunit of mitochondrial ATPase (Roberts et al_, 1979).
The nature of the residual ATPase activity of the leaky pho J_ mutant
is due to a heterogenous population of ATPase molecules (Somlo et al_,
1977; and Somlo and Krupa, 1979), created due to a frameshift in the
Oli 2 gene and its partial compensation (Somlo et £l_, 1985).
R RThe sole resistance phenotypes of the mutations Oli 2-76 and Oss 1 -92 
is further verified at the level of the ATPase complex with the informa­
tion that the I^q values (see Table 6 .i i i) demonstrate that each allele 
causes at least a 5 fold increase over the wild type progenator for 
their respective drugs, but still maintain wild type sensitivities 
for other inhibitors of oxidative phosphorylation. These rare mutations 
are well sited for further molecular analysis (for further information 
see Chapter 7). The Oli 2 mutation of Macino and Tzagoloff, (1980),
Oli 2-118, also bears out its cross resistance in vitro, demonstrating
Icri values some 7 and 8  fold over wild type for oligomycin and ossamycin bU
respectively. It is noted that this allele also produces an I5Q value 
for venturicidin which is double that of the wild type, the drug binding 
sites may overlap. This conclusion is further substantiated by consider- 
ing the wide cross-resistance imposed by the Oli 1 allele Oli 1-110, 
the Oli 1 gene, subunit 9, may play a central role in the binding 
of many drugs affecting ATPase functions by interaction with the Fo 
moiety of mitochondrial ATPase. The Oss 2 allele, Oss^ 2-101, presumably
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Table 6  . i i i
Inhibition of Mitochondrial ATPase by Various Inhibitors
Strain Mutation h o  Va1ues (ug/mg protein)
0 1  i gomyci n Ossamyci n Venturicidin Triethyltin
D273/10BA1 Wi ld type 3.0 3.0 0.4 0 . 8
027/76 01 iR2-76 17.5 3.0 0.3 0 . 6
D27/A118 01iR2-118 19.5 25.0 0.7 0 . 8
D27/110 0 1 iRl- 1 1 0 19.0 2 2 . 0 0 . 8 0.9
D27/92 0s s R 1-92 3.0 15.0 0.4 0 . 8
D27/101 0ssR2-101 4.5 9.5 0.5 0 . 8
M5-16 mit oxi 3 3.0 3.0 0.4 0 . 8
M28-81 mit pho 1 1.5 2 . 0 0.4 0 . 6
mitl75 mit mitl75 2.5 3.0 0.3 0 . 8
Ml 7-231 mi t Cob 1 3.0 3.0 0.4 0 . 8
D2 2 Wi ld type 2.5 2 . 0 0 . 2 0 . 2
D22/69 VenR 4.0 4.0 1.5 1 .5
D22/72 R6 GR 4.0 4.0 1 . 0 1.5
D22/EC6 tetr 4.5 4.0 1.5 1.5
also centred on the subunit 9 gene, shows cross-resistance, although 
not to the same degree.
The mit mutations directed at cytochrome oxidase and apocytochrome b 
have little effect on their respective sensitivities to the drugs
directed at OS-ATPase. The pho ]_ mutation shows a higher sensitivity 
to the drugs than the wild type, possibly due to an altered ATPase. 
The mit' mutation mit 175, despite mapping in the Oli 2 region (Connerton 
et 1^_, 1984), shows little deviation from wild type in respect of 
its sensitivities to drugs directed at mitochondrial ATPase. The
nature of this mutation remains obscure.
The strains based on the wild type D22 and selected for antibiotic
resistance to venturicidin, rhodamine 6 G and triethyltin show apparently 
cohesive behaviour, since all show wide cross-resistance j_n vi vo but 
only slightly raised resistance phenotype i_n vitro. These mutations
may not be centred on specific genes whose products are structural
proteins of mitochondria.
Monitoring of Mitochondrial Membrane Potential in Yeast 
Figure 6 .i presents a series of fluorescence traces obtained from 
in situ lysed wild type yeast protoplasts (D273/10B Al) in the presence 
of 1mM of the fluorescence dye DSMP+ (Excitation 479nm Emission 589nm) 
and DSEP+ (Excitation 479nm-Emission 582nm). After the initial burst 
of fluorescence due to non-specific emission, both dyes are observed 
to undergo a steady increase in fluorescent intensity which eventually 
stabilises after 3-5 minutes (see Figure 6 .ia and b for DSMP+ and 
DSEP+ respectively). The second slower build-up of fluorescence is
sensitive to CCCP and titratable with tributyltin oxide. This behaviour 
resembles that of rat liver mitochondria studied in previous chapters 
of this thesis. Further evidence as to the nature of the fluorescence 
signals is provided by its sensitivity to potassium ions in the presence
DSEP Mediated Membrane Potential Dependent 
Fluorescent Changes of ijn situ Lysed 
Yeast Spheroplasts
Fig
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e 
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of valinomycin. This is strong evidence that the trialkyltin titratable 
fluorescence is the result of endogenous mitochondrial membrane poten­
tials, since Saccharomyces cerevisiae is not prevented from growth 
on glucose by valinomycin but only on non-fermentable carbon sources, 
indicating the antibiotic's vital action is centred on the mitochondrial 
oxidative process. As a consequence of the yeast's insensitivity
to va1inomycin/KT gradients under fermentative growth, Kovac and Varecka, 
(1981), demonstrated that neither whole cells nor protoplasts are 
affected in the cyanine dye based system by 0.1M KC1 in the presence 
of valinomycin.
The styryl dyes have little effect on whole yeast cells other than 
an intrinsic increase in fluorescence due to the turbidity of the 
suspension and light scattering, this is in contrast to the cyanine 
dye reported by Kovac and Varecka, (1981). Neither do osmotically 
stable spheroplasts produce fluorescent signals which respond to the 
specific uncouplers of mitochondrial membrane potential. However, 
a somewhat depressed response is observed with the general pore forming 
agent nyastatin, possibly due to a partition of the dye across the 
plasma membrane (see Figure 6 .ii a and b). It is interesting to note 
that at this point the dye DSEP + gives a better signal to noise 
ratio than its DSMP+ counterpart. DSEP+ produces much less intrinsic 
fluorescence on addition to turbid material, and as such is more suitable 
for the application of the above technique, where relatively dense 
suspensions of lysed protoplasts are employed.
Inhibitors of the respiratory chain also cause a marked drop in membrane 
potential. Figure 6 .iii demonstrates the effects of rotenone, antimycin 
A and cyanide in reducing membrane potential via the inhibition of 
complexes I, III and IV respectively. The fall in membrane potential 
initiated by the respiratory chain inhibitors is less marked than
Figure 6 . i i Changes in DSEP+ Fluorescence with 
Intact Spheroplasts
>
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the actions of the uncouplers presented above. This is possibly due 
to the presence of residual metabolites liberated on protoplast lysis 
and/or the endogenous intra-mitochondrial ATP level of the mitochondria 
so liberated. Additions of exogenous succinate (5mM) after inhibition 
by rotenone certainly suppresses the fall in potential.
The mitochondrial ATPase inhibitors oligomycin, ossamycin and venturi - 
cidin had little effect on the fluorescence level of DSEP+. Despite 
inhibition of complex V the membrane potential remains unchanged. 
However, the inhibitor DCCD which will affect ATPase demonstrates 
a modest fall in membrane potential as monitored by DSEP+. This may
result from other DCCD mitochondrial interactions, in particular with 
cytochrome oxidase (complex IV).
Mutant Mitochondrial Functions
Table 6 .iv summarises the application of the above technique to the 
mutant strains together with their respective ATPase activities. 
The mutations' origins have been described in Table 6 .i in the ‘Materials 
and Methods' section of this chapter, but basically they fall into 
four categories. The first is represented by DS14, a petite strain 
deficient in most respiratory functions. The strains had accordingly 
no mitochondrial membrane potential as detectable by sensitivity to
the uncouplers CCCP, triethyltin, '1799' and valimomycin mediated 
potassium uptake, nor oligomycin sensitive ATPase activity. The second 
group are those mutations which are bioenergetically competent but 
possess bona fide mitochondrial ly located drug resistant mutations. 
As described earlier in this chapter, they display their corresponding 
resistant and cross-resistant phenotypes at the level of the ATPase. 
All have wild type mitochondrial potentials and sensitivities to
uncouplers, further evidence to their lesions solely conferring an
inability to bind the respective drugs efficiently.
Table 6 .iv
Legend
The properties of the mutant mitochondria are summarised in terms 
of their resistance (R) or sensitivities (S) to various drugs. 
The ATPase activities and fluorescence signals are scored as three 
crosses (+++) for wild type properties, two crosses (++) signifi­
cantly diminished ( >50%), and one cross ( + ) for residual activity 
(>1 0 %).
Th
e 
In
 V
it
ro
 
Ac
ti
vi
ti
es
 
of
 
Mi
to
ch
on
dr
ia
ll
y 
Di
re
ct
ed
 
Mu
ta
ti
on
s 
of
 
S.
 
ce
re
vi
si
ae
The third class of mutation are the mit mutations having specific 
lesions in mitochondrial genes, those of Oxi ^ (encoding the large 
subunit of cytochrome oxidase), Cob (encoding apocytochrome b), pho 
(encoding subunit 6  of OS-ATPase) and mitl75 (of unknown function 
in the 01 i 2 region). All the mutations as described above have oligo- 
mycin sensitive ATPase activities (however, pho has a particularly 
sensitive enzyme complex), however, those mutations affecting structural 
elements of the respiratory chain produce depressed fluorescent responses 
which are insensitive to most uncouplers. The exception being CCCP 
which appears to command a more wide ranging effect. The pho 1 mutation 
displays expected wild type sensitivities to the uncouplers, however, 
the mutation mitl75 mapping in a similar region of the genome (Connerton 
et al, 1984), behaves as those mutations in the genes of electron 
transport complexes. This mutation displays only a residual membrane
potential under these conditions which is sensitive to CCCP, but is 
insensitive to triethyltin, ‘1799’ and valinomycin mediated potassium 
diffusion. This evidence suggests mitl75 is deficient in an element 
of the electron transport machinery, a fact born out by an aberrant
cytochrome spectra (see the following chapter for further information). 
The fourth and final class of mutation employed in this study are 
those mutants selected as drug resistant to the mitochondrial directed 
inhibitor triethyltin, rhodamine 6 G and venturicidin, but whose genetic 
location is not mitochondrial. In general, these mutations despite
requiring 10-40 fold drug concentrations to affect growth i_n vivo,
do not have corresponding in vitro activities, neither as an insensitive 
ATPase to triethyltin or venturicidin, or an insensitivity to the 
effects of triethyltin on membrane potential. These mutations are 
essentially wild type in their j_n vitro behaviour. This data must
lead to the conclusion that the mutations are not in genes specifying
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structural elements of mitochondria. The mutations may affect their 
resistance in either more efficient detoxification or permeation of 
the cell membrane.
6.4 Conclusion
A qualitative assay of mitochondrial membrane potential has been devel­
oped in the yeast Saccharomyces cerevi si ae based on the in si tu lysis 
of protoplasts in the presence of the fluorescent styryl dye DSEP+. 
The use of DSEP+ in this application has proved to be more favourable 
over that of its analogue DSMP+, due to inherent reduction in the 
signal to noise ratio of the fluorescence. The assay system has been 
shown to respond to uncouplers of mitochondrial membrane potential 
in a specific manner, in particular with the imposition of a potassium 
diffusion gradient in the presence of valinomycin which is known only 
to affect yeast during oxidative growth.
An attempt has been made to coordinate the in vivo and i_n vitro modes 
of action of yeast mutations directed at mitochondrial functions. 
These studies have been based on the mutations' abilities to effect 
mitochondrial drug sensitive ATPase activity and uncoupler sensitive 
membrane potential. Attention has also been focussed on both _i_n vi vo 
and ni vitro cross-resistant drug mutations, despite having a single 
mitochondrial locus. The inhibitory sites of ATPase/synthase inhibitors 
oligomycin, ossamycin and venturicidin may overlap.
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Chapter _7
DNA Sequence Analysis of the Oli 2 Region of the mt-Genome of S.cerevisiae
7.1 Introduction
The following chapter is aimed at elucidating the aminoacid changes
in the Oli 2 region of yeast mitochondrial DNA (mt DNA) responsible
for the resistance to oligomycin and ossamycin. The alleles chosen
R Rfor this study are Oli 2-76 and Oss 1-92, which are unique mutations 
showing no cross-resistance, both hi vi vo (Lancashire and Matoon, 
1979), and vi tro (see Chapter 6  of this thesis). Such data is
consistent with the mutation's loss of affinity for the drugs at, 
or close to, their specific binding sites. Further localisation of
the drug resistant alleles was accomplished by five structure genetic
mapping, using the technique of petite deletion mapping (Connerton
et al, 1984). The starting grande (e+ ) for this study was a double
mutant containing both the Oli 2-76 and Oss 1-92 alleles and as such
was chosen for subsequent molecular analysis. DNA sequence data between 
the Oxi 3 gene (subunit 1 of cytochrome oxidase) and beyond the end 
of the Oli 2 gene will be presented in this chapter (see Figure 7.i,
and Dujon, 1982 for genome organisation), including the recently reported 
subunit 8  sequence (or Aap 1 gene) and putative maturase (Seraphin
et al, 1985). Corroborating data will also be presented as to the 
nature of the drug resistant alleles as single point mutations in 
the strains D27/76 and D27/92 for oligomycin and ossamycin respectively. 
(For further information see the following introductory paper).
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F ig u re  7.Î Physical and genetic map of the mitochondrial genome of the yeast S ac-  
c h a r o m y c e a  c e rc v is ia c . The map has been taken from Dujon (1983). Restriction map 
(inner circles) shown here is from the "long strain" (KL14-4A). For comparison with the 
short strain, see Morimoto Sc Rabinowiti (1979). The genes have been placed on the 
genetic map (outer circle) on scale with respectto restriction sites. The references for 
various genes have been given in the text. exons, l*v.*.*.J open reading frames,
introns.
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Genetics of Oxidative Phosphorylation: Petite Deletion 
Mapping of the OH 2 Region of the Mitochondrial Genome 
of Saccharomyces cerevisiae
I F. Connerton. M .K . Ray. W .E. Lancashire*, and D .E . G riffiths
Department o f Chemistry and Molecular Science, University of Warwick. Coventry CV4 7AL. U K .
Summary. Petite deletion mapping has been carried out for 
the OH 2 region o f  the m itochondrial genome o f  Saccharo­
myces cerevisiae to produce a fine structure genetic map. 
Previously unlocated m it mutants together with the drug 
resistant loci Oli 2 and Oss 1 have been ordered between 
the cytochrom e oxidase and apocytochrom e b genes.
As a result o f  this study a series o f  isogenic p  clones 
have been isolated spanning the Oli 2 region.
Introduction
Two regions o f the m itochondrial genome o f  Saccharo- 
m yces cerevisiae have been associated with m itochondrially 
synthesised subunits o f  oligomycin-sensitive adenosine tri­
phosphatase (A TPase). The regions were originally defined 
as two genetically unlinked loci conferring oligom ycin resis­
tance, Oli / and Oli 2 (Avner and G riffiths 1973; Avner 
et al. 1973).
The Oli l  region was further defined by genetically 
linked vcnturicidin and ossamycin resistant m utants. Yen 
and Oss 2 . together with two more oligomycin resistant loci, 
Oli 3 and Oli 5 (Lancashire and G riffiths 1975a ; Lancashire 
and M attoon 1979a). and the pho-2  aerobic growth defi­
cient m utants (Foury and Tzagoloff 1976; Coruzzi et al. 
1978). The Oli 2 locus was found to be genetically linked 
to another weakly oligomycin resistant m utation, Oli 4 
(Clavilier 1976), an ossamycin resistant m utation, Oss l 
(Lancashire and M attoon 1979a) and non-allelic aerobic 
growth deficient m utants, ph o-l  (Foury and Tzagoloff 
1976; Coruzzi et al. 1978) and pho-8, V (D arlison and Lan­
cashire 1980).
I)N A  sequencing studies have confirmed the Oli l  gene 
encodes subunit 9 o f  the oligomycin-sensitive ATPase 
(Hensgens et al. 1979; M acino and T zagoloff 1979a, b) 
while the Oli 2 gene has been located in a reading frame 
specifying a protein o f  259 am ino acids and 28.25  K D  m o­
lecular weight (M acino and Tzagoloff 1980). T he identifica­
tion o f  the Oli 2 gene product is less obvious since no fur­
ther am ino acid data is available, but 22 .(K) K D  subunit 6 
(T zagloff and M eagher 1972) has been put forward as a
* Present Address: Department o f Biochemistry, Imperial College.
London SW7 2AZ. U K 
Offprint requests to: D.E. Griffiths
candidate and recently re-established as a highly cyclohexi- 
mide resistant protein o f  20 .00  K D  (Som lo et al. 1982).
Recom bination analysis between the Oli 2. Oli 4 and 
ph o-l  genetic markers has suggested an order o f  Oli 2 
PHO-1 OH 4 (Som lo et al. 1977). similarly the Oss 1 
marker has been located between Oli 2 and Oli 4 (Lancas­
hire and M attoon 1979a). However it has also been noted 
that the interpretation o f  recom bination data from intralo­
cus and interlocus crosses in this area o f  the genome is 
difficult, due to unexpected allele-specific polarity phenom­
ena and map expansion effects (Lancashire and M attoon 
1979a).
The m il m utations have not been physically character­
ised with reference to known drug resistance mutations and 
may be with-holding further functional information. This 
paper therefore describes a fine structure genetic map o f 
the Oli 2 region including the drug resistant loci Oli 2. Oss / 
and the m il loci, while generating petites suitable for DNA 
sequence analysis.
Materials and Methods
/. Yeast Strains
The genotypes and origin o f  the grande and mil tester 
strains o f  Saccharomyces cerevisiae used in this study are 
listed in Table 1. The discrim inative p  clones presented 
here are all derived from  the starting grande C D  40 by 
ethidium bromide mutagenesis.
2. Media and Chemicals
The following media were used; NO (1 %  yeast extract, 
1%  peptone. 2%  glucose, 0 .05  M Na. K phosphate buffer, 
pH 6.25). N3 (as NO but 2 %  glucose is replaced by 3%  
glycerol). W O (0 .67%  yeast nitrogen base without amino 
acids. 2%  glucose). Y P D  (1 %  yeast extract. 1%  peptone. 
2 %  glucose) and Y P 10 (1 %  yeast extract. 1%  peptone, 
10%  glucose). F o r solid media 2 .3%  agar was added to 
the above.
A ntibiotic media (N 301 and N30s) were prepared by 
adding m ethanolic solutions o f  oligomycin (1.0 pg ml) and 
ossamycin (2 .0  pg ml) respectively to N3 medium after au­
toclaving as described previously (Lancashire and Griffiths 
1975b).
Oligomycin was purchased from Sigma and ossamycin 
was a gift from Dr. H. Schm itz, Bristol-M yers Co.
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Tabic I. Strains o f  Saccharomyces ceree is iac
Strain Genotype Origin
Nuclear Mitochondrial
D27 a m et p '
JC 8 AA1 a leu  k a r  1 P°
D27/76 7 m et P* o/r2-76
C D I5 a leu k a r  1 P * O S S ' 1-92
a  leu k a r  1 + 1-92. oir2-76DB1 p O S S '
7  + + met
DB1-1C 7  m et P ' O S S ' 1-92, fdr2-76
CD40 a leu k a r  1 P ‘ O S S ' 1-92. oh'2-7ft
C D24 7 his k a r  1 />' m it pho-9
CIMI 7 his k a r  1 p ' m it pho-8
mit 175 7 ura P * m it
M28-81 7 m et P' m it p /lit-  1
M6-239 L 7 lys 2 P ‘ m it p h o -1
Ml 7-231 7 m et P * m it ath-l
Ml 7-162 7 m et P* m it cob-2
M9-3 7 p ro to P* m it o.xi-2
M9-3/L 7 lys 2 P* m it o.xi-2
M9-94 7 proti» p ' m it oxi-1
M9-94L 7 ly s 2 P ' m it oxi-1
M5-16 7 p ro to P * m it oxi-3
M5-16/L 7  ¡vs 2 P ' m it o x i-3
Subclone o f D273-10B AI(A. TzagolofT) 
Lancashire and Mattoon (1979b) 
Lancashire and Mattoon (1979a) 
Lancashire and Mattoon (1979a)
JC 8 AA1 x D27 76
Meiosis o f DB1
Cytoductant from cross JC8/AA1 x DB-1C 
Darlison and Lancashire (1980)
Darlison and Lancashire (1980) 
Bolotin-Fukuhara et al. (1977) 
l oury and Tzagoloff (1976)
Darlison and Lancashire (1980)
Tzagoloff et al. (1976)
Tzagoloff et al. (1976)
Slonimski and Tzagoloff (1976)
Selection for lysine auxotrophy 
Slonimski and Tzagoloff (1976)
Selection for lysine auxotrophy 
Slonimski and Tzagoloff (1976)
Selection for lysine auxotrophy
3. E thidium  Brom ide M utagenesis
T he grande C D 4 0  was grown to late-log phase in liquid 
Y P D  before dilution into Y P D  plus 10 pg ml ethidium b ro ­
mide and incubated with shaking in the dark for 24 h at 
29° C. A fter which the culture was further diluted into Y P D  
plus 20 ng ml ethidium brom ide and incubated again. Sam ­
ples were withdrawn from the culture a fter 4 and 8 h and 
either washed and plated on solid Y P D  or subjected to 
further sequential treatment with ethidium bromide.
4. Screening o f  p  clones
T he screening o f  p  clones was perform ed as essentially 
described in ‘ Procedure A ' by Carignani el al. 1979.
5. Restoration Test o f  m il m utants by p  clones
T h e m it strains o f  the senitive strain D 27 were grown 
to late log phase in either Y P 10  or liquid Y P D  and a cell 
suspension spread onto W O plates (2 x 107 cells), p  clones 
were then cross-replica plated from N O  m aster plates to 
the tester law n. T he m ating plates were incubated for 3 days 
at 29° C. T h e  resulting diploid growth was then velveteen 
replicated o n to  N 3, N301 and N3()s plates and growth 
scored after 3 days at 29° C.
Results and Discussion
In this study over 1,000 p  clones were screened for their 
retention and discrim ination o f  genetic markers directed 
tow ards the OH 2  region o f  the m itochondrial genome. R e­
presentatives o f  the classes o f  p  clones produced in this 
study are presented in T ab le  2, showing the m it x p  and 
an t s x p  restoration  crosses in m atrix form . The prim ary 
p  clones w ere designated LP, IC, FC  and M R . the prod­
ucts o f  fou r independent ehtidium brom ide treatm ents o f
the starting grande C D 40 and a digit (from 1 to 9). then 
by preceding the digit with an appropriate letter in alpha­
betical order (eg. I C 1 - I C 9 .  I C A 1 - I C A 9 .  ICB1 - e t c  ). 
Secondary and tertiary clones were further designated by 
second and third digits respectively. These strains are in 
general based on the short m itochondrial genome o f  D 273- 
10B/A1 with the exception o f  m it 175 which is derived from 
the grande F F 1 2 1 0 -6 C  (Bolotin  Fukuhara et al. 1977). 
The grande C D 40, m it strains C D 2 4  and CD41 were con ­
structed by cytoduction to possess defined nuclear genomes 
o f  opposite m ating types (Lancashire and M attoon 1979 b).
T he coretention and codeletion o f  the m arkers in the 
p  clones is consistant with the assum ption that none o f  
the p  m utants presented here have doubly deleted or ge­
netically rearranged genomes.
Approximately 26%  o f  the to tal p  clones screened had 
detectable functional genetic inform ation. O f these 75%  
complemented the mit testers M 9-3, L. M 9-94 L and M 5- 
16/L deficient in cytochrom e oxidase activity (Slonim ski 
and T zagolo ff 1976). The remaining 25%  appear to retain 
equally portions o f  the COB-ho.x and OH 2 regions, as ascer­
tained by the restoration o f  oxidative growth and drug resis­
tivity in m utants deficient in cytochrom e b or directed at 
oligomycin-sensitive A TPase function.
The coretention and codeletion data in petites allow 
a map order to  be deduced for the markers as summarised 
in Fig. 1. T he pho-8  and pho-9  m utations are not allelic 
with the pho-1 m utations in M 28-81 and M 6-239 (D arlison 
and Lancashire 1980), the two groups are in fact separated 
by the OH 2 and Oss 1 resistance loci. Petites descrim mating 
the pho-8  and pho-9  m utations have also been isolated, indi­
cating these alleles are not hom oallelic and indeed have 
been observed to  undergo partial com plem entation in pho- 
8  x pho-9  crosses on oxidative m edia (Connerton. I .F .. un­
published results).
It is most likely that the resistance loci lie in the OH 2 
coding sequence which probably codes for subunit 6 o f
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I able 2. The Restoration Matrix for the Oli 2 Region
p (a) P * mit Ot)
M9-3 L M9-94 L M5-16 1 CD-41 CD-24 D27-OIÌ' D27-OSS' M28-81 M 6-2 39 - mit 175 Ml 7-231 Ml 7-162
CD-40 IC5 » * * . . . * * * . . . . . . ... . . . *♦ .  . ** . . . . . .
CD-40 LPB42 ** * . *** ** * . .  . . . . . . .
CD-40 IC93 *** . . . * * * ... . . .
CD-40 ICA42 *** . . . 5 c 3 c 3 c . . . . . .
CD-40 IC93I . . . * . Ic . . .
CD-40 ICA424 . . . 2 c *
CD-40 IC93A5 
CD-40 ICB2
*. * *
. . . . . .
CD-40 ICB28 . . .
CD-40 ICB9 * * » . . . * . . . . . . .
CD-40 IC IM . . . .  * * * 4 c 2 c .  . . . .
CD-40ICSA8 
CD-40 ICD9 M . . . *
. 5 c .  . . . .
CD-40 ICB93 ** *
CD-40 IC 2 . . . * * * * * * . . . . . . 3 c .
CD-40 ICB4 * * * . . . . . . * ** . . . . . . Ic
CD-40 IC 5A6 * * » . . . . . . .  . . . . . . . . .
CD-40 IC2B1 . . . * * . . . . . . . .  .
CD-40 IC2C4 * * * * ** . . . . . . 5 c
CD-40 IC2L9 * * * * * ** . . . . . . *
CD-40 FCD6 * * * NT ** . . .
CD-40 LPA1D1 NT ** . . . . . . * . **
CD-40 FCD62 NT ** . . . . . .
CD-40 M R53 * . . . . . .
CD-40 1.1*81 * . . . . . .
CD-40 MR6 * * ♦ * . . .
CD-40 MR66 
CD-40 IC2I 96 M
CD-40 LPA12
Scoring of the diploids on non-fermentable substrate: 
* * *  = full and confluent growth of diploids 
**  = full but not confluent growth of diploids 
* = full growth but less than 10 diploid colonies 
nc = number of diploid colonies of 5 or less 
No mark = no growth 
NT -  no test
M5-16/L
ï >
CXI 1
pho-8 pho-9 o il  ? 033  1 M28-B1 M6-239/L mit 175
.UK  i i I k - L -
OLI 2
cb
AAPl
MI7-23I M17-162
cc3-tga
Fig. I. The enclosed boxes represent recognised genes while the dotted lines represent intergenic regions containing hitherto unassigned 
mutations
the oligomycin-sensitive ATPase. The pho-1 mutations are 
also likely to be within this structural gene.
The location o f  the pho-8  and pho-9  m utations is quite 
open to speculation. These m utations lie on the O xi 3 side 
o f  OH 2 and they are readily descriminated from the o/i 2 
m utations in petites and may be located in a different gene. 
Sequencing data upstream o f OH 2 (L innane. A.W .. per­
sonal com m unication) has revealed a putative reading 
frame o f  144 base pairs which has been suggested to be 
associated with an apparent 10.00 K D  protein observed on
gels and named A A P l .  This gene could therefore be the 
location for the pho-8  and pho-9 mutations. Alternatively 
these m utations could be located in the 5' flanking region 
o f the OH 2  gene and therefore in a controlling region(s). 
Clearly it is important to rationalise these alternaives, and 
sequencing o f  petite and grande DNA is presently underway 
to accomplish this.
In order to understand any controls employed within 
the m itochondrial genome it is important to be able to 
identify deficient m utants both within and out o f  the coding
52
sequences o f  m itochondrial genes. The pho-S  and pho-9  m u­
tants show some potential in achieving the latter o f  these 
goals for a m itochondrial A T P  synthetase gene.
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7.2 Materials and Methods 
Materi als
All chemicals used were of analytical grade. All restriction enzymes 
and DNA modifying enzymes were purchased from commercial sources (BRL, 
BCL). Aha 111 was a gift from P & S Biochemicals. Ligase was either 
from BRL or obtained as a gift from Anglia Biotechnology. When lyophil- 
ised restriction endonucleases were purchased (Lyphozymes, BRL), they 
were reconstituted according to the supplier's recommendations. Bacter­
ial alkaline phosphatase (BAP) and calf thymus intestinal phosphatase 
(CIP) were purchased from Sigma. The antibiotics ampicillin, tetracy- 
clin, and chloramphenicol were also purchased from Sigma. Cycloheximide 
was purchased from BDH. Electrophoretic grade agarose was purchased 
from Sigma or BRL. Low melting point (LMP) agarose was purchased 
from BRL. Acrylamide and bis-acrylamide were purchased from Sigma 
or 8 DH. Urea was purchased from Fisons or BDH. Trizma base and boric 
acid were purchased from Sigma. Caesium chloride was purchased from 
Fisons. The indicator reagents BCI6  (X-gal or 5-bromo-4-chloro-3-indoyl- 
8 -D-galactoside) and IPTG (isopropyl- B -D-thiogalactopyranoside) were 
purchased from BRL. Polyethylene glycol 6,000 was purchased from 
BDH. The DNA binding dyes ethidium bromide, bis-benzymide (Hoechst- 
33258) and DAPI (4'-6 -di amidi no-2-phenyl indole di hydrochloride) were
purchased from Sigma. All unlabelled deoxy and dideoxy nucleotide
32P-labelled deoxynucleotide 
35c
triphosphates were purchased from BCL.
i i,
S-labelled methionine 
were purchased from Amersham. Nitrocellulose sheets were purchased 
from Schleicher and Schull. X-ray film was purchased from Fuji. 
Finally, anti-F,-ATPase antiserum was a kind gift from Professor G.Schatz,
Biozentrum, Basel.
4 ..
Stock Cultures
The yeast strains utilised in this chapter, and their growth conditions, 
have been detailed in Chapter 6 and again in the preceding introductory 
paper.
E. coli strains HB101 (Bolivar and Backman, 1979), and JM1 03 (Messing 
et al, 1981), were used for the propagation of plasmids and M13 single 
stranded phage respectively (see Table 7.i for genotypes).
Cloning Vehicles
The high copy number derivative of pBR322, pAT 153, was used for the 
cloning of mt-DNA fragments (Twigg and Sherratt, 1980). Suitably 
amplified mt-DNA fragments were further subcloned into the replicative 
forms of the M13 single stranded phage vectors mp8 , mp9 (Messing and 
Viera, 1982; and Viera and Messing, 1982), mplO and mpll (Messing,
1983), for sequencing by the dideoxy chain termination method (Sanger, 
1977 ; and Sanger £t aj_, 1980).
Methods
1. Isolation of mt-DNA from Yeast
Mitochondrial DNA was isolated by bis-benzimide/CsCl buoyant density 
ul tracentrifugation as essentially described by Hudspeth et £l_, 1980. 
Briefly, the yeast mitochondrial fraction was isolated as described 
in Chapter 6 , with the exception of 250mM mannitol replacing 0.5M 
sorbitol in the breaking buffer. The mitochondrial pellets were lysed 
in lysis buffer (1 OmM ’’ris/HCl pH 7.5, 1 OniM EDTA, 1 OCmM NaCl and either 
2 sarkosyl or 1 SDS) and repeatedly extracted with phenol: chloroform: 
isoamyl alcohol (24:24:1). The DNA was finally precipitated from the 
aqueous fraction by making the solution 0.3M Na-acetate and adding 
2 volumes of ethanol at -20° C. The DNA precipitate was pelleted at
4°C by centrifugation at 10,000 x g and taken up in TE (lOmM Tris/HCl 
pH 7.5, ImM EDTA). To this, solid caesium chloride was added to give
1T a b le7 .  ia  E . c o li  st rain
St ra in Ge no type l ie m ark
HBlOi F  , hsd S 2 0  (rfl  , Thi s  s t ra in  is an
m l) , rec A 13, ara-14, hybrid of  h.', co lt K 12
I’ roA'J,  lac Y 1, gal/C2, and /:. c o li  B. For
rps 1/20 ( S m ' ), xyl-5, details,  see Boyer &
m t l - 1, sup E4 4 ,  \ Roul and- Dussoix 
(1969) ;  Bol ivar  A' 
Bock man (1979)
J M 103 A (lac pro),  thi ,  str A, A host o f  K - 12 origin,
end A, sbcB15 , restr ict ion minus hut
hsd/f* * 4, sup E, F modif icat ion plus.
t ra l ) 3 6 ,  proAB,  lac /*, modif icat ion plus.  See
Z AM 15 Messing e t  at , 1981 for
details.
T a b l e 7 . i b M-13 vectors  and their  cloning sites.
Vector Cloning site References
mp7 E c o R l  - BarnU 1 - Sai l/Acc  1/Hinc 11- 
- Ps t l  - Sa i l  - B a r nl l l  - E c o R l
Messing et al  (1980)
mp8 E c o R l  - Sinai  - B a m l l l  - Sal l/Acc 1/HirulI- 
- Smal  - HindIII
Messing & Viera  (1982)
rnp9 Hindl l l -  Pst I  - Sa l l/Acc  t/l l incl l -  
- S ma l  - KcoR 1
Vi era  & Messing (1982)
mp 10 E c o R l  - SstI  - S m a l  - B a m l l l  - Xbal -  
- Sa l l/Acc  I /1 l ine 11 - Pst I  - Hindlll
Messing (1983)
mp 11 Hindll l  - PstI  - Sa l l/Acc  1 / H inc 11- 
- X b a l  - R ami l  1 - S m a l  - SstI  - E c o R l
n
1 4 :-»
a refractive index of 1.390 and finally, bis-benzimide added to a 
final concentration of lOOug/ml. Ultracentrifugation was performed 
in a Beckman L5-65 machine at 45K r.p.m. (at 15° C) for 24-42 hours 
using the 50 Ti rotor.
The resulting DNA bands were collected under lonn-wave UV illumination, 
the mt-LNA migrating towards the low density zone or the top of the 
gradient. The nuclear DNA, r-DNA satellites and covalently closed 
3ym plasmids banded successively at increasing densities. The resulting 
CsCl fractions were extracted with CsCl saturated isopropanol to remove 
bis-benzimide before dialysis for 24 hours at 4°C against repeated 
changes of TE buffer.
CsCl gradients containing DAP1 and ethidium bromide were also employed, 
but in general proved less effective.
2. Isolation of Plasmid DNA
Plasmid DNA was isolated either in large scale or in mini scale prepara­
tions.
Large scale preparation of Plasmid
Plasmid DNAs were isolated in large scale according to the method 
of Katz et al, (1973). 15-20ml of LB medium containing the appropriate 
antibiotics (Ampicillin 100yg/ml or Tetracyclin 12.5„g/ml) was inoculated 
with a single bacterial colony. They were grown overnight with vigorous 
shaking at 37° C. Next morning, this overnight late log culture was
inoculated into one litre of LB medium with the proper antibiotic
o
(with or without 0.5 glucose) and shaken for 4-6 hours at 37 C. (¡he
A¿ nn of the culture would be approximately 0.4). Then 5ml of a solution buU
of chloramphenicol (34mg/ml in ethanol) was added to it (final concentra- 
of chloramphenicol was 170ug/ml) and incubated at 37°C with vigorous 
shaking for a further 12-16 hours (overnight). These cells were
harvested by centrifugation at 5000 r.p.m. for 10 minutes at 4°C (Sorvall
GSA rotor) and washed with 20ml of 1 OmM Tris-Cl, ImM EDTA, pH 8.0. 
The cells were resuspended in 8.4ml of 25" sucrose, 50mM Tris-Cl, 
pH 8.0 and transferred to an Erlenmeyer flask. Then 1.4ml of lysozyme 
(lOmg/ml in 50mM Tris-Cl, pH 8.0) was added to it and kept on ice 
for 5 minutes with gentle swirling. 4.6ml of 0.25mM EDTA (pH 8.0) 
was added to it slowly and kept on ice for another 10 minutes with 
gentle swirling. Then 9.6ml of lysis mix (50ml 20 Triton, 125ml 0.25M
EDTA, 25ml 1M Tris-Cl, pH 8.0 and 300ml water) was added to it slowly 
with swirling. After 10 to 15 minutes the chromosomal DNA was spun 
out either at 19,000 r.p.m. (Sorvall SS34 rotor) for 1 hour or at 30,000 
r.p.m. (Beckman Ti 50 rotor) for 45 minutes. The supernatant was 
extracted with phenol two or three times and adjusted to 0.3M Na-acetate 
before the addition of two volumes of cold ethanol. The DNA was spun 
down at 10,000 r.p.m. for 10 minutes at 4° C and redissolved in TE 
buffer (lOmM Tris-Cl, pH 7.5, ImM EDTA). About lOgm of CsCl was dissol­
ved into the DNA solution and the final volume was made to 11ml (a
refractive index of 1.30). Ethidium bromide was added to it to
a final concentration of about 200 to 300pg/ml (from a lOmg/ml stock 
solution). The solution was centrifuged at 45,000 r.p.m. for 36-40 
hours in a Beckman 50 Ti or 65 rotor at 15° C. The plasmid bands were 
collected either with a fine tipped Pasteur pipette, or with the help 
of a syringe. Ethidium bromide was extracted (three times) with isoamyl 
alcohol (saturated with CsCl) from the collected fractions which were 
then dialysed against TE buffer (two or three changes) at 4° C overnight. 
DNA was precipitated with 2 volumes of ethanol and 0.3M Na-acetate 
(final concentration at -70°C for 3 hours or at -20°C overnight). 
Mini-scale praparaion of Plasmid ("Mini - lysate" method)
This procedure was generally followed to screen a large number of 
transformants at a time. The method is more or less similar to that
Mtf
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described by Birnboim & Doly (1979). Small shaking overnight cultures 
(about 1ml each) were centrifuged in a 1.5ml microfuge tube (Eppendorf 
tube) for 2 to 3 minutes. The supernatant was discarded and the cells 
were resuspended in 0.1ml lysis solution (25mM Tris-Cl, pH 8.0, 1 OmM 
EDTA, 50mM or 1% glucose, 2mg/ml lysozyme) by vortexing and left on 
ice for 30 minutes. Then 0.2ml of alkaline SOS solution (0.2M NaOH,
1 SDS) was added and the tubes were left on ice for 5 minutes with 
occasional mixing by inversion. The suspensions should become viscous, 
then 0.15ml of high salt solution (3M Na-acetate, pH 5.0) was added,
mixed and the tubes were left on ice for a further hour. A heavy
white precipitate should form which was removed by centrifuging for 
10 minutes at room temperature. The supernatants were transferred 
to new microfuge tubes. 1ml of ethanol was added to each tube and 
placed at -20°C for 30 minutes. 'hey were centrifuged again in the 
microfuge for 3-5 minutes. The pellets were then dissolved in 0.1ml 
of 0.1M Na-acetate (pH 6.0) and 2.0ml of cold ethanol was added to
them and left at -20° C for 10 minutes. They were centrifuged again 
for 5 minutes and the DNA pellets were dried under vacuum. The dried 
DNA pellets were dissolved in 20-50ul of TE buffer which could be 
digested with most restriction enzymes without further purification.
3. Isolation of ss DNA from M 13
The ssDNAs were isolated using the procedure described by Sanger _et al_, 
(1980). Briefly, 1/40th dilution of a fresh overnight culture of
JM103 in 2 x TY was divided into 1ml aliquots. Phage plaques were 
inoculated into diluted JM103 with the help of sterile toothpicks. 
They were incubated at 37°C with shaking for about 7 hours. The culture 
was poured into 1.5inl microfuge tubes and centrifuged for 10 minutes. 
The supernatant was transferred into another 1.5ml microfuge tube 
(Eppendorf) making no effort to transfer completely. The supernatant
s '
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was either stored at 4°C at this stage, or the procedure was continued 
to completion. In the former case the supernatant must be re-centrifuged 
to remove any cells which grew during storage before isolation of 
phage DNA. The pellets were stored at -20°C with 7.5 DMSO as a stock 
of the recombinant phage. To the supernatant 200 ul of PEG solution 
(20 polyethylene glycol (PEG), 2.5M NaCl ) was added and left at room 
temperature for 30 minutes. The viral pellets were collected by centri­
fugation for 5 minutes in a microfuge. The supernatant was discarded 
and any trace amount of supernatant was wiped out with a Kim wipe 
or removed by a drawn out Pasteur pipette. To the white phage pellets 
lOOul of TE (lOmM Tris, pH 7.5, O.lmM EDTA) were added, and vortexed 
for 5 seconds to suspend the virus. The suspended virus particles 
were re-vortexed for 10 seconds in the presence of 50 wl of phenol 
and kept standing at room temperature for 10 minutes. 'he suspension 
was re-vortexed for another 10 seconds and microfuged for 3-4 minutes. 
The aqueous phase was collected carefully with the help of drawn out 
Pasteur pipettes and transferred to a fresh Eppendorf tube. The aqueous 
phase was extracted twice, either with 2 volumes of chloroform or 
2 volumes of diethyl ether to remove PEG and traces of phenol. 10c 1 
of 3M Na-acetate and 250m1 of ethanol were added to the finally extracted 
aqueous solution and placed at -20°C overnight. Phage DNAs were col­
lected by centrifugation for 10 minutes at 4°C in a Sorvall SS-34 
rotor using a suitable adaptor. The DNA pellets were washed with 
lml of cold ethanol in a microfuge at room temperature, dried under 
vacuum and dissolved in 15 to 20ul of TE buffer (lOmM Tris-Cl, pH.7.5, 
lOmM EDTA) and stored at -20°C.
4. Restriction Enzyme digests and Ge1 -e 1ectrop horesis
Restriction endonuclease digests were performed as recommended by 
the suppliers, before heat shocking at 65° C for 3-5 minutes with
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the addition of 10 glycerol, 0.01J bromophenol blue as gel loading
buffer. Agarose (1-1.b%) gel-electrophoresis was performed in open 
tanks as submarines in 50mM Tris-3orate, ImM EDTA, pH 8.3 buffer. 
The gels were run at 40mA for 3-4 hours before staining in electro­
phoresis buffer plus 1 ug/ml ethidium bromide for 20 minutes. The 
gels were observed and photographed using a Fotodyne UV transilluminator 
and Polaroid CU5 land camera fitted with a Kodak 23A Wratten filter.
5. Nick Translation
32P-labelled probe DNA was obtained as described by Rigby et aj_, ( 1977), 
using the following protocol:
5u1 10 x nick translation buffer (0.5mM Tris/HCl pH 7.2, 0. 1M Mg S0^,
1mM DTT, lmg/ml BSA).
lug DNA
1 nmole each of cold dNTPs (minus the hot comoonent)
100 pmoles of a-^P-dNTP (25uCi)
O.Olug DNase 1
3-5 units of E.coli DNA polymerase 1
H^0 to make 50ul total volume and incubate for 1 hour at 15°C.
The reaction was terminated by the addition of 5 ul 250mM EDTA pH 8.0. 
The unincorporated dNTPs were removed by selective isopropanol precipita­
tion of the DNA with 2.5M NH^ -acetate.
6. Southern Hybridisation and Dot Blot
The method of Southern, 1975, was used as described in Maniatis et al, 
1982. Dot hybridisation was performed to identify recombinant Ml 3
single stranded clones. This was performed by spotting out 2yl of single 
strand preparation onto nitrocellulose allowing the filter to air 
dry and baking for 2 hours at 80 °C i_n vacuo. The filter was then 
washed in 6 x SSC before prehybridisafion and hybridisation, as described 
in Maniatis et al, 1982.
i l. 0
7. Colony Hybridisation
Colony hybridisation was performed using the method of Grunstein and 
Hogness, ( 1975), as described in Maniatis et aj_, ( 1982).
8. Isolation of Competent Cells
About 2ml of 2 x TY or LB media were inoculated with JM103 or HB101 
respectively, from single colonies and incubated overnight at 37°C in 
standing culture. 10ml of the appropriate medium was inoculated by 
a 10 fold dilution of the overnight culture and allowed to grow at 
37° C with shaking until 0.3-0.4 A^qq was achieved, approximately 3 
hours. The cells were harvested after chilling on ice at 7,000 xg 
for 5 minutes. The pelleted cells were resuspended in a half volume 
of 50mM CaCl and kept on ice for 20 minutes. The cells were centrifuged 
again and resuspended in a 1/1 Oth volume of 50mM CaCl . The resulting 
competent cells were kept on ice for a further 40 minutes before use 
in transformation.
9. Ligation and Transformation 
Plasmid Vector:
Ligation Mix
50-100ng dephosphorylated linearised vector DNA
> lOOng target DNA with compatible ends
2wl 10 x ligase buffer (0.7M Tris/HCl pH 7.5, 70mM MgC^)
2ul lOOmM ATP 
2m 1 50mM DTT
1 or 2 units of T4 DNA ligase
H.,0 to make 20ul total volume and incubate overnight at 15°C 
Add 0.2ml of competent HB101 and keep on ice for 30 minutes, heat 
shock at 42° C for 2 minutes, add 1ml of LB and incubate for 1 hour 
at 37°C before plating on LA plates plus 50pg/ml ampicillen and incubate 
overni ght.
Ml 3 Vector
Ligation Mix
20ng dephosphorylated linearised vector DNA 
>50 ng target DNA with compatible ends 
2ul 10 x ligase buffer 
2ul 1OmM ATP 
2m1 5OmM DTT
1 or 2 units of T4 DNA ligase
H20 to make 20ul total volume and incubate overnight at 15°C 
Add 0.3ml of competent JM103 and keep on ice for 30 minutes, heat 
shock at 42°C for 2 minutes and add to H-Top agar at 45° C containing 
15m 1 of 2°( X-gal, 25m 1 of 2 .5 % IPTG and 0.2ml of exponentially growing 
JM103. Plate the above mixture on minimal + glucose plates and incubate 
overni ght.
10. Gel Purification of DNA
DNA was size fractionated by gel-electrophoresis (usually restriction 
fragments) and the relevant sized DNA excised from the LMP agarose 
gel. The gel slice was diluted by half in TE before melting at 65°C 
and repeated phenol extraction to produce a clear aqueous/organic 
interphase. The aqueous phase was then collected, extracted with
diethylether and concentrated by ethanol precipitation.
11. DNA Sequencing by the Dideoxy Chain Termination Method
(Sanger, 1977; Sanger et aj_, 1980)
A. Primer Annealing Reaction
5u 1 (approximate!y 0.5 g) template DNA 
2ul (4ng) 15bp primer oligonucleotide
1 m 1 10 x Klenow buffer (70mM Tris/HCl, pH 7.5, 70mM MgCl^' 0.5M.NaCl) 
4.5ul H 2 0  
12.5u1 Total
The above mixture was sealed in a microfuge tube and placed in an 
85° -90°C water bath for 5 minutes, then the whole bath was allowed 
to cool slowly to room temperature.
The following reactions were carried out with a - P-dGTP and as such 
are not suitable for use with other radioactive deoxynucleotides, without 
further manipulation. The following solutions were prepared and stored 
at -20°C.
A° Mix:
20u1 0.5mM dTTP
20u1 0.5mM dCTP
B. Dideoxy Sequencing Reaction
3 2
lui 0.5mM dATP
lui 0.05mM dGTP
20ul 10 x Klenow buffer
G^_ Mix :
20u 1 0.5mM dATP
20ul 0.5mM dTTP
20ul 0.5mM dCTP
lui 0.05mM dGTP
20ul 10 x Klenow buffer
li Mix:
20u 1 0.5mM dATP
20u 1 0.5mM dCTP
lui 0.5mM dTTP
lui 0.05mM dGTP
20ul 10 x Klenow buffer
C° Mix :
20ul 0.5mM dATP
20ul 0.5mM dTTP
lui 0.5mM dCTP
lui 0.05mM dGTP
20u 1 10 x Klenow buffer
ddA (1.OmM): diluted 1:: 10
ddG (0.7mM): di1uted 1:: 14.5
ddt (2.OmM): diluted 1 : 5
ddC (0.35mM): diluted 1:: 28.5
After annealing was completed, the following additions were made:
1 Ml (lOuCi) a-32P-dGTP
1m1 0.1M DTT
1m1 (1 unit) large fragment DNA polymerase 1 (Klenow)
3wl aliquots were dispensed into microfuge tubes labelled A, G, T and C, 
containing 1 ul each of the appropriate N° and ddN solutions. The 
reactions were then allowed to proceed for 15 minutes at 30° C before 
adding the cold chase, lyl of 0.5mM dGTP, and incubating for a further 
15 minutes. The reactions were terminated by the addition of 10 ul 
of formamide-dye mix (0.1T (W/V) xylene cyanol, 0.1 bromophenol blue,
lOmM EDTA, 95 deionised formamide) and placed on ice before boiling 
and loading onto the gel .
C. Gel Electrophoresis and Autoradiography
8 or 6 denaturing polyacrylamide gels containing SM urea and lOOmM 
Tris Borate, lOmM EDTA gel buffer were used. 'he gels were covered 
with cling film, then covered with X-ray film and frozen at -70° C 
overni ght.
12. j_n Vivo Labelling of Yeast Proteins
35Yeast cells were labelled with S" inethioni ne as spneroplasts, essen­
tially as described by Nelson and Schatz, (1930). Briefly, yeast 
were grown to exponential phase in YPGal before harvesting and suspending 
in labelling media at 30°C for 3-4 hours. The radioactive probe was 
then initiated with 100wCi of 35S-methionine to 100ml of the original 
culture volume. The cells were incubated for a further hour before 
chasing with 1 casaminoacids for 2 hours. 'he spheroplasts were 
then lysed and mitochondria isolated as described in Chapter 6. The 
labelled procedure was performed with or without the drug cycloheximide 
(100 ug/ml ) to inhibit cytoribosome protein synthesis and specifically 
label mitochondrial translation products.
i13. Immunoprecipitation of the OS-ATPase Complex
Labelled mitochondria were extracted with 0.5 Triton X-100 and the 
non-solubi1ized protein removed by centrifugation in a Sarstedt microfuge 
3 x 10 minutes at 4°C. The clarified supernatant was then added to 
and equal volume of antisera prepared against purified F, -ATPase and 
incubated with gentle shaking overnight at 4°C. The immunoprecipitate 
was centrifuged out at 4° C in the Sarstedt microfuge for 10 minutes 
and washed twice with 25mM phosphate buffer pH 7.5, 0.5 Triton X 100.
1 4 ,  S D S - PAGE
SDS-polyacrylamide gel electrophoresis was performed as 20cm x 20cm 
x 1mm slab gels as essentially described by Lamelli, (1970). Routinely, 
gradient gels were utilised, composed of 8.5-12.5 and 10-15 gradient 
slabs with 6.25 and 8.5 stacking gels, respectively. The immuno- 
precipitates were suspended in 40u1 of sample buffer, boiled and loaded 
onto the gels which were run overnight at 15-20mA. The resulting 
radioactive bands were fixed in 10 methanol, 10 acetic acid and 
80 water for 1 hour and visualised by fluorography as described 
Bonner and Laskey, (1974).
by
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7.3 Results and Discussion 
The Mitochondrial ATPase Complex
In parallel to DNA sequencing studies, the mitochondrial translation 
products and mitochondrial ATPase components were examined for abnormal­
ities by in vi vo labelling in the presence of eye 1 ohexi mi de and immuno­
précipitation of hoio-mtATPase from a Triton extract by anti F ,-ATPase. 
Figure 7.ii demonstrates the i rrmunopreci pi tabl e bands of the ATPase 
complex. The bands visualised here are those which remain associated 
with the complex after mild detergent extraction, as the antisera 
used will only recognise the F, portion of the enzyme complex, and 
therefore may not be completely representative of the full functional 
entity. Bearing this limitation in mind, the following analysis may 
be made.
Figure 7.i i c and d show clearly the i mnunoprecipitable mitochon-
drially translated Fo components of the OS-ATPase complex, the ubiquitous 
protein labelled subunits 6, 8 and 9 corresponding to the known genes
Oli 2, AAP1 and 01i 1 respectively (see Roberts et aU 1979, and Marazuki 
et al, 1983). The Oli 2 gene product appears normal from the mutant
strain CD40 lending more evidence that drug resistant mutations are 
point mutations not disturbing the integrity or apparent function 
of the ATPase complex. The holo-mtATPase complex (Figure 7 .i ib ) appears 
to consist of 10 subunits, the apparent molecular weights of which 
are inset. The visible F , components of which have been identified 
by running simultaneously on the same gel purified F,-ATPase and staining 
separately with coomassie blue. This would appear to leave 2 subunits 
unaccounted for, which are apparently nuclear encoded and synthesised 
on cytoribosomes. Candidates for these are the OSCP and the possible 
yeast equivalents of Fg and Factor B, although their molecular masses 
are at variance.
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Cloning of the Oli 2 Region
The initial strategy employed was to clone the Eco- 6  and Eco-7 fragments 
of the grande mitochondrial genomes in the plasmid vector pAT-153. 
These fragments were known to contain the Oli 2 gene, ascertained 
by comparing the genetic and physical maps of grandes and petites 
rescuing the loci responsible for oligomycin resistance (Prunell et al, 
1977; Sanders et^  aj_, 1977; and Morimoto and Rabinowitz, 1979a and b). 
The pedigrees of all the strains employed here were based on the mito­
chondrial genome of D273/10B, the so-called short mitochondrial genome 
omitting some of the introns of the mosaic genes Oxi 3 (the gene coding 
for subunit 1 of cytochrome oxidase) and Cob (the gene coding for 
apocytochrome b), diagnosed by producing nine EcoRl fragments after 
digestion and resolution by agarose gel electrophoresis. Clones of 
the Eco- 6  and Eco-7 fragments were obtained by 'shotgunning' EcoRl 
generated restriction fragments of the grande mitochondrial genome
into EcoRl linearised vector pAT153. These clones were identified
32by colony hybridisation using a P-labelled probe, obtained from
the petite genome DS-14 containing the Oli 2 gene (Macino and Tzagoloff,
1980). The positively identified recombinants were then screened 
for the nature of their inserts by EcoRl digestion of mini-prep lysates. 
Such preparations yielded either 1.7Kb Eco-7 or 2.55Kb Eco- 6  bands 
on agarose gel electrophoresis, the correct clones were named pSCXME6  
and 7 where X delineates the parental yeast strain. Figure 7. i i i 
shows a flow diagram of the experiments involved in this procedure. 
Initial restriction maps were obtained for these clones based on single, 
double restriction enzyme digests and end labelling of the excised 
gel fragments and partial digestion with restriction enzymes (Smith 
and Birnstiel, 1976). Restriction maps of these fragments are presented 
in Figure 7.iv.
Table 7.Ü Recombinant E . co li clones and the parental yeast strains.
Name of the recombinants Parental yeast strain Mitochondrial genotype
pSC273ME6 £  pSC273.ME7 D273-10D/A1 p Oli 2* Oj j I*
PSC27ME6 & pSC27ME7 D27 p‘ Oii2* Oj j I ’
pSC603ME6 & PSC603ME7 D603-3B p ’
pSC22ME6 & PSC22ME7 D22 p’
pSC40ME6 £  pSC40ME7 CD40 p' 0 h 2 R O s i l*
pSC24ME6 £  pSC24ME7 CD24 m it pho9
pSC41ME7 CD41 m it  pho8
pSCl75ME6 £  PSCl75ME7 mit-175 m it
PSC76ME6 £  pSC76ME7 D27/76 p' 01 i2 R 0 « 1*
pSC92ME7 D27/92 p 0 l i 2 $ Oss \ R
PSC l4M E 6 £  PSC14ME7 DS14 p 0/.2*
C sC l/B is-^e nzim id e  gradient 
EcoR1 digestion of mtDNA
1* Agarose
mini -  prep’ plasmid
Colony hybridise
EcoR1 digest
32
P - labelled 
DS14 mtDNA
• *
;
Cs C I /  Bis -  b e n z i m i d e  gradient  
_ 1
EcoR1 digestion of mt DNA
1 ’ • Agarose
Ligate into 
pAT 153
Patch out 
RAmp colonies
:
i H
c
f  ig.7. iii2
Kbp
3,50 
p A T 153
2,55
1,73
m i n i -  p r e p '  plasmid EcoR1 digest
C o l on y  hybridise
32
P -  label led 
DS 14 mt DNA
< •
Restriction Maps of pSCME6  and pSCME7 Clones
Legend :
A. Restriction map of pSC40ME6 showing the ordered Sau 3A fragments
and their respective approximate sizes in base pairs of the inserted 
mitochondrial DNA.
B. Restriction map of pSC40ME7 showing the ordered Hpa 11 fragments
and their respective approximate sizes in base pairs of the inserted 
mitochondrial DNA.
1
1 6 . '
A
H H
E = EcoRl 
H = Hpa II 
S = Sau 3A
P Pst 1
1 6 4
Nucleotide Sequence of the Oli 2 Region
The complete nucleotide sequence of the Oli 2 region is presented
in Figure 7.v from the grande strain CD40 which bears the resistance 
R Ralleles for Oli 2-76 and Oss 1-92. The sequence spans 4,349 bp comprised 
of two EcoRI restriction fragments cloned originally in pAT-153, the 
first stretching from the C-terminal end of the Oxi 3 gene to the 
C-terminal end of the Oli 2 gene, including the Aapl gene sequence, 
some 2,571 bp. The second EcoRI fragment is continuous with the first 
about the EcoRI site within the Oli 2 gene coding sequence and extends 
1,784 bp downstream including a long putative open reading frame inter­
rupted by a series of '6 +C' rich sequences (RF3). The subcloning
and sequencing strategy employed in this study is shown in Figure
7.vi superimposed on the above reading frames. The codon usages of 
these genes is presented in Table 7.jii, where, as expected, the third 
base bias is towards A or T.
The AAP1 Gene
The Aapl gene (ATPase associated protein or subunit 8  of OS-ATPase,
Macreadie et aj^ , 1983), starts at 1,017th nucleotide and spans a reading 
frame of 144 bp corresponding to a protein product of 48 aminoacids
and 5.5 K Daltons molecular weight. The reading frame commences with 
f-met (ATG) and is terminated by an ochre codon (TAA) which is again
repeated in frame 27 bp downstream. The ochre codon has been used
for all yeast mitochondrial genes examined so far. 199 bp upstream 
of the ATG initiation codon is the modified consensus sequence 
(-ATATAAGTA-) which is the putative transcriptional initiation sequence 
(Tabak et al, 1983). However, evidence has been produced based on 
'Northern' blot, Sl-mapping and j_n vi tro capping experiments that 
the Oli 2 region is co-transcribed with the mosaic Oxi 3 gene (Hensgens
et al, 1983; Christianson and Rabinowitz, 1983; Tabak et al^, 1983;
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Arainoacid Codon Subunit-6 Subunlt-8 Subunit-9
Ala GCA 2 0 4
GCT 11 0 5
GCC 0 0 1
GCG 0 0 0
Arg AGA 4 2 1
AGG 0 0 0
CGA 0 0 0
CGT 0 0 0
CGC 0 0 0
CGG 0 0 0
Asp GAT 4 0 0
GAC 0 0 1
Asn AAT 14 1 1
AAC 0 0 1
Cys TGT 1 0 1
TGC 0 0 0
Glu GAA 3 0 1
GAG 1 0 0
Gin CAA 5 3 1
CAG 0 0 0
Gly GGA 2 0 2
GGT 14 1 8
GG C 0 0 0
GGG 0 0 0
His CAT 4 0 0
CAC 0 0 0
II* ATT 31 3 7
ATC 5 1 2
Lau TTA 47 12 il
TTG 0 0 0
Lys AAA 5 1
2
AAG 0 0
Met ATG 9 4
3
ATA 1 0
Phe TTT 15 4
1
c o d o n . u s e  (Contd- )
P r o
S e r
Thr
T r p
T y r
V a l
TOTAL
X 7 * •
TTC 6 3 6
CCA 4 2 1
CCT 4 1 1
CCC 0 0 0
CCG 0 0 0
TCA 1 1 1 5
TCT 5 2 0
TCC 0 0 0
TCG 0 0 0
AGT 3 0 0
AGC 0 0 0
ACA 9 1 2
ACT 6 0 0
ACC 0 0 0
ACG 0 0 0
CTA 3 1 1
CTT 2 0 0
CTC 0 0 0
CTG 0 0 0
TGG 0 0 0
TGA 5 0 0
TAT 9 3 1
TAC 2 0 0
GTA 7 1 5
GTT 5 1 1
GTC 0 0 0
GTG 0 0 0
2 5 9 48 76
Osinga et £l_, 1984; and Simon and Faye, 1984). It is quite possible 
in vivo that mRNA synthesis may originate as a long co-transcript 
of Oxi 3, Aapl, 01 i 2 and RF3, but additionally a shorter co-transcript 
may also occur from upstream of Aapl, certainly such a sized RNA has 
been identified on 'Northern' blots (Ray, 1985).
The predicted molecular weight of this protein is 5.5 K Daltons, which 
is not observed on immunoprecipitates of OS-ATPase. Certain Aapl 
mit* mutants have been correlated with the loss or aberrant mobility 
of a 10 K Dalton protein on SDS-PAGE, the apparent gene product 
(Macreadie et £l_, 1983; and Marazuki et £l_, 1983). These observations
have been rationalised with the purification and aminoacid sequence 
determination of the protein (Velours et al_, 1984). The aminoacid 
sequence confirms the DNA sequence predicted molecular weight of the 
protein, and it has further been observed that the purified protein 
migrates according to the predicted molecular weight on formamide 
gel systems. It remains to be discovered whether the observed 10 
K Dalton protein is a functional dimer as is the hexameric structure 
predicted for subunit 9 of OS-ATPase (or the DCCD binding protein, 
Tzagoloff et aj_, 1976; and Tzagoloff and Akai, 1972).
The predicted structure of subunit 8  is a single transmembrane a-helix 
with charged groups extending either side of the lipid bilayer. Other 
homologous poteins have been discovered within various mitochondrial 
genomes (see Figure 7. vi ii) although E.coli has no apparent homologous 
counterpart. However, the predicted secondary structure of the E.coli 
subunit b protein closely resembles the subunit 8  predicted structures 
and have been proposed to be analogous (Ray, 1985).
The 01i 2 Gene
The 01 i 2 gene (or subunit 6  of OS-ATPase, Roberts et aj_, 1979), is 
located 709 bp downstream of the Aapl gene and constitutes a 777 bp
M  ■»
open reading frame of 259 codons. The predicted molecular weight 
of the polypeptide product is 28.5 K Daltons, which is somewhat higher 
than the observed polypeptide product of some 20 K Daltons on SDS-PAGE 
(see an earlier section of this chapter; Roberts et al^, 1979; Marazuki 
et al, 1983; Somlo et^  1^_, 1982 and 1985). The predicted ami noacid 
sequence of this protein is very hydrophobic and can potentially form 
seven transmembrane o -helices (see Ray, 1985 for a detailed study). 
The primary aminoacid sequences and predicted secondary structures 
are similar to those predicted from DNA sequences of other mitochondrial 
genomes (see Figure 7.vii and Figure 7.vii1).
The drug resistant mutations were located in CD40 by comparison with 
wild type sequences at the 171st and 254th residues for oligomycin 
and ossamycin. These changes have been confirmed by sequencing the 
singly resistant strains D27/76 and D27/92 (see Figure 7.ix and 7.x 
respectively). Oligomycin resistance appears to be associated with 
a single T*A transition, corresponding to the replacement of a highly 
conserved isoleucine residue with phenylalanine. An exchange in this 
codon has also been observed by Macino and Tzagoloff, (1980), associated
D
with oligomycin resistance of the allele 0 1 i 2-118 where the same 
isoleucine residue had been substituted with methionine. A third 
Oli 2 allele has been investigated by Novitski et al_,(1984); the 01 iR2-23 
allele is associated with the exchange of a conserved serine residue 
in the 175th residue to threonine. This region of the subunit 6 gene 
(the 'Oli 2 block') appears to be conserved throughout evolution, 
and in addition to binding oligomycin may be functionally involved 
in the energy conservation system of the OS-ATPase.
Another oligomycin resistant mutation has been located towards C00H- 
terminus of the subunit 5 gene, the 01 i ^  4-622 allele defining a second
recombination group within the gene or the 'Oli 4 block' (Macino and
\F i g u r e 7 . V Ü  C o m p a r i s o n  o f  a m i n o a c i d  s e q u e n c e s  o f  t h e  s u b u n i t - 6  o f  t h e  
O.S.ATPas e  f r o m  v a r i o u s  o r g a n i s m s .  (1) E. c o l l ,  (2) A s p e r g i l l u s  n i d u l a n s  
(3) S a c c h a r o m y c e s  c e r e v i s i a e ,  (4) B o v i n e ,  (5) Human ( 6 )  Mous e ,  (7) D r o s o p h i l a  
m e l a n o g a s t e r , ( 8 )  D r o s o p h i l a  y a k u b a ,  T he  a m i n o a c i d  s e q u e n c e s  h a v e  b e e n  
a r r a n g e d  t o  e s t a b l i s h  maximum h o m ol o g y .
A i n d i c a t e s  n o t h i n g  b u t  a g ap  w i t h i n  t h e  s e q u e n c e s  t o  e s t a b l i s h  h o m o l o g y .
1 .MASENMT--- PQDYIGHHLNNLQLDLRTFSLVDPQNPQNPPATFWTINIDSMFFSWLGLLFLVLFRSVAKK
2 . MYQ— FNFILSPLDQFEIRDLFSLNANVLGNIHLSITNIGLYLSIG------------ LLL-TLG YHL-AHN
3 . MFNLLNTYIFSPLDQFEIRTLFGLQSSFIDLSCLNLTTFSLYIIV------------ LLVITSLYTLTNNN
4 .MN-------------- EN— LFT---SFITPVILGLPLVTL —  IVLF-PS-------- LLFPTSNR-LV— S
5.MN-------------- EN— LFT---SFIAPTILGLPAAVL— ILLF-PP-------- LLIPTSKY-LI— N
6 .MN-------------- EN— LFA---SFITPTMMGFPIVVA— IIMF-PS-------- ILFPSSKR-LI— N
7 . MMTNLFSVF---DP-----LAIFNFSLNWLSTFLGLLMIPS-IYWLMPSRYNIMWNS-ILLTLHK-------
8 . MMTNLFSVF---DP-----LAI FNLSLNWLSTFLGLLMI PS-I YWLMPSRYNIMWNS-ILLTLHK-------
ATSGVPGKFGTAIELVIGFVNGSVKDMYHGKSKLIAPLALTIFVWVFL----------- MMNLMDLLPYIAEHV
NKIPNN-WSISQEAIYATVHSIVINQLNPTKGQL----------- YFP-FIYALFIFILVNNLIGMVPYSFAST
NKIIGSRWLISQEAIYDTIMNM------- KGQIGG----KNWWGLYFP-MIFTLFMFI FI ANLISMI PYSFALS
NRFVTLQWMLQLVS----------------K -QMMSIHNSKGQYWTL---MLMSLILFIGSTNLLGLLPHSFTPT
NRLITTQWLIKLTS----------------K-QMMTMHNTKGRTWSL---MLVSLIIFIATTNLLGLLPHSFTPT
NRLITTOWLIKLTS----------------K-QMMLIHTPKGRTWTL---MIVSLIMFIGSTNLLGLLPHSFTPT
------------Ep----------------KTLLGPSGHHNGSTFIFISL— FSLILFNNFM-- GLFPYIFTST
------------Ep----------------KTLLGPSGHHNGSTFI FI SL— FSLILFNNFM-- GLFPYIFTRT
LGLPALRWPSADVNVTLSMALFIGVLILFYSIKMKGIGFTKELTLGPFNHWAFIPVNLILEGVSLL--- SKPV
SHFILTFSMSFTIVLGATF-LGLQRHGL------ K----FFSLFVPSGCPLGLLPLLVLIEFISYL----SRNV
AHL----- VFIISLSIVIWLGNTILGLY------KHGWVFFSLFVPAGTPLPLVPLLVIIETLSYI----ARAI
TQL----- SMNLGMAI PLWAGAVITGF------RNKTKASLAHFLPQGTPTPLIPMLVII ET I SLF IQPMALA-
TQL----- SMNLAMAIPLWAGTVIMGF------ RSKIKNALAHFLPQGTPTPLI PMLVI IETISLLIQPMALA-
TQL----- SMNLSMAI PLWAGAVITGF------ RNKLKSSLAHFLPQGTPISLIPMLIIIETISLFIQPMALA-
SHLTLT----- LSLALPLWLCFML YGW------1NHTQHMFAHLVPQGTPAILMPFMVCI ET I SN 11R PGTLA-
SHLTLT----- LSLALPLWLCFML YGW------1 NHTQHMFAHLVPQGTPAI LMPFMVC IETIRNI IRPGTLA-
SLGLRLFGNMYAGELIFILIAGLLPWWSQWI LNVPWAI FI FHI LI ITL---------- QAFI FMVLTIVYLSMA
SLGLRLAANILSGHMLLSILSGFTYNIMTSGILFFFLGLIPLAFIIA-FSGLELAIAFIQAQVFWLTCSYI--
SLGLRLGSNILAGHLLMVILAGLTFNFMLNLFTLVFGFFVPLAMILA-IMILEFAIGIIQSYVWTI LTASYL--
-- VRLTANITAGHLLI-HLIGGATLALMSISTTTALITFT---ILILLTILEFAVAMIQAYVFTLLVSLYL---
-- VRLTANITAGHLLM-HLIGSATLAMSTINLPSTLIIFT---ILILLTILEIAVALIQAYVFTLLVSLYL---
-- VRLTANITAGHLLM-HLIGGATLVLMNISPPTATITFT---ILLLLTILEFAVALIQAWFTLLVSLYL---
-- VRLTANMIAGHLLLTLL-GNTGSS-MSYM----LMTFLLMAQIALLV-LESAVAMIQSYVFAVLSTLYS---
-- VRLTANMIAGHLLLTLL-GNTGPS-MSY---- LLVFLLVAQIALLV-LESAVTMIQSYVFAVLRTLYS---
SE-- E-H
KD-GLDLH
KD-TLYLH
HDNT
HDNT
HDNT
SEVN
REVN
F i q u r e Z v i i i  C o m p a r i s o n  o f  Amino a c i d  S e q u e n c e s  o f  S u b u n i t - 8  f ro m V a r i o u s  
O r g a n  i s m s .
* i n d i c a t e s  same a m i n o a c i d  i n  m o r e  t h a n  two p h y l o g e n e t i c  g r o u p s .  O r g a n i s m s  
a r e :  1 A s p e r g i l l u s  a m s t e l o d e m i ,  2  A s p e r g i l l u s  n i d u l a n s ,  3  S a c c h a r o m y c e s
c e r e v i s i a e  4  Human, 5  B o v i n e ,  6  Mo us e ,  7  D r o s o p h i l a  m e l a n o g a s t e r  
8  D r o s o p h i l a  y a k u b a .  h a s  b e e n  i n t r o d u c e d  w i t h i n  t h e  s e q u e n c e s  t o
e s t a b l i s h  maximum h o m o l o g y .  Ho mo l o g o u s  r e g i o n s  h av e  b e e n  shown i n  c o l o u r .
P i n k ,  common t o  a l l  o r  f u n g i  o n l y ;  y e l l o w ,  mammals and  i n s e c t s  o r  mammals o n l y  
o r a n g e ,  i n s e c t s  o n l y .
* * • • * * *
1 . MPQLVPFFFVNQW-YAFVNL-TVLIYAFTK F I I P K L L R I F I S R I V I -------------------- NKL
2 . MPQLVPFFFVNQVI - F A F I V L - T V L I Y A F T K ----- Y I L P R L L R T Y I S R I Y I --------------------- NKL
3 . MPQLVPFYFMNQLITYGFLI.M-ITLLILFSQ FLLPMILRLYVSRLFI -------------------- SKL
4 . MPQLNTTVWPTMITPMLLTL-FLITQLKMLNTNYHLPPSP-KPMKMKNYNK----- PWEPKWTKICSLHSLPPQS
b .MPQLDTSTWLTMILSMFLTL-FLITQLKVSKHNFYHNPELTPTKMLKQNT--- PWETKWTK1 YLPLL.L.PL
6 . MPQLDTSTWFITI SSM-ITLFFLLTQLKVSSQTFPLAPSPKSLTTMKVKT------- PWELKWTKIYLPHSLPQQ
7 . IPQLAPI SWL L LF I I F S T L  —  FLLTCSXNYYSYMPNSPKSNEL KNINLNSMNW— KW
3 . IPOLAPIRWLLLFIVFSTL— FLLTCSINYYSYMPTSPKSNEL----- KNINLNSMNW--KW
Figure 7.ix
Nucleotide Changes at the 01i2 Locus
Legend:
A. Autoradiogram of a sequencing gel of the recombinant clone 84066
D
containing the Oli 2-76 allele at the nucleotide A marked with 
an arrow. The wild type sequence indicates a T at the corresponding 
position resulting in a aminoacid change of methionine to phenyl­
alanine.
B. The similar nucleotide change found in the singular resistant 
strain 027/76 confirming the nucleotide change responsible for 
oligomycin resistance.
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Nucleotide Changes at the 01i 2 Locus
Legend:
A. Autoradiogram of a sequencing gel of the recombinant clone 84066
p
containing the Oli 2-76 allele at the nucleotide A marked with 
an arrow. The wild type sequence indicates a T at the corresponding 
position resulting in a aminoacid change of methionine to phenyl - 
alani no.
B. The similar nucleotide change found in the singular resistant 
strain D27/76 confirming the nucleotide change responsible for 
oligomycin resistance.
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Tzagoloff, 1980). The mutation is due to the alteration of the 232nd 
residue, where a conserved leucine is changed to phenylalanine. Also 
within the 101 i 4 block' Slott et £l_, (1983) have identified a codon 
change responsible for oligomycin resistance in a mouse cell line 
where a conserved valine has been replaced by a glutamic acid residue.
Both the Oli 2 and 01 i 4 associated changes have one characteristic 
in coimon, they occur adjacent to a glutamic acid residue within a 
hydrophobic segment of the subunit 6  protein. Because the mutations 
reported here and previously have apparently no bioenergetic handicap 
(see Chapter 6  and Griffiths and Houghton, 1974), they are probably
not directly involved in proton translocation, but apparently interfere 
with the binding of oligomycin by hydrophobic interaction adjacent 
to charged residues where the drug may exert its effect.
Ossamycin resistivity exerted by the allele Oss 1-92 is due to a change 
of a conserved aspartic acid residue to asparagine by virtue of a
G-»A transition in the nucleotide sequence (see Figure 7.x). The amino- 
acid change due to ossamycin resistance is in the 254th residue near
the carboxyl terminus. This region probably lies outside the membrane 
as predicted from its charged nature. Therefore, it is likely that 
ossamycin binds by a charge interaction and causes inhibition at the
initial site of transfer of the proton channel by direct interaction 
or conformational change.
However, ossamycin resistance may have other contributing factors 
in subunit 6 , since certain Oli 2 mutations show cross-resistance 
(Lancashire and Mattoon, 1979; and Griffiths and Houghton, 1974). 
Therefore, other residues may have indirect effects. For example, 
the allele Oli R 2-118 sequenced by Macino and Tzagoloff, (1980), is 
cross resistant to ossamycin despite being within the same codon disting­
uished from oligomycin in this study. This phenomenon has been put
1 7 8
Figure 7.x
Nucleotide Changes at the Ossi Locus
Legend:
A. The autoradiogram shows a DNA sequencing gel of recombinant 
clone 82737 containing the wild type sensitive allele at the 
Ossl locus. The G marked with an arrow undergoes a change in 
the 0 s s R1-92 allele.
B. The autoradiogram shows a DNA sequencing gel of recombinant clone 
84077 containing the ossamycin resistant allele Oss 1-92. The 
sequence is that of the non-transcribing strand and shows the 
G-A nucleotide transition from that of the wild type in track A.
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Figure 7,x
Nucleotide Changes at the Ossi Locus
Legend:
A. The autoradiogram shows a DNA sequencing gel of recombinant 
clone 82737 containing the wild type sensitive allele at the 
Ossl locus. The G marked with an arrow undergoes a change in 
the OssRl-92 allele.
B. The autoradiogram shows a DNA sequencing gel of recombinant clone
R T84077 containing the ossamycin resistant allele Oss ’ 1-92. The 
sequence is that of the non-transcribing strand and shows the 
G-A nucleotide transition from that of the wild type in track A.
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to use to examine intra-codon cross-over in the mitochondrial genome, 
allowing the experimenter to follow the transmission of the parental 
alleles, while searching for true intra-codon recombinants by their 
predicted sensitivities to the drugs and thereby generating further 
point mutations within the Oli 2 locus. Such recombinant strains
have been isolated and subsequent molecular analysis is presently 
under investigation (Connerton et ¿1_, 1984b).
The sites of drug resistance discussed above are shown in Figure xi.
RF3
The open reading frame downstream of 01 i 2 starts with an AUG codon 
80 bp downstream of the Oli 2 gene and terminates at a G+C rich cluster 
at the 3,008th nucleotide with an opal codon. A second reading frame 
overlaps at +1 bp and continues until an ochre codon at the 3,323rd 
nucleotide just beyond a second G+C rich cluster. A third reading 
frame overlaps at +1 bp and terminates at nucleotide 3,780 with an 
ochre termination codon. Finally, a fourth ORF overlapping by +1 bp 
terminates at an ochre codon at nucleotide 4,266. It has been postulated 
that since the whole of this region is transcribed, the overlapping 
reading frames may be translated as a continuous polypeptide by virtue 
of frameshifting events forced upon the mitoribosome by the strong 
secondary structures imposed upon the mRNA by the internal G+C rich 
clusters (Seraphin et al_, 1985). Such an event would give rise to 
a 500 ami noacid long protein, presumably at low levels, a fact which 
may be required physiologically. Certainly instances of frameshifting 
in yeast mitochondrial DNA are known, (Hensgens et al_, 1984). Indeed 
the mitochondrial translation machinery has been shown to suppress 
frameshift mutations (Fox and Weiss-Brummer, 1980; and Somlo et al,
1985), even in the same transcript. Further evidence as to the express­
ion of the putative protein comes from an examination of the aminoacid
1F i g u r e  7.xi C o m p a r i s o n  o f  t h e  drug r e s i s t a n t  s i t e s  o f  t h e  s u b u n i t - 6  f rom 
v a r i o u s  o r g a n i s m s .  * i n d i c a t e s  t h e  a l t e r e d  a m i n o a c i d  i n  d r u g  r e s i s t a n t  
s t r a i n .  A m i n o a c i d s  a r e  shown a s  s i n g l e  l e t t e r  c o d e .
S .  c e r e v i s i a e
A.  n i d u l a n s
B o v i n e
Human
Mouse
Ra t
D. m e l a n o g a s t e r  
D. y a k u b a
• •
P L L V L I E F I S Y L  
P L L V I  I E F I S Y L 
P M L V I  I E T I S L F  
P M L V I  I E T I S L L  
P M L V I  I E T I S L F  
P M L I  I  I E T I S L F  
P F M V C I E T I S N I  
P F M V C I E T I R N I
( a )  O L I 2 M u t a t i o n a l  s i t e
L E F A I G I  I Q S Y V W  
L E L A I A F I Q A Q V F  
L E F A V A M I Q A Y V F  
L E I A V A L I Q A Y V F  
L E F A V A L  I Q A V V F  
L E F V V A L I Q A Y V F  
L E S A V A M I Q S Y V F  
L E S A V T M I Q S Y V F
( b )  O L I4  M u t a t i o n a l  s i t e
S .  c e r e v i s i a e
A.  n i d u l a n s
B o v i n e
Human
Mouse
R a t
0 .  m e l a n o g a s t e r
D. y ak u b a
E .  c o l i
Y L - - - K D T L Y L H
Y I - - - K D G L D L H
Y L - - - H D N T
Y L - - - H D N T
Y L - - - H D N T
Y L - - - H D N T
Y S - - - S E V N
Y S - - - S E V N
Y L S M A S E - - E H
( c )  O s s i  M u t a t i o n a l  s i t e
sequence, which reveals two peptide motifs, PI and P2, which are common 
to all maturase enzymes discovered in mitochondria (Michel ejt 
1982 and Waring et aj^ , 1982), (see Figure 7.xii ). It may well be
that RF3 is responsible for processing the Oxi 3-01i 2 multigenic 
transcript. However, certain strains of S.cerevisi ae do not possess 
the RF3 sequence (Cobon et al_, 1982; and Séraphin et 1985). It
may be that these strains have a completely functional protein encoded 
elsewhere within their mitochondrial genomes. This is possible since 
Michel (1984), has discovered a similar organised sequence, RF2, down­
stream of the Oxi 2 gene. The RF2 reading frame contains 'G+C rich 
clusters found here, these sequences also occur throughout the genome 
of S.cerevi si ae, their function as yet remains obscure (Figure 7.xiii).
A mit mutation has been localised downstream of Oli 2 (see introductory 
paper to this chapter), based on petite deletion mapping and its rescue 
by the defined petite CDS14, a cytoductant of DS14 (Macino and Tzagoloff, 
1980). If this mutation resides within the RF3 sequence, then it 
may be translated. It has been shown that the mutation causes a loss 
of subunit 1 of cytochrome oxidase and the production of a series 
of aberrant peptide products on analysis of the mitochondrial translation 
products of the mutant (J. Velours, personal communication). By analogy 
to RNA splicing mutants of apocytochrome b (Kreike et al_, 1979), 
the mitl75 mutation may be deficient in the splicing of the Oxi 3 
gene, in which case RF3 is a bona fide maturase.
Sequencing studies on the mutant strain are presently under way and 
have revealed only one base change so far at nucleotide 4,152 where 
a C-A transition is present, and results in the loss of a Hinf 1 restric­
tion site as compared with the wild type. This base transition results 
in a conservative codon change, maintaining phenylalanine at the 462nd 
aminoacid residue. This sort of event cannot be the mutational site,
1 . 3
Figure 7 .xi i
Comparison of Peptide Motifs in Maturases
P I P2
Sc RF3 - Y L S G L I E G D G Y I -  104aa
Sc A I  3 - Y L A G L I E G D G S I -  120aa
SC A I4 -W L A G L ID G D G Y F -  94aa
Sc A I5 * - Y L S G L F E G D G N I -  97aa
Sc B I4 -W L A G L ID G D G Y F -  94aa
Sc RF1 -W L V G F TD G D G S F - 124aa
Sc RF2 -W L S G F V V G D G Y F - 121aa
An A I 2 - Y L A G L I E G D G T I -  107aa
An A I3 - Y L A G L I D G D G H F -  99aa
An B I 1 - Y L V G L F E G D G Y F -  120aa
Nc B I2 -F L A G L V D G D G Y I -  119aa
Nc B I2 -F L A G L V D G D G Y I -  144aa
Nc 012 - Y IT G F V D G E G  -  158aa
Sp A I2 -Y L A G L I D G D G H F -  99aa
CONSENSUS -Y L A G L * D G D G + F -
W S E I
-W L A G F TA A D G S F -
-W L A IL T D A D G N F -  
-W F V G F F D A D G T I -  
-W LTG FN D A D G Y F - 
-W F M G F F D A D G TI -  
- W I L G F I E A E G T F -  
- F I L G F I E A E G T F -  
-W L S G F IE A D G S F -  
-W LAGFSDADASG- 
-W L V G F IE A E G C F -  
-W I V G F I Y S K G S F -  
-W IV G F T C S E G S F -  
-W IR G F IE G E G  -  
-W LA G FS D A D A S F-
-W L * G F / D A D G S F - 
I  E E T
Legend:
Comparison of the dodecapeptide sequences PI and P2 which feature 
in the intron ORF's of group IB and are present in RF1 and RF2. 
Distances between PI and P2 are in aminoacids. The meaning of the 
symbols drawn in the consensus sequence are the following: *: majority 
of apolar AA; +: majority of non-ionic polar AA;/: any AA. Sc: 
Saccharomyces cerevisiae; An: Aspergillus nidulans; Nc: Neurospora 
crassa; Sp: Schizosaccharomyces pombe.
Comparison of GC Clusters in Yeast Mitochondrial DNA
Legend:
Homologies between GC clusters, GC rich sequences 
clusters 1 or III and II are aligned to illustrate 
similarity. Bases diverging from the consensus are 
letters. Extra bases are indicated below the sequences.
The sources of the sequences are as follows:
a. Coruzzi et al, 1981.
b. Michel, 1984.
c. Hensgens et al, 1983.
d. Goursot et al, 1982.
e. Bonitz and Tzagoloff, 1980.
f. Miller et al, 1983.
g. Sor and Fukuhara, 1980.
h. Tzagoloff et al, 1980.
i. Nobrega and Tzagoloff, 1980.
related to RF3 
their sequence 
in lower case
Figure 7.xiii
C L A S S  Aj.
R F3 I  
RP3 I I
RF1 
RF2 I  
A I 5  A
O R I s l  
O R Is 3  
O R Is  4 
O R Is S  
O R Is 6 a  
O R Is 6 b  
t R N A s e r 2 
tR N A as n  
T S L
IS S r R N A  
O L I I  E 
O L I I  B 
3 'C O B  A 
3 ‘ COB B
CONSENSUS
C LA S S  Bj_
CONSENSUS
RF2 I I  
RF2 I I I  
RF2 I V
RF3 I I
TAGTTCCGGGGCCCCGCCACGGGAGCCGGAACCCCGCAAGGAG +
TAGTTCCGGGGCCCGGCCACGGGAGCCGGAACCCCaCAAGGAG +
TAGTTCCGGGGCCCGGCCACGGGA-CCGGAACCCCGAAAGGAG 
TAGTTCtGGGGCCCGGCCACGGGAGCCGGAACCCCGTAAGGAG 
TAG TTtCGG GG gCCGG aCcaG GG A-CCGGAACCCCaAAAGGAG 
TAGTTCCGGGGCCCGGCtACGGGAGCCGGAACCCCGAAAGGAG 
TAGTTCCGGGGCCCGGCCACGGGAGCCGGAACCCCGAAAGGAG 
TAGTTCCGGGGCCCGGCCACGGGAGCCGGAACCCCGGAAGGAG 
TAGTTCCGGGGCCCGGCCACGGGAGCCGGAACCCCGAAAGGAG 
TAGTTCCGGGGCCCGGCCACGGGAGCCGGAACCCCGAAAGGAG 
TAGTTCCGGGGCCCGGCCACGGGAGCCGGAACCCCGAAAGGAG 
TAGTTCCGGGGCCCGGCCACGGaAGCCGG-ACCCCGAAAGGAa 
TAGTTCCGGaGCCCGGCCACGGGAGCCGGAACCCCG-AAGGAa 
T A G T T C C G G G t  tCCGGCCACGGGAGCCGGAACCCCtAAAGGAG 
TAG TTC CG GGG CC CG GC CAC -GG AGCC -GAA-C C CGAAA GGAG 
TAGTTCCGGGGttCGGCCACGGGAGCCGGAACCCCGAAAGGAG 
TAGT-CCGG GGCCCGG CCAC-GGA-CCG GAACCCCG AAAGG AG 
TAGTTCCGGGGCCCGGtCACGGaAGCCGGAACCCCGCAAGGAG 
TAGTTCCGGGcCCCGGCCAC^jGGAaCCGGAACCCCcGAAGGAG
T A G T T C C G G GGCCCGGCCACGGGAGCCGGAACCCCGNAAGGAG
♦
+
♦
+
+
+
+
TAGTTCCCGCTTC GCGGGAAÇCCCGNAAGGAG
TAG TTC CC GC TTC GC GGG AACC CC GTAAGGAG 
cAGTTCCCG CTTCG CGG GAACCCCG TAAGG AG 
TAG TTC C C G C TTC G C G G G A A C C C C G TtA G G A G
(a)
( b )  
(C )  
( d )  
(d) 
( d )  
( d )  
( d )
( d )
( e )  
( a )  
( f  ) 
(Q ) 
(h)
( h )
( i )  
( i )
( b )
( b )
( b )
TAGTcCCgGCccC^GCcGGg ACCCCGC A AGGAG +
i :> 6
but merely a conservative polymorphism. This event has been observed
before in the subunit 6  gene, leading to an new Sau 3A site at the 
226th codon in the strains 022 and JM6  (Ray, 1985, and Novitski et al_,
1984). However, such a conservative change would suggest some constraint 
on the system to maintain the RF3 sequence intact.
7.4 Conclusion
D
The nucleotide changes associated with the resistance alleles Oli 2-76
p
and Oss 1-92 have been determined. These changes occur close to con­
served glutamic acid residues within the structural gene for subunit 
6  of the mitochondrial ATPase complex in the yeast Saccharomyces 
cerevi siae. These regions may define in part the binding sites for 
the drugs and their inhibitory sites in blocking oxidative phosphory­
lation. Although these sites may overlap on subunit 6 , as ascertained 
by the cross resistance of the 01i^2-118 allele. The predicted aminoacid 
sequence of the subunit 8  gene is colinear with the experimentally 
determined aminoacid sequence (Velours £t al_, 1984).
The DNA sequence presented here also defines a new putative gene down­
stream of Oli 2. The sequence consists of four overlapping reading 
frames interrupted by G+C rich clusters. The expression of the full- 
length predicted polypeptide would be dependent on frameshifting events 
during mitochondrial translation. The putative polypeptide product 
would contain two peptide motifs which are indicative of a maturase 
activity, possibly to splice the Oxi 3 - Oli 2 multigenic transcript. 
The mit* mutation mitl75 maps in this region and affects the production 
of a full length functional Oxi 3 gene product, despite its apparent 
map position.
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APPENDIX 1
Introduct i on
Organotin compounds have been widely used as biocidal agents (partic­
ularly triorganotins), and plastic stabilisers. The introduction 
of these compounds into the environment has raised concerns as to 
how they may interact with biogeochemical cycles. Consequently, a 
need has arisen for simple analytical methods for the determination 
of various organotin compounds within environmental and biological 
samples. To this end the following method was developed.
In previous studies gas chromatographic methods have been utilised 
for the simultaneous determination of tetraalkyl- and trialkyltins 
(Arakawa et al, 1981a and 1981b) which could be applied to biological 
extracts. However, these methods suffered from difficult preparation 
and failed to reproducibly detect dialkyltin species because of their 
adsorption and decomposition during chromatography.
Previous studies have also utilised spectrofluorometric techniques 
for the determination of organotins. These studies have been based 
on the enhanced fluorescence of 3-hydroxyflavone and 2‘, 3', 4', 5', 
7 -pentanydroxyflavone (the latter is more commonly known as morin).
The fluorescence of 3-hydroxylflavone with triphenyltin has been used 
to measure submicrogram amounts of this species in potatoes (Vernon, 
1974), and water (Bluden and Chapman, 1978). This assay has since 
been further refined and used to measure triphenyltin in a variety 
of samples (Baker et al, 1980; Aldridge and Street, 1981). However, 
this approach is limited since only the trimethyl- and triphenyltin 
complexes exhibit fluorescent properties in aqueous solution (Blunden 
and Chapman, 1978; Aldridge and Street, 1981) and the presence of 
chloride destabilises the complex when exposed to light (Aldridge 
and Cremer, 1957). More recently, the fluorescent properties of
3-hydroxyflavone and organotins have been studied further, where it 
appears that other n-alkyltin species will form fluorescent complexes 
when obtained by boiling in toluene (Blunden and Smith, 1982). However, 
the applicability of this technique to biological materials is undoubt­
edly questionable.
More success,however, has been achieved using morin, which produces 
fluorescent complexes with mono di- and trialkyltins which produce 
various intensities of green fluorescence which may be calibrated 
with known quantities of the individual species (Arakawa et al, 1983). 
These complexes appear stable under laboratory conditions, and the 
presence of various other organometal compounds did not interfere 
with the assay. One drawback of the assay is the need to extract 
the organotin from samples into a hexane solution. Although the authors 
of this work presented apparently reproducible procedures for such 
extractions, they are time consuming. Nevertheless, the coupling
of this technique with high performance liquid chromatography and 
thin-layer chromatography has allowed the simultaneous determination 
of a variety of organotin compounds (Yu and Arakawa, 1983).
During the progress of these studies, the above morin based method 
was reported, although it appears a sensitive and reproducible assay, 
it does suffer in its requirement for hexane extraction, whereas the 
following method is applicable in aqueous solution for n-alkyltins 
and, as such, may offer certain advantages to the investigator.
Materials and Methods 
Reagents
Trimethyltin chloride (Me3 SnCl), triethyltin chloride (E1 3 SnC 1 ), tri- 
propy1 tin chloride (Pr3 SnCl), tributyltin chloride (Bu 3  SnCl) and 
triphenyl tin chloride (Ph3 SnCl) were all purchased from BDH Chemicals Ltd 
U.K. Trioctyl tin chloride (Oc3 SnCl) and tri cyclohexyl tin hydroxide
A  >»
(Ocj SnC1) and tricyclohexyl tin hydroxide (Cy3 SnOH) were purchased 
from Dow Chemical Company USA. Monoethyltin trichloride (EtSnClj), 
and diethyltin dichloride (Et2 SnCl2 ) were purchased from the Ventron 
Corporation USA. Tributyltin oxide ((Bu^Sn^O), tributyltin phosphate 
((BujSn) 2 PO^ ), and tributyltin malate (Bu3 SnCl2 CC2  C2 H 2  C0 2 CH3 ) were 
gifts from Schering Industrie-Chemikalien, West Germany. These organo-
tins were made up in 2ml batches of 01 .M in ethanolic solution and 
kept dark. 1 .aniline-8 -napthalene sulphonate (ANS) was purchased from 
Eastman-Kodak Ltd., USA. ANS was kept as a lOmM aqueous solution in the 
dark.
Apparatus
All fluorescence measurements were performed with a Perkin-ElmerMPF-3 
spectrofluorometer in four sided 4ml quartz cuvettes. Spectrophotometry 
was performed on a Shimadzu R500 instrument.
General Procedure
To a 4ml cuvette up to 0.1ml additions of organotin in ethanolic solution 
were made, before the addition of ANS and water to make 10 pM. The 
cuvette was mixed and immediately placed in the fluorometer (Excitation 
380nm - Emission 460nm) which had been blanked with an equal concentra­
tion of ANS solution, prior to use.
Results 
Principle
ANS fluoresces at 460nm when excited at 380nm, the intensity of this 
fluorescence may be increased by the addition of trialkyltin. The
observed increase in intensity can be correlated proportionately to 
the addition of increased amounts of the trialkyltin species. The
emission spectra presented in Figure lAi demonstrate this function 
for n-tributyltin chloride on ANS fluorescence which, in common with 
other trialkyltins, has no fluorescent properties of its own.
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Figure 1 A.i
Emm. (nm)
Emmission Spectra of Tributyltin - ANS Complex
Legend :
Emission spectra of tributyltin - ANS complex excited at 380nm with 
0 , 1 , 2 , 4 , and 6  x 1 0 "^M concentrations of tributyltin chloride
in the presence of 25 x 10*^M ANS.
Figure 1 A.i i
1 0 1
(nm)
Spectral Changes Accompanying the Addition of Equimolar Quantities of ANS
and Tributyltin Chloride
Legend:
a. 0 . 1  x 1 0 ‘3M tributyltin chloride
b. 0.1 x 10'3M ANS
c. 0.1 x 10'3M ANS and tributyltin chlorideX
u jOrQ
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The increase in fluorescent intensity of the tributyltin -ANS complex 
is accompanied by a change in the absorption spectrum with the modifica­
tion of peaks at 350 and 375nm and the production of a new peak at
282nm over the basic ANS spectrum. These spectral changes are presented
in Figure lAii, which are indicative of the formation of a charge
transfer complex between ANS and the trialkyl tin.
Further investigation of this interaction was carried out utilising 
‘h NMR (90MHz ). Presented in Figure lAiii are a series of spectra 
of lOmg/ml solutions of ANS and tributyltin chloride in dutero-methanol. 
Tributyltin chloride produces a 'H spectrum with a complex splitting 
pattern, due to the interaction of -Cl^- protons with the various 
tin nuclei which possess spin. The alkyl protons resonate upfield 
(0.89 - 1.83 S/ppm), which produce a triplet of nine equivalent CH3
protons (0.89, 0.97 and 1,04 i/ppm) and 3 x 6  lH of three non-equivalent 
-CH^- protons (1.16 - 1.83 s/ppm).
ANS produces a typical downfield ‘H spectrum consisting of ten aromatic 
and two amino protons (6.77 - 8.42 5/ppm).
On mixing these reagents, no change in chemical shift or splitting
of the n-butyl protons were observed, however, the aromatic protons, 
although similarly not experiencing any appreciable change in chemical 
shift, do exhibit a variation in splitting, suggesting a possible 
close interaction with the n-butyl protons present. The exact nature 
of this interaction cannot be determined from this data, but changes
in the n •» n* transitions experienced by the aromatic systems may
be envisaged, based on the above evidence, which in turn, may certainly
modify the fluorescent properties of the system.
Calibration and Detection Limits
Calibration curves were obtained using a standard 25 uM solution of 
ANS and making small ethanolic additions of triorganotins serially
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Figure lA.iii 
^  90MHz Spectra
Legend:
A. 90MHz spectrum of 1-analino-8 -napthalene sulphonate (ANS), 
1 Omg/ml.
B. 1H 90MHz spectrum of tributyltin chloride (TBT), lOmg/ml.
C. H^ 90MHz spectrum of ANS + TBT complex, 1 Omg/ml.
M
eO
H

AN
S 
+ 
TB
T
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diluted as described in 'General Procedures'. Ethanol was never allowed 
to exceed 1% of the total solvent. Table lAi provides the linear 
concentration ranges and detection limits of the method under the 
above conditions for various triorganotins.
Table lAi demonstrates the applicability of the method to mono, di- 
and triethyltin chlorides, although a reduction in the sensitivity 
is experienced with the loss of consecutive n-alkyl groups. Most 
sensitive under these conditions is the detection of n-trialkyltins. 
Varying the anion of the tributyltin derivatives appears to make little 
difference to the linear concentration ranges with these compounds. 
This phenomenon provides for the advantage of allowing the investigator 
to assay alkyltins at various stages of degredation and/or metabolism, 
when applied to test samples. However, the detection of specific 
trialkyltin compounds can only be attempted with a priori knowledge 
of the anion under investigation.
It must also be noted that the assay does not extend to aryltins, 
since neither triphenyltin chloride, nor the penta-coordinate complex 
2 -((dimethyl amino) methyl) phenyl diethyltin chloride, respond in 
this system.
Recovery from and the Determination of Trialkyltins, in the Presence 
of Biological Samples
The assay provides the flexibility of allowing the investigator to 
make quick estimations in aqueous suspensions of biological samples, 
or allowing extraction and concentration with n-hexane before
determination.
Exogenous tributyltin chloride was added to rat liver homogenates 
and the samples diluted and assayed for alkyltin concentration in 
aqueous suspension, as described in the 'General Procedures'. The 
detection level of such a procedure was 10 x 10”  ^M final concentration
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Table 1Ai
Typical Conditions Employed to Measure uM Quantities of n-alkyltin
Compound Wavelength(nm) 
Ex Em
Cone. Range 
(1xl0"6 M)
Detection Limit 
(lxlO'^M)
Me3 SnC1 380 460 2 .0 - 80 1 . 0
EthSnCl3 380 460 5.0- 25 5.0
EthgSnC^ 380 460 2 .0 - 2 0 2 . 0
Eth3SnCl 380 460 2 .0 - 1 0 0 1 . 0
Pr3SnCl 375 455 1 .0 - 1 0 0 0 . 2
BUjSnCI 374 455 0.5-100 0 . 1
(Bu3 Sn) 2 0 374 455 1 .0 - 1 0 0 0.5
(Bu3 Sn)2 P0 4 374 455 1 .0 - 1 0 0 0.5
8 u3Sn
C0 2 C2 H2 C0 2 CH3 374 455 1 .0 - 1 0 0 0.5
OctjSnCI 370 460 3.0- 50 1 . 0
Cy-jSnCI 370 460 5.0- 50 1 . 0
Ph3 SnC1 380 460 - -
1 i
or 30 nmoles of tributyltin chloride.
However, if the n-hexane extraction procedure of Arakawa et al, 1981b, 
was pursued some 92% ± 1 (the average and deviation of five estimates) 
of the total tributyltin chloride added was recoverable, allowing 
3.5* 1 . 0  nmoles of the alkyltin to be detectable in total samples.
It is proposed that the above method should provide a useful, reliable 
and rapid assay for various n-alkyltins.
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APPENDIX 2
Toxicological Studies with Organotins
Investigations of the Fungistatic and Bacteriostatic Activities
of Organotins
As discussed earlier, the use of organotins as biocides has increased 
in recent years, and has diverged with more varied methods of synthesis 
of functionally substituted organotin compounds. The use of these 
compounds has been reviewed and commented upon by several authors: 
Stapher, 1969; Evans and Smith, 1975; and Smith, 1982. Presented
here are a series of results based on ester tin derivatives synthesised 
at Akzo Chemie UK with a view to finding fresh alternatives with which 
to continue functional studies.
In previous studies the basic n-alkyltins have almost always proved 
to be the best formula, and the model compound n-tributyltin oxide 
has, similarly, proved intransient in its structure when attempting 
to modify its biocidal activities, (Kerk et 1^_, 1954, 1956, 1957, 
1959a, b, c, and d). This approach has indeed been disappointing.
However, such studies have confirmed that certain organotins used
as PVC stabilizers in contact with edible goods have low toxicity 
(Penninks and Seimen, 1982), and occasionally have identified useful 
compounds, for example, the penta-coordinate species Ve2283 (Aldridge, 
1978).
The following results are based on minimum inhibitory concentration 
values (MIC-values) which prevent growth under stringent fermentative 
and oxidative conditions of obligate aerobes. The MIC-values are 
in parts per million (ppm) and were produced using a Dynatech MIC-2,000 
system, which is located in Duren, West Germany. The test organisms 
employed were two strains of yeast (D22 and D27) of the species 
Saccharomyces cerevisiae and the Gram positive and negative bacteria
Bacillus subtills and Escherichia coli respectively (ATC 1831, K12).
The two modes of growth provide diagnostic evidence as to the mode 
of action of the inhibitor under test. Trialkyl tins and uncouplers 
in general, are more potent under oxidative conditions, which is compati­
ble with their in vitro activities on various biosystems energy conserva­
tion functions. The use of such drugs under these conditions has 
allowed the isolation resistant mutants directed at bioenergetic functions 
(Griffiths, 1976). The yeast culture media employed has been described 
earlier in this thesis, and Merck Casoboullion was used to culture 
both species of bacterium. Tables 2A 1, 2, 3, 4 and 5 represent MIC-
values of various organotins grouped together under similar basic 
chemical structures.
As with other studies cited above, the functional substitution of 
alkyltins appears to reduce their biocidal activities. Such results 
taken as a whole, suggest that high biological activity is by no means 
a rule, but rather the exception, a situation which is in direct contrast 
to that of other heavy metals of which organic derivatives are documented 
eg. lead, mecury and antimony.
Despite the above general conclusion, it is noteworthy that this study 
has identified a compound (Table 2A3.4, di-n-butylchlorotin malate) 
which has a bacteriostatic activity, similar to that of n-tributyltin 
oxide (30ppm) in commercial use. It affects yeast at 30ppm which 
is half the concentration of any other compound studied here, but 
still six times that recorded for n-tributyltin oxide under similar 
conditions. Unlike n-tributyltin oxide, the compound has the same 
activity independent of the mode of growth, whereas most n-alkyltins 
show a 5  - 1 0  fold difference in active concentration between oxidative 
and fermentative growth conditions. The presence of the malate function 
in general, appears to affect the toxicity pattern as observed in
2  > 2
TABLE 1
P r o d u c t s
D22 P27 E . c o l i B . s u b t i l t s . .
(B u A c )  S n Ox Fm Ox Fm Ox Fm Ox Fm
1 ..
SCK-CKOHCKpOPh 1 25 125 250  1 2 5 -2 5 0 250 2 5 0 - 50C 1 2 5 - 2 5 C 5 0 0
2 •
C0 2 CH=CKCC2C H . 1 C CO 2 5 0 1 0 0 0  500 50c 1 0 0 0 5 c : - i c c c 1CCC
3 .
aft
1 25 250 250  5CC 10CC > 1 0 0 0 1 0 C0 > 1 0 0 0
I o
TABLE 2
P r o d u c t s
2iJ.)
(Bu A c ) 2  Sn R 2
D22
Ox Fn
D27
Ox Fm
5 . c o l l  
Ox Fm
B . s u b t i l i s  
Cx Fm
1 .
S -  CH2  
I
S -  C H -C H 20H ‘ l a 7 167
S -  C -C H o - O -F h  
I *
S -  C
?5 0
Id ?  375 ! 750  7 5 0
250
; i
1 2 5  1 C C 0  ! 2 5 0  1 0 0 0  2 ^ 0  5 0 c
750  7 5 0
2 5 c  2 5 0
( o >
S C 2 He
50 c > 5 0 0  ! > i c c c  > i o c g  ; > 5 0 0  > 5 0 0  2 5 0  50c
5 .-
=s 50 c >500 500 >500 | > 5 0 0  > 5 0 0  > 5 0 0  >500
TABLE 2 (Cont'd)
6 .
SCH2CO2CH3 5OO
¡
25O 2 5 0
1
1
2 5 0 3 0 -6 0
i
3 0 -6 0 1 2 5 -2 5 0 2 5 0
7 .
SCH2CH2CC2 125 125 2 5 0 5CC 10CC 5CG 1 0 0 0 1000
6 .
s - c - o  ^ h 9 25C >1000 500 '»lOOO 10CC 500 10CC 10CC
9 .  Hj
s c :-:2 c c 2 c h 2-  c - c^ 25c c,c t 2 5C "CO 2 CC CCC 2 CC 50 c
c 2 h 5
1
1
1C .
j
SCH2 C02 CH2 CH2 0ClfH9 375 750 1 75c
J
137 ’ 375
1
^50 3 7 5 375
l i * 500 >1 0 CC
1
11 5 CC>1 CCC > 1000 >1000 TiCCC > 1 0 0 0
SC H o-C -O C K -C H O -C -C H
2 Ö t
2 SK2
i
1
j
1
1 2 .
Cl
2 5C 25c
1
10CC 5CO 5C0 50c
1
1 2 5 c
1
2 5 0
TABLE 2 (cont'd)
2 0 5
1 3 .
0 -C -C H =C H -g -O C H -
IV.
/CI
v C-C-CH«CE-g-OCH 3
1 5 .
,C1
‘ C -  C -  CH=CH -  C-OCI4.H9
i c
2 5 0  2 5 0
5 C0  1 2 5
500 50C 2 5 0  500
1 0 0 0  2 5 0
! !
I 250 25C 1 CC0  250
500  5CC
5C0 5cc
25C 500
2 5 0  250
25C 250
TA B LE 3
P r o d u c t s
D22 D27 E . c o l l B . s u b t l l i s
(B u A c )^  S n  R Ox Fra Ox Fm Ox Fm Ox Fm
1 .
P t V  2 " 187 93 187 650 750 375 375 375
2 .
0 -g -C H 2 -S K 187 375 187 375 375 750 375 750
3 CH3 ' V o T 1'oo2.o-o-lOj,ci 750 1 5 0 0 1 5C0 1 5 0 0 750 1 5 0 0 1 5 0 0 1 5 C0
w.
H O -
CC2 ( O J
1 0 0 0 1CCC 1CC0 >1000 >1000 1 0 0 0 1 0 0 0 100 c
C02 CHOP. 2 5 0 1 2 5 250 500 500 2 5 0 250 500
6 .
3 = 0 , - 0
750 375 1 5 0 0 375 1 5 0 0 1 5 0 0 1 5 0 0 1 5 0 0

TABLE 5
Prpav.cts
C l D 2 2 D27 E . c o l i B j s u b t i l i s
1
B u ^ S n -R Ox Fra Ox Pm Ox Fm
* •
Ox F a
1.
s - ( c h 2 ) 1 1 - c k 3 500 10 0 0 10 0 0 1 0 0 0 1 0 0 0 500 1 0 0 0 500
2 .
SC H 2 C0 2 CK2 CKClfK9
c 2 h 5
375 1 5 0 0 750 1 5 0 0 7 5 0 750 750 750
3 .
0 - C - ( C H 2 ) 1 0 -C H 3
c
500 1 0 0 0 500 1 0 0 0 1 0 0 0 500 1C 0 C 500
»f.
0 - C - C H = C H - C -0 - C H ,  
M II 3 
0 0
3 0 -6 0 30 60 3 0 -6 0 2 5 - 5 0 2 5 - 5 0 2 5 - 5 0 25-50
5 .
0 —C —C u —C u C —0 —S n —Bu^ 
II K K ll 1 * 
0  0  C l
60 60 250 250 6 0 - 1 2 5 3 0 -6 0 3 0 -6 0 3 0 -6 0
6. Rx (C8 -C1 2 )
C-C-C-Rp 
II '
0  a 3
60 30 250 250 60-125 60-125 3 0 -6 0 60-125

2 i 0
Tables 2A4 and 5. The structure activity relationship of the malate 
substitution may only be speculated upon at this time. As malate 
is a well characterised metabolite, it may provide a recognisable 
group for cell transport, although upon entry, its mode of action 
is certainly more diverse than n-alkyltins; as the cells' mode of 
growth (oxidative or fermentative) has no impact on the substituted 
compound's activity. Preliminary results suggest that similar to n- 
alkyltins, n-dibutylchlorotin malate will inhibit energy linked functions 
in vitro, but other effects are also expected.
Electron Micrographic Evidence for the Macro Action of Triorganotins 
Aerobic cultures of the yeast Saccharomyces cerevisiae (D27) have 
been subjected to increasing concentrations of n-tributyltin oxide 
(both lethal and sublethal) and the cell surface of these specimens 
observed by scanning electron microscopy.
The experimental cells were grown to exponential phase under oxidative 
conditions, before treatment with n-tributyltin oxide, then incubated 
for a further 4 hours before the samples were diluted and plated to 
assess cell viability. The remaining cells were pelleted in a bench 
centrifuge (2 k x g) and resuspended in 25% glutaldehyde for 30 seconds 
fixation. The cells were then washed 3 times in sterile distilled 
water before the samples were mixed with acetone and fixed to sample 
stages. The specimens were then gold shadowed for 30 seconds, before 
inspection under the scanning electron microscope.
Presented overleaf are a series of electronmicrographs produced using 
the above protocol.
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Figure 2A.i
A. Control Cells in the Absence of Tributyltin Oxide 
Legend:
The control cells opposite show healthy yeast cells demonstrating 
budding (centre right) and the residual bud scars of the parent (centre). 
One cell in view shows a crumpled effect which is presumed to be 
a deformation due to fixation.
B. Cells Treated with 3ppm of Tributyltin Oxide
Legend:
The cells opposite display swelling and a certain degree of cell 
breakage. Cell leakage is visible in the centre of the electron- 
micrograph. Samples of these cells taken prior to fixation showed 
55% viability compared with the control samples.
C. Cells Treated with 5ppm of Tributyltin Oxide
Legend:
The cell pictured in Figure 2A.iC has completely ruptured due to 
swelling. It has swollen to some 4 or 5 times the size of the healthy
cells and the cell surface also appears to be severely disrupted. 
Cells subjected to these conditions are only some 5% viable and further 
lethality is envisaged with prolonged exposure.
In general, cells exposed to trialkyl tin appear to undergo gross 
swelling before cell breakage and ultimately, cell death.
LFigure 2 h .j_
A. Control Cells in the Absence of Tributyltin Oxide
Legend:
The control cells opposite show healthy yeast cells demonstrating 
budding (centre right) and the residual bud scars of the parent (centre'. 
One cell in view shows a crumpled effect which is presumed to be
a deformation due to fixation.
B. Cells Treated with ¿ppm J  Tributyltin ( xide
Legend:
The cells opposite display swelling and a certain degree of cell 
breakage. Cell leakage is visible in the centre of the electron- 
micrograph. Samples of these cells taken prior to fixation shewed
•35 viability compared with the cont-'ol samples.
C. Cells Treated with 5ppm jaf Tributyltin Oxide 
Legend:
"he cell pictured in Figure LA.iC has completely ruptured due to 
swelling. It has swollen to some A or 5 times the size of the healthy 
cells and the cell surface also appears to be severely disrupted. 
Cells subjected to these conditions are only some 5 viable and further 
lethality is envisaged with prolonged exposure.
In general, cells exposed to trialkyltin appear to undergo gr ;ss 
swelling before cell breakage and ultimately, cell death.
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